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ABSTRACT 
 
Survival analysis today is widely implemented in the fields of medical and biological 
sciences, social sciences, econometrics, and engineering. The basic principle behind the survival 
analysis implies to a statistical approach designed to take into account the amount of time 
utilized for a study period, or the study of time between entry into observation and a subsequent 
event. The event of interest pertains to death and the analysis consists of following the subject 
until death. Events or outcomes are defined by a transition from one discrete state to another at 
an instantaneous moment in time. In the recent years, research in the area of survival analysis has 
increased greatly because of its large usage in areas related to biosciences and the pharmaceutical 
studies. After identifying the probability density function that best characterizes the tumors and 
survival times of breast cancer women, one purpose of this research is to compare the efficiency 
between competing estimators of the survival function. Our study includes evaluation of 
parametric, semi-parametric and nonparametric analysis of probability survival models. 
Artificial Neural Networks (ANNs), recently applied to a number of clinical, business, 
forecasting, time series prediction, and other applications, are computational systems consisting 
of artificial neurons called nodes arranged in different layers with interconnecting links. The 
main interest in neural networks comes from their ability to approximate complex nonlinear 
functions. Among the available wide range of neural networks, most research is concentrated 
around feed forward neural networks called Multi-layer perceptrons (MLPs). One of the 
 xiii 
 
important components of an artificial neural network (ANN) is the activation function. This work 
discusses properties of activation functions in multilayer neural networks applied to breast cancer 
stage classification. There are a number of common activation functions in use with ANNs. The 
main objective in this work is to compare and analyze the performance of MLPs which has back-
propagation algorithm using various activation functions for the neurons of hidden and output 
layers to evaluate their performance on the stage classification of breast cancer data. 
Survival analysis can be considered a classification problem in which the application of 
machine-learning methods is appropriate. By establishing meaningful intervals of time according 
to a particular situation, survival analysis can easily be seen as a classification problem. Survival 
analysis methods deals with waiting time, i.e. time till occurrence of an event. Commonly used 
method to classify this sort of data is logistic regression. Sometimes, the underlying assumptions 
of the model are not true. In model building, choosing an appropriate model depends on 
complexity and the characteristics of the data that affect the appropriateness of the model. Two 
such strategies, which are used nowadays frequently, are artificial neural network (ANN) and 
decision trees (DT), which needs a minimal assumption. DT and ANNs are widely used 
methodological tools based on nonlinear models. They provide a better prediction and 
classification results than the traditional methodologies such as logistic regression. This study 
aimed to compare predictions of the ANN, DT and logistic models by breast cancer survival. In 
this work our goal is to design models using both artificial neural networks and logistic 
regression that can precisely predict the output (survival) of breast cancer patients. Finally we 
compare the performances of these models using receiver operating characteristic (ROC) 
analysis. 
 1 
 
 
CHAPTER ONE  
Introduction 
1.1 Cancer 
In modern medicine, the term tumor means a neoplasm (from Ancient 
Greek νεο- neo- "new" and πλάσμα plasma “formation, creation” in field medicine) is an 
abnormal mass of tissue as a result of uncontrolled growth or division of cells. Some neoplasms 
do not cause a lump or form an additional tissue. They are called benign. Cancer is 
a malignant neoplasm or malignant tumor. This malignant neoplasm or tumor is the largest cause 
for death in United States Cancer. Cancer is not a new disease from the present generation, it has 
been documented and recorded on a papyrus from ancient Egypt, in 1500 B.C. This oldest 
document has details that were recorded on a papyrus, documenting 8 cases of tumors occurring 
on the breast. Further descriptions can be found in ancient writings of Chinese and Arabic 
literature.  
As mentioned earlier, cancer is a condition of abnormal and rapid cell destruction inside 
the tissues making a mass of extra tissues which is known as tumor. The cancer disease is 
majorly classified into two types based on the tissue or tumor growth. Benign and malignant. 
Unlike benign tumors which are assumed not harmful, malignant tumors are formed by jumping 
of cancer cells to other parts of the body. Scientists have stated the reason behind formation of 
such condition is due to adhesion property of the cancer causing cells which is stated as the 
metastasis. The major types of cancers are breast cancer (in women), leukemia (in children), 
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prostate cancer (in men) and colon cancer. Our present dissertation deals with the subject of 
breast cancer in women with condition of malignancy. Table 1.1 below gives a brief statistics of 
estimated deaths of different types of cancers observed in women during 2013 (Source: 
American Cancer Society). 
 Table 1.1:  Summary of major cancers in women 
 
 
 
 
 
 
 
 
1.2 Breast Cancer 
Breast has been considered as a symbol of femininity, fertility and beauty. Breast disease 
has been known to mankind since old times. Due to the unmistakable side effects particularly at 
later stages, the bumps that advance into tumors have been recorded by doctors promptly in time. 
Unlike other inside malignancies, bosom bumps have a tendency to show themselves as 
noticeable tumors. 
Different types of cancers in 
women 
Percentages 
Lung & Bronchus 72,220 (26%) 
Breast 39,620 (14%) 
Colon & Rectum 24,530 (9%) 
Pancreas 18,980 (7%) 
Ovary 14,030 (5%) 
Non-Hodgkin Lymphoma 8,430 (3%) 
Leukemia 10,060 (4%) 
Uterine corpus 8,190 (3%) 
Liver & intrahepatic bile duct 6,780 (2%) 
Brain/Other nervous systems 6,150 (2%) 
All sites 273,430 (100%) 
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Breast cancer is the most common effecting disease in women and second most cause of 
death for women in United States. It is the cancer that starts in the tissues of the breast with 
uncontrolled multiplicity affects other parts of the body causing death. There are certain cases of 
breast cancer observed in men, but it accounts for less than 0.05% of all the cases diagnosed. 
Breast cancer is classified into two main types: 
 Ductal carcinoma: starts in the tubes (ducts) that move milk from the breast to the 
nipple. Most of the cases fall under this breast cancer.  
 Lobular carcinoma: starts in parts of the breast, called lobules that produce milk.  
In very rare cases, breast cancer can start in other areas of the breast. According to 
American Cancer Society (ACS), even at the age of 85 one in eight women are diagnosed with 
breast cancer. In 2013, an estimated 232,340 new cases of invasive breast cancer are expected to 
be diagnosed among the women, and about 2240 new cases are expected in men. In addition to 
this facts, 64,640 new cases of the in situ breast cancer are expected in the women; of which 85% 
approximately fall into category of ductal carcinoma. One good thing about breast cancer is that 
it can be treated if it is detected in early stages. The most common outward signs of detection are 
formation of lumps, or nipple tenderness or thickening of area near the breasts or a dimple in the 
breast. Less commonly observed signs include breast swelling and enlarged underarm area.  The 
important risk factors include gender, age, family history, early menarche, late menopause, 
physical inactivity, alcohol consumption, among many others. Other clinical factors for increase 
in risk are high bone mineral density, biopsy confirmed hyperplasia, high dose radiation to the 
chest, long menstrual history etc.  
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1.3 Survival Analysis 
Survival analysis today is implemented in almost all fields of sciences. An analysis which 
is performed to determine the probability of occurrence of the events associated with death or 
failure after treatment to the subjects is termed as survival analysis. This classification is 
applicable with help of machine- learning methods that evolve categorical results with 
predetermined time intervals. Survival analysis of breast cancer has acquired good importance 
for cancer detection in early stages taking into consideration risk factors. Different kinds of 
survival studies in present day include clinical trials, prospective cohort studies, retrospective 
cohort studies and retrospective correlative studies. Survival analysis deals with time to event 
modeling data with censoring.  Censoring is mechanism of identification of the data values 
which do not follow up until end of the experiment. In many cases data considered for survival 
analysis are right censored which implies that the concerned subjects leaves the study before the 
event has occurred or study ends before the event has occurred. The primary interest is to 
investigate the time to event or the survival probability. The statistical methods employed in 
study of survival and hazard probability can be performed parametrically, semi-parametrically 
and non-parametrically based on the nature of the data. 
1.3.1 Non-Parametric, Parametric and Semi-parametric Analyses 
Non-parametric survival analysis is used to analyze the data avoiding assumptions for the 
underlying distributions. This kind of analysis restricts the data from occurrence of potential 
errors. One of the commonly used non-parametric estimator is Kaplan-Meier estimator also 
called as product limit estimator. The plots of product limit estimator is a graph with declining 
steps. At times censoring data predicts more accurate results with product limit estimator. 
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Parametric survival analysis assumes functional form of probability distribution for the 
variables that provides the influence of explanatory variables on survival time. The strength of 
this analysis is the estimation is relatively easy and survival curves are smoother as they draw 
information from whole data. This parametric analysis is carried out using two different 
approaches which are regression parametric models (Accelerated Failure Time models) and 
Proportional Hazard (PH models). The name ‘accelerated life’ is extracted from the industrial 
applications where the items are subjected to worse conditions than the item usually encounter in 
real life, so that the experiment is completed in short period of time. Acceleration Failure models 
are usually applied to the log of the survival time. Different AFT models are generated by 
assuming different distributions to error term of expression. Estimation of such models using the 
maximum likelihood is computed for the censored data. 
The intermediate model between above two analyses is semi-parametric survival analysis 
or Cox-regression analysis. It overcomes the disadvantage of the non-parametric analysis of 
comparing the survival functions for limited number of groups. Cox regression models or PH 
models are used for the survival time estimation making assumptions to hazard function in the 
formula. Distribution for the baseline hazard are assumed to follow exponential, Weibull, log-
normal, log-logistic or generalized gamma. Even though cox models have driven statistical 
innovations in past decades, there is more to come in future.  
1.4 Logistic Regression 
Logistic regression is mostly used to predict a categorical (usually dichotomous) variable 
from a given set of independent variables.  If all the independent variables are continuous, we 
usually employ discriminant analysis for modeling the data. In case if all or few independent 
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variables are categorical, logistic regression analysis is the best choice. Also on the other hand, 
logistic regression makes no assumptions about the distributions of the independent 
variables.  One of the most commonly used tools of medical and clinical applied statistics and 
discrete data analysis is logistic regression. It is put forward around 1940’s against the Fisher’s 
1936 classification method and considered as center part of many research studies.  Logistic 
regression also finds applications in the fields of engineering, opinion polls, marketing etc. 
In logistic regression, the predicted dependent variable is a function of the probability 
that a particular subject will be in one of the categories (two categories in case of dichotomous 
dependent variable). In other words, logistic regression is used to predict the probability that the 
'event of interest' will occur as a function of one (or more) discrete/continuous and/or 
dichotomous independent variables (either 0 or 1). For example identifying the relationship 
between a binary outcome (dependent) variable such as presence or absence of disease when we 
are given with predictor (explanatory or independent) variables such as patient demographics or 
imaging findings. The important difference between what is being estimated by a logistic 
regression model and that estimated by a linear model is that linear regression attempts to predict 
the value of the dependent variable as a linear function of one or more independent variables. 
Whereas logistic regression attempts to predict the probability that a unit under analysis will 
acquire the event of interest as a function of one or more independent variables.  
1.5 Artificial Neural Networks 
The implementation of artificial neural networks (ANNs) in the field of survivability is 
suggested to address the limitations of traditional regression methods. ANNs are algorithms 
which are patterned after the structure of human brain. They possess series of mathematical 
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equations and terms to simulate the biological process such as learning and memory. Neural 
networks offers the ability to detect the complex nonlinear relationships between dependent and 
independent variables. ANNs find applications in the fields of social sciences, clinical studies,  
Financial models, altitudes in educational sciences, social mobility, travel behavior, social capital 
among many others. A basic neural network consists of input, hidden and output layers. The 
interconnected nodes in different layers possess weights which are adjusted to find the most 
reliable outcomes by a process termed as learning or training. The most commonly used neural 
network is multilayer perceptron which consists of one input, one output and one or more hidden 
layers. The principle of MLP is to reduce the discrepancy between the real and predicted 
outcomes by propagating discrepancy in backward direction. The merits of trained ANNs is the 
capability to elevate the information present in the hidden layers without the effect of constraints 
on the data representation. Limitations of ANNs include its black box nature, greater 
computation burden, and proneness to over fitting etc. Due to its effective analysis of more 
complex data, ANNs are used to analyze non-linear covariates, time dependent covariates and 
versatility among high order covariates. Comparing to traditional regression models ANNs have 
provided better results concerning to the cancer research.  
1.5.1 ANN and Statistics 
The artificial neural network (ANNs) and literature in statistics discusses almost same 
concepts but usually with different terminology. Sometimes the same term in these both 
literatures may have a different meaning. Below in the Table 1.2 we have mentioned few of such 
terms used in both the cases. 
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1.6 Linking ANN, Logistic Regression and Survival analysis 
Survival analysis methods deals with waiting time, i.e. time till occurrence of an event. 
Commonly used method to classify this sort of data is logistic regression. However, sometimes 
the underlying assumptions of the model may not be true. In model building, choosing an 
appropriate model depends on complexity and the characteristics of the data that effect the 
appropriateness of the model. One strategy, which is used nowadays frequently, is artificial 
neural network (ANN) model which needs a minimal or no assumptions. My current research is 
aimed to compare survival models and predictions of the ANN models for stage classification, 
survival and logistic modeling for breast cancer survival.  
Table 1.2: ANN and Statistical jargon 
 
 
  
 
 
 
 
 
 
 
Neural networks Statistics 
Architecture Model 
Inputs 
Independent (predictor) 
variable 
Outputs 
Dependent (outcome) variable, 
predicted value 
Connection weights Regression coefficients 
Bias weight Intercept parameter 
Error Residuals 
Supervised learning 
Regression, discriminant 
analysis 
Unsupervised 
learning 
PCA, Data reduction, 
Clustering 
Training set Sample data 
Testing set Hold-out data 
Learning, training Parameter estimation, fitting 
Training case, pattern Observation 
Cross-entropy 
Maximum likelihood 
estimation 
Classification Discriminant analysis 
Activation function Inverse link function in GLIM 
Epoch Iteration 
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CHAPTER TWO  
Parametric Analysis of Breast Cancer Tumor Sizes 
 
2.1 Introduction 
Any cancer that grows in our body is always dangerous. If it exists one must try to locate 
and get it out of our body immediately. Breast cancer is a signature disease of Western 
populations. Breast cancer is a cancer that starts in the tissues of the breast. There are two main 
types of breast cancer. Ductal carcinoma starts in the tubes (ducts) that move milk from the 
breast to the nipple. Most breast cancers are of this type. Lobular carcinoma starts in parts of the 
breast, called lobules that produce milk (1 –3). In very rare cases, breast cancer can start in other 
areas of the breast. The three most important things that we can do to find a growth in the breast 
that may become malignant are: regularly scheduled mammograms, annual clinical breast exams 
with your health practitioner, and monthly breast self-examination (4). 
 
2.2 Facts and Numbers 
Cancer is a major cause of morbidity in the United States, with a total of 1.34 million 
cases reported during 2005 from 49 of the 50 states (5). According to American Cancer Society 
(ACS), about 1 in 8 women in the United States (12%) will develop invasive breast cancer over 
the course of her lifetime (6). In 2016, an estimated 246,660 new cases of invasive breast 
cancer (includes new cases of primary breast cancer among survivors, but not recurrence of 
original breast cancer among survivors) are expected to be diagnosed in women in the U.S., 
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along with 61,000 new cases of non-invasive (in situ) breast cancer and an estimated deaths due 
to breast cancer would be around 40,450 (6, 7). 
About 2,600 new cases of invasive breast cancer were expected to be diagnosed in men in 
2016. Less than 1% of all new breast cancer cases occur in men. For women in the U.S., breast 
cancer death rates are higher than those for any other cancer, besides lung cancer. Also besides 
skin cancer, breast cancer is the most commonly diagnosed cancer among U.S. women. More 
than 1 in 4 cancers in women (about 28%) are effected with breast cancer.  
2.3 Questions of Interest 
Q1: What is the probability distribution function (PDF) that best characterizes the 
behavior of malignant tumors for Whites, African Americans and other races? 
Q2: Is there any statistical difference between mean tumor sizes between the three races 
(Whites, African Americans and Others) in the study? 
Q3: Is there any statistical difference between mean tumor sizes of any two races? 
Q4: If a lady feels a tumor while self-examining, what is the confidence interval 
estimation for the average tumor size based on her race? 
2.4 Data Description 
The Surveillance, Epidemiology, and End Results (SEER)-Medicare database links data 
from the National Cancer Institute’s SEER cancer registry program with claims data from 
Medicare, the federally funded insurance program for the US elderly. These data are made 
available to investigators and have been used extensively in research (details at 
http://healthservices.cancer.gov/seermedicare/). This resource is valuable for conducting research 
on cancers. (8-14) 
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SEER is a National Cancer Institute-funded program collecting data on cancer incidence 
and survival from US cancer registries (http://www.seer.cancer.gov). SEER began in 1973 with 9 
state and metropolitan area cancer registries. Successive expansions in 1992 and 2001 led to the 
inclusion in SEER of 17 cancer registries that presently cover approximately 26%of the US 
population. In total, 146 million person-years are covered during 1973–2007, with 3.1 million 
incident cancers on the basis of a positive or negative test. The US National Cancer Institute’s 
Surveillance, Epidemiology, and End Results (SEER) program began collecting the data for 
many cancers in almost 17 registries.  
We obtained breast cancer incidence data from the US National Cancer Institute’s SEER 
program. We used patient and population data from the SEER 9 Registries Database (15, 16) the 
information that we have used in this present study is obtained from SEER database registry. 
This data source SEER (16) (Surveillance Epidemiology and End Results), which is a unique, 
reliable and essential resource for investigating the different aspects of cancer. The SEER 
database combines patient-level information on cancer site, tumor pathology, stage, and cause of 
death (3, 4). 
 In this work, we preprocessed the SEER data (period of 1992-2008 with all records 
named in breast.txt) for breast cancer to remove redundancies and missing information. The 
resulting data set had 47,167 malignant tumor records, which then pre-classified into three 
groups of races. “Whites” (37,341; 79.15%), “African American” (4,234; 9%) and “Others” 
(5,592; 11.85%) are given in Table 2.1.  
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Table 2.1 Race and age details 
Race N Percent 
Minimum 
age 
Median age 
Maximum 
age 
1 37341 79.17 21 62 102 
2 4234 8.98 22 57 102 
3 5592 11.86 21 53 99 
 
In this work, demographic information included age, race, and marital status. Tumor 
characteristics like tumor size (1mm to 998mm), stage of cancer (I, II, III, IV), tumor grade (1, 2, 
3, 4, or unknown), and tumor treatment (1, 2, 3, 4) are included.  
From Table 2.1, median age at diagnosis in the White women is 62 years (range 21 to 
102 years) compared with a median age of 57 years in the African American women (range 22 to 
102 years) and a median age of 53 years in the Other races women (range 21 to 99 years). There 
are 62.15% survival and 37.35% of not survived patients in our data (Table 2.2) and from Table 
2.3, majority of patients (about 92%) are diagnosed when they are in stages 1 and 2 and very few 
(about 8%) of them are diagnosed in advanced stage of breast cancer. 
 
Table 2.2 Survival status details 
Status Frequency Percent 
Cumulative 
percent 
Dead (0) 17853 37.85 37.85 
Survived (1) 29314 62.15 100.00 
 
Table 2.3 Breast cancer stage wise details 
Stage Frequency Percent 
Cumulative 
percent 
1 23345 49.49 49.49 
2 20017 42.44 91.93 
3 2600 5.51 97.45 
4 1205 2.55 100.00 
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Figure 2.1 Race wise tumor classification chart 
 
2.5 Parametric Analysis of tumor size 
Most clinical research involves the collection of some form of quantitative data. The 
purpose of collecting data is to obtain information that will allow one to infer or draw 
conclusions about the specific characteristics of a certain large group of subjects or events based 
on the observation of a few (17 - 20).To select the proper statistical test it is important to know 
how the data are distributed. The word parametric, or parameter, relates to the nature of data, i.e., 
the assumptions about particular data. The primary assumptions are that the data points are 
randomly drawn, that the population is normally distributed and that there is homogeneity among 
variances. Parametric tests are more stringent than nonparametric tests, and the results tend to be 
more powerful. 
In our work we performed parametric analysis to determine the best fitted distribution 
that characterizes the behavior of tumor size for each race by setting the hypothesis as follows: 
𝐻0: 𝑇ℎ𝑒 𝑡𝑢𝑚𝑜𝑟 𝑠𝑖𝑧𝑒 𝑑𝑎𝑡𝑎 𝑓𝑜𝑙𝑙𝑜𝑤𝑒𝑑 𝑎 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝑝𝑎𝑟𝑎𝑚𝑒𝑡𝑟𝑖𝑐 𝑚𝑜𝑑𝑒𝑙  
𝐻1: 𝑇ℎ𝑒 𝑡𝑢𝑚𝑜𝑟 𝑠𝑖𝑧𝑒 𝑑𝑎𝑡𝑎 𝑑𝑖𝑑 𝑛𝑜𝑡 𝑓𝑜𝑙𝑙𝑜𝑤 𝑎 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝑝𝑎𝑟𝑎𝑚𝑒𝑡𝑟𝑖𝑐 𝑚𝑜𝑑𝑒𝑙 
Total Malignant 
Tumors 
Men Women 
Race = Whites (79%) 
Race = African Americans (9%) 
Race = Others (12%) 
Stop 
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After performing many trials, from the class of many parametric distributions, based on 
the results of minimum Anderson-Darling value, we identified that Inverse Gaussian distribution 
as the best probabilistic distribution function that characterizes the behavior of the malignant 
tumors for all the three races considered in this study. 
 
2.5.1 Inverse Gaussian distribution 
Over a century, family of Inverse Gaussian distributions had attracted the attention of 
many researchers in many fields (21). When the data possess some extreme values in it, we need 
a distribution that can take all the values into consideration, one such is Inverse Gaussian 
distribution. This is also known as Inverse normal distribution or Wald distribution. Inverse 
Gaussian distribution is 2-parameter family of continuous probability functions with support on 
(0, ∞). This distribution is derived while observing the Brownian motion i.e., random movements 
of atoms and molecules by Schrodinger in 1915 (23).   
The Hazard rate function of Inverse Gaussian distribution is uni-modal which increases 
from zero to its maximum value and decreases asymptotically to a constant. The most 
differentiating fact is extreme values of outcomes can occur with almost all outcomes being 
small. It is a right-skewed distribution with long tail. For these reasons Inverse Gaussian 
distribution is often used in reliability and survival analysis. Various insurance problems and 
stock markets follow this distribution (22).  
The distribution is described by two parameters. Mean or location (µ >  0) and precision 
or shape (λ > 0). Let us suppose x1, x2, x3… xn be n independent and random variables. If xi 
follows the inverse Gaussian distribution, then probability density function of𝑥𝑖~ 𝐼𝐺 (µ, 𝜆) is 
𝑓(𝑥, 𝜃) = (
𝜆
2𝜋𝑥3
)
1
2
𝑒𝑥𝑝 {−
𝜆(𝑥 − 𝜇)2
2𝜇2𝑥
} , 𝑥 ≥ 0;  𝜃 = (𝜇, 𝜆)𝑇 
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The expected value is given by mean µ and variance is equal to
𝜇3
𝜆
. The cumulative distribution 
function is given by 
𝐹(𝑦) = 𝜙(𝑦) + exp (
2𝜆
𝜇
) (−√
4𝜆
𝜇
+ 𝑦2) ; −∞ < 𝑦 < ∞ 
W is the standard normal distribution function. Clearly, as
𝜆
𝜇
→ ∞, 𝐹(𝑦) → 𝜙(𝑦). The 
confidence interval for true mean of this distribution is given by ?̂? ± 𝑧𝛼
2⁄
(𝑛𝜆)−1 2⁄ ?̂?3 2⁄  
 
2.5.2 PDF for White women 
 
Figure 2.2 PDF for white women: Inverse Gaussian Distribution 
The fitted PDF and CDF of tumor sizes for white race women is  
 
𝑓(𝑥, 𝜃) = (
43.93
2𝜋𝑥3
)
1
2
𝑒𝑥𝑝 {−
43.93(𝑥 − 32.76)2
2(32.76)2𝑥
} , 𝑥 ≥ 0; 
 
𝐹(𝑦) = 𝜙(𝑦) + exp(2.682) (−√5.36 + 𝑦2) 
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Figure 2.3 Inverse Gaussian CDF for White Women 
 
Figure 2.4 Inverse Gaussian PP Plot for White Women 
 
Figure 2.2 is the fitted Inverse Gaussian PDF with estimated shape and location 
parameters as 43.933 and 32.756 respectively. From Figure 2.3 the CDF graph explains how well 
the distribution fit to data and the PP plot in Figure 2.4 is approximately linear and confirms 
about the fitted distribution. 
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2.5.3 PDF for African American women 
Figure 2.5 below is the fitted Inverse Gaussian PDF for AA women with estimated shape 
and location parameters as 66.614 and 39.611 respectively. From Figure 2.6 the CDF graph 
explains how well the distribution fits to data and the PP plot in Figure2.7 is approximately 
linear and confirms about the fitted distribution. 
 
 
Figure 2.5 PDF for African American Women: Inverse Gaussian distribution 
 
The fitted PDF and CDF of tumor sizes for African American race women is  
 
𝑓(𝑥, 𝜃) = (
66.61
2𝜋𝑥3
)
1
2
𝑒𝑥𝑝 {−
66.61(𝑥 − 39.61)2
2(39.61)2𝑥
} , 𝑥 ≥ 0; 
 
𝐹(𝑦) = 𝜙(𝑦) + exp(3.363) (−√6.73 + 𝑦2) 
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Figure 2.6 Inverse Gaussian CDF for African American Women 
 
Figure 2.7 Inverse Gaussian PP Plot for African American Women 
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2.5.4 PDF for Other Races 
Figure 2.8 below is the fitted Inverse Gaussian PDF for other race women with estimated shape 
and location parameters as 55.703 and 36.846 respectively. From Figure 2.9 the CDF graph 
explains how well the distribution fit to data. The fitted PDF and CDF of tumor sizes for other 
race women is  
𝑓(𝑥, 𝜃) = (
55.70
2𝜋𝑥3
)
1
2
𝑒𝑥𝑝 {−
55.70(𝑥 − 36.85)2
2(36.85)2𝑥
} , 𝑥 ≥ 0; 
𝐹(𝑦) = 𝜙(𝑦) + exp(3.02) (−√6.05 + 𝑦2) 
 
 
 
Figure 2.8 PDF for Other races: Inverse Gaussian Distribution 
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Figure 2.9 Inverse Gaussian CDF for Other race women 
 
2.5.5 Summary of PDF’s 
 
Table 2.4 PDF summary for three races 
RACE ?̂? ?̂? 
White 43.933 32.756 
African American 66.614 39.611 
Others 55.703 36.846 
 
 
Table 2.5 has the race wise details of 95% and 99% confidence interval estimation of true 
mean tumor size based on Inverse Gaussian distribution. After identifying the distribution 
functions that best characterizes the probability distribution of malignant tumors for the three 
races, we proceed to compare the differences of mean tumor sizes for the three races. 
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Table 2.5 The mean tumor size and confidence intervals of all the three races 
Race ?̂? ?̂? SD 95% CI for 𝝁 99% CI for 𝝁 
1 32.756 43.933 28.284 (32.47, 33.04) (32.38, 33.13) 
2 39.611 66.614 30.545 (38.69, 40.53) (38.40, 40.82) 
3 36.846 55.703 29.967 (36.06, 37.63) (35.81, 37.88) 
 
2.6 Comparison of mean tumor sizes 
Let 𝜇𝑤, 𝜇𝑎𝑎, 𝑎𝑛𝑑 𝜇𝑜𝑡ℎ represent mean tumor sizes of whites, African Americans and other 
races respectively. Our interest is to test the hypothesis whether all the three races have same 
mean tumor size or otherwise. 
𝐻0: 𝜇𝑤   = 𝜇𝑎𝑎  = 𝜇𝑜𝑡ℎ 𝑣𝑠. 𝐻1:  𝐴𝑡 𝑙𝑒𝑎𝑠𝑡 𝑜𝑛𝑒 𝑜𝑓 𝑡ℎ𝑒𝑚 𝑖𝑠 𝑛𝑜𝑡 𝑒𝑞𝑢𝑎𝑙. 
By performing a one way ANOVA at 5% level of significance, we obtained the p-value 
which is very low(p < 0.0001); leading us to the conclusion that there is significant difference 
between the average tumor sizes of all the three races. So, we now proceed in pair wise testing of 
mean tumor sizes for all three races. The Table2.6 below has the details of the results after 
performing t-test for pair wise testing. Clearly, we conclude that the average tumor size is 
significantly different for all the three races in this study. 
  
Table 2.6 Pair wise comparison of mean tumor sizes 
HNull HAlternative P-value Conclusion 
95% CI for mean 
differences 
𝜇𝑤   = 𝜇𝑎𝑎 𝜇𝑤not equals 𝜇𝑎𝑎 0.001 Reject Null (8.107, 8.659) 
𝜇𝑎𝑎   = 𝜇𝑜𝑡ℎ 𝜇𝑎𝑎not equals 𝜇𝑜𝑡ℎ 0.0001 Reject Null (-10.191, -7.760) 
𝜇𝑤   = 𝜇𝑜𝑡ℎ 𝜇𝑤not equals 𝜇𝑜𝑡ℎ 0.0002 Reject Null (-18.547, -16.171) 
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Previous studies (24 - 26) have shown that breast cancer in these younger women is more 
aggressive, with higher rate of occurrence and recurrence rates compared with older women. In 
our study we have the median age of women for all the three races more than 50 years. In Table 
2.7, we classified the tumor stage taking age group into consideration. The majority of women 
are in the ages from 45 to 79. From Table 2.8 and Figure 2.11, African American women are the 
majority of population in all the age groups who are diagnosed with breast cancer. Table 2.8 
gives the age group wise confidence interval for mean tumor size for all the three races. Very 
interestingly, from Figure 2.10 majority of women in younger ages (20 – 44 years) are identified 
with stage-2 breast cancer.  
Table 2.7 Age group Vs. Stage classification 
AGE Stage 1 Stage 2 Stage  3 Stage 4 All 
 Count Row% Count Row% Count Row% Count Row% Total 
20-24 7 25.93 17 62.96 3 11.11 0 0.00 27 
25-29 67 26.59 152 60.32 25 9.92 8 3.17 252 
30-34 239 27.86 481 56.06 94 10.96 44 5.13 858 
35-39 700 34.08 1157 56.33 152 7.40 45 2.19 2054 
40-44 1456 37.89 1992 51.83 305 7.94 90 2.34 3843 
45-49 2153 41.54 2560 49.39 348 6.71 122 2.35 5183 
50-54 2561 45.78 2546 45.51 342 6.11 145 2.59 5594 
55-59 2634 50.44 2209 42.30 250 4.79 129 2.47 5222 
60-64 2723 53.92 1999 39.58 209 4.14 119 2.36 5050 
65-69 2909 56.58 1892 36.80 199 3.87 141 2.74 5141 
70-74 2997 59.35 1755 34.75 169 3.35 129 2.55 5050 
75-79 2496 58.03 1509 35.08 199 4.63 97 2.26 4301 
80-84 1526 55.49 993 36.11 143 5.20 88 3.20 2750 
85+ 877 47.61 755 40.99 162 8.79 48 2.61 1842 
All 23345 49.49 20017 42.44 2600 5.51 1205 2.55 47167 
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Figure 2.10 Stages vs. age group 
 
Table 2.8 Age group based race wise confidence interval of tumor sizes  
Age 
Group 
Race 1 Race 2 Race 3 
 Mean S.D 
C.I (95%) 
Mean S.D 
C.I (95%) 
Mean S.D 
C.I (95%) 
L.C.I U.C.I L.C.I U.C.I L.C.I U.C.I 
20-24 27.12 15.75 19.40 34.84 26.86 13.67 16.73 36.99 18.5 3.32 15.25 21.75 
25-29 33.53 74.51 22.70 44.36 56.2 162.8 3.02 109.38 54.2 167.6 -2.14 110.54 
30-34 36.24 82.99 29.51 42.97 46.8 124.2 24.94 68.66 28.55 22.25 24.99 32.11 
35-39 29.44 60.16 26.36 32.52 28.46 22 25.57 31.35 39.19 114.91 27.37 51.01 
40-44 27.79 59.2 25.58 30.00 40.23 110.44 29.35 51.11 26.84 55.2 22.74 30.94 
45-49 27.81 70.22 25.57 30.05 35.8 89.67 27.88 43.72 27.11 67.33 22.71 31.51 
50-54 25.06 62.78 23.15 26.96 36.92 95.54 28.89 44.95 24.01 38.44 21.44 26.58 
55-59 24.44 68.85 22.31 26.57 28.56 64.53 23.03 34.09 23.81 55.75 19.62 28.00 
60-64 22.20 59.49 20.36 24.04 26.27 51.07 21.63 30.91 22.21 44.1 18.58 25.84 
65-69 23.03 67.36 20.99 25.07 35.11 104.32 25.51 44.71 19.52 16.65 18.05 20.98 
70-74 20.41 53.55 18.81 22.00 30.67 78.75 22.47 38.87 29.45 101.49 19.18 39.72 
75-79 21.31 48.48 19.75 22.86 34.58 98.68 23.52 45.64 19.84 14.66 18.10 21.58 
80-84 22.65 51.02 20.62 24.68 26.81 21.21 23.79 29.83 21.89 25.49 17.49 26.29 
85+ 29.43 73.19 25.91 32.95 30.42 23.38 26.20 34.64 25.12 16.65 21.10 29.14 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Stage 1 Stage 2 Stage  3 Stage 4
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Figure 2.11 Race wise comparison of mean tumor sizes 
 
2.7 Conclusion  
The PDF for all the three races is identified as Inverse Gaussian and the details about 
mean tumor sizes along with 95% and 99% confidence intervals for mean tumor sizes for all the 
three races were tabulated in Table 2.5. One way ANOVA was performed for comparing mean 
tumor sizes of three races and at 5% level of significance, we conclude that the average tumor 
size for all the three races is statistically not the same. Later, we performed pair-wise testing 
between the races and the results are tabulated in Table 2.6. From these results we conclude that 
the average tumor sizes are significantly different for all the three races. Also compared with 
Whites and other race women, African American women have comparatively a greater mean 
tumor sizes and Whites have the least. This is also supported by the results published in Table 
2.7. Finally grouping ages into groups of 5, we also stratified the number of women diagnosed 
with breast cancer in different stages and Table 2.8 gives the race wise confidence intervals. 
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CHAPTER THREE  
Statistical Analysis on Survival times of Breast Cancer Data 
 
3.1 Introduction 
Cancer is a major cause of morbidity in the United States, with a total of 1.34 million 
cases reported in the year 2005 from 49 of the 50 states (6). Cancer incidence typically rises with 
age, and a disproportionate fraction of cases occur among the elderly. According to the statistical 
sources, today in the United States, approximately one in eight women over their lifetime have a 
risk of developing breast cancer. The statistical methods for survival analysis have been 
extracted from the biomedical and epidemiologic studies of humans and animals. Basically, 
survival analysis has its application in data evaluation on the length of time it takes for 
occurrence of a specific event of interest. The event of interest can be death of person or an 
animal or any living being or study of termination of particular equipment. One can identify the 
survival rate with a possibility of data collection related to a particular disease. From the recent 
data the survival rate of patient with breast cancer is 88% after 5 years of diagnosis and 80% 
after 10 years of diagnosis (27). 
 In his book ‘Natural and Political Observations upon the Bill of Mortality’, John Graunt's 
classified registered deaths by age, period, gender and cause of death, suggested for the first time 
that death be regarded as an event which deserves systematic study (28,29). Survival data is 
mainly concerned with time or study analysis of subject or event of interest. This data may also 
contain subjects which have not experienced its effect over a time or complete study of 
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analyticity.  For instance, some patients may still be alive at the end of a study period. For these 
subjects, the exact survival times are unknown. This scenario can also be exhibited when the 
individuals do not follow-up after certain medical attention after a period of study. This would be 
beyond the practical limits to wait until every subject has died before conducting any analysis 
which is an intrinsic characteristic of survival data. This pattern of behavior cannot be validated 
to military and defense officers. Their survival time is usually estimated as the length of survival 
time at the time of leaving service and becoming the reserve. The officers that are still active at 
end of the study period are treated as censored observations. Further studies like data collection, 
evaluation and results related to objective are discussed in following sections. 
3.2 Questions of Interest 
Q1: Is there a significant difference in the average survival time between the three races? 
Q2: Is there a significant difference in the average survival of any two races? 
Q3: What is the appropriate probability distribution function (PDF) that best characterizes the 
survival time of subjects under study for Whites and African Americans and other races? 
Q4: What is the behavior of survival functions for all the three races? 
Q5: What are hazard and cumulative hazard curves explaining the behavior of the variable of 
interest? 
3.3 Data Description 
The information that we have used in this present study is obtained from SEER database 
registry. This data source SEER (Surveillance Epidemiology and End Results), which is a 
unique, reliable and essential resource for investigating the different aspects of cancer. The 
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SEER database combines patient-level information on cancer site, tumor pathology, stage, and 
cause of death (15, 16). In this work, we preprocessed the SEER data (period of 1992-2008 with 
all records named in breast.txt) for breast cancer to remove redundancies and missing 
information. The resulting data set provide 47,167 records, which then pre-classified into two 
groups of “survived” (29,314; 62.15%) and “not survived” (17,853; 37.85%). The “survived” 
class is all records that have a duration period value greater than or equal 204 months and the 
“not survived” class represent the remaining records. In all these cases of breast cancer women 
analyzed, which included 79.17% White women, 8.98% African American (AA), and 11.86% 
other races women (American Indian/AK native, Asian/ Pacific Islander). Our primary variable 
of interest here is the survival time and its probabilistic behavior. The overall description is 
provided in Table 3.1 and Figure 3.1 provides with the race wise descriptive statistics of the 
survival time. Table 3.3 and Table 3.4 have the details about race wise and treatment wise 
survival or otherwise of women considered in our data. 
Table 3.1 Descriptive Statistics of survival time in months 
Race Sample Size Range Mean Variance Median C.V 
Whites 37341 202 100.05 2512.7 98 0.50102 
AA 4234 202 89.183 2742.1 84 0.58717 
Others 5592 202 101.5 2201.5 97 0.46225 
 
 
Table 3.2 Survival based classification 
Censor Frequency Percent Cumulative % 
0 (Dead) 17853 37.85 37.85% 
1 (Censored) 29314 62.15 100.00% 
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Table 3.3 Race wise survival classification 
Race Coded  Censor = 0 Censor = 1 Total 
Whites (W) 1 
Frequency 14229 23112 37341 
Percent 38.1 61.9 100 
African  
Americans (AA) 
2 
Frequency 1992 2242 4234 
Percent 47.0 53.0 100 
Others (Oth) 3 
Frequency 1632 3960 5592 
Percent 29.2 70.8 100 
 
 
 
Figure 3.1 Race wise survival classification 
 
Table 3.4 Treatment Classification 
Treatment Coded  Censor = 0 Censor = 1 Total 
No treatment 1 
Frequency 6053 14656 20709 
Percent 29.2 70.8 100 
Radiation 2 
Frequency 11116 14489 25605 
Percent 43.4 56.6 100 
Radiation & 
Surgery 
3 
Frequency 182 33 215 
Percent 84.7 15.3 100 
Surgery 4 
Frequency 502 136 638 
Percent 78.7 21.3 100 
 
 29 
 
 
Figure 3.2 Treatment based survival classification 
 
3.4 Comparing Survival times 
Kaplan Meier (KM) curve (30, 31) or the product-limit survival plot indicates the 
unconditional probability that a subject will survive beyond time t but do not indicate the 
proportion of subjects surviving to time t. Since all observations are considered alive at 
beginning of study, the KM survivor function starts at 1 and declines as subjects fail over time. 
From the Figure 3.3, we can see that the survival probability of an observation lasting beyond 
time period 100 months is about 0.7 for White race women, 0.58 for African American women 
and 0.78 for other race women. And the survival probability of a women with breast cancer 
surviving beyond time 150 months is about 0.56 for White women, 0.48 for African women and 
0.64 for other race women.   
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Figure 3.3 Product-Limit survival probability of the three races 
 
Table 3.5 Race Wise Summary Statistics for duration 
 
 
 
Table 3.6 Test of equality between three races 
Test of Equality over Strata 
Test Chi-Square DF 
𝑷𝒓 > 
Chi-
Square 
Log-Rank 346.8230 2 <.0001 
Wilcoxon 403.2763 2 <.0001 
-2Log(LR) 332.1676 2 <.0001 
Summary of the Number of Censored and Uncensored Data 
Values 
Stratum RACE Total Censored Failed 
Censored 
(%) 
1 W 37341 23112 14229 38.11 
2 AA 4234 2242 1992 47.05 
3 Others 5592 3960 1632 29.18 
Total  47167 29314 17853 37.85 
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Results of the comparison of survival curves between the three races are shown in Figure 
3.2, Table 3.5 and Table 3.6. Table 3.5 has details about race wise censored data followed by test 
of equality over the three races in Table 3.6. From Table 3.5, there were a total of 17853 women 
(38%) who died of breast cancer. There were a total of 29314 women (62%) that were alive at 
the last assessment period. Also, the log-rank test, which places more weight on larger survival 
times, is more significant than the Wilcoxon test, which places more weight on early survival 
times. Clearly, the rank tests for homogeneity in Table 3.6 indicate a significant difference 
between survival times between all the three the races (p < 0.0001 for the log-rank test and p < 
0.0001 for the Wilcoxon test). From Figure 3.3, other race women live significantly longer than 
White and African American race women, while African American women comparatively have 
less survival. 
 
Figure 3.4 Negative Log Survival DF 
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Figure 3.5 Log Negative Log vs. Log Duration Survival DF 
A plot of the estimated survivor function against time, a plot of the negative log of the 
estimated survivor function against time, and a plot of the log of the negative log of the estimated 
survivor function against log time are given in Figure 3.3, Figure 3.4, and Figure 3.5 
respectively. Figure 3.4 and Figure 3.5 provide an empirical check of the appropriateness of the 
exponential model and the Weibull model, respectively, for the survival data. 
If the exponential model is appropriate, the curve in Figure 3.4 should be approximately 
linear through the origin. Clearly from Figure 3.4 we cannot proceed with exponential model. If 
the Weibull model is appropriate, the curve in Figure 3.5 should be approximately linear. From 
Figure 3.5, we can notice a non-linear trend in the data, which stops us to proceed even with 
Weibull model. Since there is more than one stratum, the Figure 3.5 plot may also be used to 
check the proportional hazards model assumption. Under this assumption, the log of the negative 
log of the estimated survivor function curves should be approximately parallel across strata, 
which in this case fails. 
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3.5 Parametric Analysis 
Probability theory defines distribution by histogram of survival times, given by 
probability density function (PDF) f (t), cumulative distribution function (CDF) which is the 
cumulative area under histogram starting from left, given by 𝐹(𝑡) = ∫ 𝑓(𝑥)𝑑𝑥
𝑡
−∞
, survivor 
function 𝑆(𝑡) =  1 − 𝐹(𝑡 ), hazard function ℎ(𝑡) =
𝑓(𝑡)
𝑆(𝑡)
 and cumulative hazard function 𝐻(𝑡) =
 ∫ ℎ(𝑥)𝑑𝑥
𝑡
0
. 
3.5.1 Probability Density Function 
The probability density function (PDF) is also very useful in describing the continuous 
probability distribution of a random variable. The PDF of a random variable T, denoted𝑓(𝑡), is 
defined by𝑓(𝑡)  =  𝑑 𝐹(𝑡) / 𝑑𝑡, where 𝐹(𝑡) is the cumulative density function (CDF).That is, the 
pdf is the derivative or slope of the cumulative density function (CDF),𝐹 (𝑡). Every continuous 
random variable has its own density function, the probability 𝑃 (𝑎 <  𝑇 <  𝑏) is the area under 
the curve between a, b. In this chapter we tried to identify the best fit probability function that 
characterizes the survival time for all the three races (Whites, AA & Others) separately. We have 
identified Generalized Extreme Value distribution (GEV) as the best fit for both White and 
African American races with -0.25296, 81.455, 49.931 and -0.17371, 67.907, 49.663 as 
estimated shape, location and scale parameters for Whites and African American women 
respectively. Lognormal is identified as the best fit for the other race women with estimated 
shape, location and scale parameters as 0.07439, -529.26, and 6.4442. Figure 3.6, Figure 3.7, 
Figure 3.8 are the PDF’s for the three races and Table 3.7 gives the details of the parameter 
estimates of the fit. 
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The Generalized Extreme Value (GEV) distribution (32 – 34) is a flexible three-
parameter model that combines the Gumbel, Fréchet, and Weibull maximum extreme value 
distributions. GEV also has a link to logit functions. GEV has the following analytic form of 
PDF, 
 
1
𝜎
exp {−(1 + 𝑘𝑧)−1 𝑘⁄ (1 + 𝑘𝑧)−1−(1 𝑘⁄ )      𝑓𝑜𝑟 𝑘 ≠ 0 
1
𝜎
exp(−𝑧 − exp (−𝑧))                                    𝑓𝑜𝑟 𝑘 = 0 
 
k, σ, µ are the shape, scale, and location parameters respectively. The scale must be positive  
(σ >0), the shape and location can take on any real value. The range of definition of the GEV 
distribution depends on𝑘. Specifically, the three cases 𝑘 = 0, 𝑘 > 0, 𝑎𝑛𝑑 𝑘 < 0 correspond to 
the Gumbel, Fréchet, and "reversed" Weibull distributions. 
The three parameter lognormal distribution (34, 35) is based on the Normal distribution. A 
random variable is log normally distributed if the logarithm of the random variable is normally 
distributed. With 𝑥 >  µ ≥  0 ;   −∞ <  𝜎 <  ∞;   𝑘 >  0, and µ is the location parameter, that 
defines the point where the support set of the distribution begins; σ is the scale parameter that 
stretch or shrink the distribution and k is the shape parameter that affects the shape of the 
distribution the probability distribution function of three parameter lognormal distribution 
function and its corresponding cumulative distribution function (CDF) are given by: 
𝑓(𝑥) =  
1
(𝑥 − 𝜇)𝑘√2𝜋
𝑒𝑥𝑝 {−
[ln(𝑥 − 𝜇) − 𝜎]2
2𝑘2
} 
 
f (x) =  
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𝐹(𝑥) = Φ {
ln(𝑥 − 𝜇) − 𝜎
𝑘
} 
FOR WHITE RACE WOMEN: The fitted GEV distribution that characterizes the breast 
cancer survival time for White race women is (𝑥) =
1
49.931
exp {−(1 +
(−0.253)𝑧)−1 (−0.253)⁄ (1 + (−0.253)𝑧)−1−(−0.253) }; 𝑤ℎ𝑒𝑟𝑒 𝑧 =
𝑥−81.455
49.931
. The graph of the 
fitted distribution is given in Figure 3.6. 
 
Figure 3.6 PDF of White (GEV distribution) 
 
FOR AA RACE WOMEN: The fitted GEV distribution that characterizes the breast 
cancer survival time for AA race women is  𝑓(𝑥) =
1
49.663
exp {−(1 +
(−0.174)𝑧)−1 (−0.174)⁄ (1 + (−0.174)𝑧)−1−(−0.174) }; 𝑤ℎ𝑒𝑟𝑒 𝑧 =
𝑥−67.907
49.663
 . The graph of the 
fitted distribution is given in Figure 3.7. 
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Figure 3.7 PDF of AA race (GEV distribution) 
  
FOR OTHER RACES WOMEN: The fitted lognormal distribution that characterizes the 
breast cancer survival time for other race women is   
𝑓(𝑥) =  
1
(0.0744)(𝑥−(−529.26))√2𝜋
𝑒𝑥𝑝 {−
[ln(𝑥−(−529.26))−6.444]2
2(0.0744)2
}.  
The PDF graph is given in Figure 3.8. 
 
 
 
Figure 3.8 PDF for Other races ( Lognormal distribution) 
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Table 3.7 Parameter estimates for the identified distributions 
Race PDF Shape(?̂?) Location(?̂?) Scale(?̂?) 
Whites Generalized Extreme Value -0.25296 81.455 49.931 
African Americans Generalized Extreme Value -0.17371 67.907 49.663 
Others Log Normal 0.07439 -529.26 6.4442 
 
3.5.2  Comparison of average survival and confidence interval estimation 
The 95% confidence intervals for the mean duration and median survival for all the three 
race women are given below in Table 3.8.The median death time (median survival) for a White 
women with breast cancer is 179 months and for African American Women is 135 months. 
There is no median value reported for the survival of other race women because the product-limit 
estimator for these data never reached a failure probability greater than 42.40% or a survival 
probability lower than 57.60%. Now we proceed to identify the survival, hazard, cumulative 
hazard functions for the three races.  
Let 𝜇𝑤, 𝜇𝑎𝑎, 𝑎𝑛𝑑 𝜇𝑜𝑡ℎ represent mean survival times of whites, African Americans and 
other races respectively. Our interest is to test the hypothesis whether all the three races have 
same mean survival time or otherwise. 
𝐻0: 𝜇𝑤   = 𝜇𝑎𝑎  = 𝜇𝑜𝑡ℎ 𝑣𝑠. 𝐻1:  𝐴𝑡 𝑙𝑒𝑎𝑠𝑡 𝑜𝑛𝑒 𝑜𝑓 𝑡ℎ𝑒𝑚 𝑖𝑠 𝑛𝑜𝑡 𝑒𝑞𝑢𝑎𝑙. 
By performing a one way analysis of variance at 5% level of significance, we obtained 
the p-value which is very low (p < 0.0001 for F=96.413); leading us to the conclusion that there 
is significant difference between the average mean survival times of the three races. Also, non-
parametric testing using Kruskal-Wallis supports the current decision. So, we now proceed in 
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pair wise testing of mean survival times for all three races. The Table 3.9 below has the details of 
the results after performing t-test for pair wise testing. Clearly, we conclude that the average 
survival times is significantly different for all the three races in this study. Additionally, at 5% 
level of significance, we conclude that average survival times of White women is greater than 
African American women and less than other race women. African American women has less 
average survival compared to the other two races. 
 
Table 3.8 Confidence intervals of mean duration and median survival 
Race Mean Survival: (95% CI) Median survival: (95% CI) 
Whites 100.05: (99.54, 100.56) 179: (175, 186) 
African Americans 89.183: (87.61, 90.76) 135: (126, 145) 
Others 101.5: (100.27, 102.73) - 
 
 
Table 3.9 Pair-wise hypothesis testing for average survival times of three races 
HNull HAlternative 
P-
value 
Conclusion 
95% CI for mean 
differences 
𝜇𝑤   = 𝜇𝑎𝑎 𝜇𝑤not equals 𝜇𝑎𝑎 0.000 Reject Null (9.28, 12.45) 
𝜇𝑎𝑎   = 𝜇𝑜𝑡ℎ 𝜇𝑎𝑎not equals 𝜇𝑜𝑡ℎ 0.000 Reject Null (-14.32, -10.33) 
𝜇𝑤   = 𝜇𝑜𝑡ℎ 𝜇𝑤not equals 𝜇𝑜𝑡ℎ 0.042 Reject Null (-2.86, -0.05) 
 
 
3.6  Cumulative Distributive Function 
The cumulative distribution function is very useful in describing the continuous 
probability distribution of a random variable, such as time, in survival analysis. The cumulative 
distribution function (CDF) of a random variable T, denoted 𝐹𝑇(𝑡), is defined by 𝐹𝑇(𝑡)  =
𝑃𝑇(𝑇 <  𝑡). This is interpreted as a function that will give the probability that the variable T will 
be less than or equal to any value 𝑡 that we choose. Several properties ofa distribution function 
𝐹(𝑡) can be listed as a consequence of the knowledge of probabilities. Because 𝐹(𝑡) has the 
 39 
 
probability0 < 𝐹(𝑡)  <  1, then 𝐹(𝑡) is a non-decreasing function of t, and as t approaches ∞, 
𝐹(𝑡) approaches 1. Figure 3.9, Figure 3.10, Figure 3.11 depict the respective CDF’s for all the 
three races.  
 
 
Figure 3.9 CDF for Whites 
 
The fitted GEV CDF for the other White women is given below. The CDF graph is given 
in Figure 3.9.  
𝐹(𝑥) = 𝑒𝑥𝑝 {− [1 + (−0.253)(
𝑥 − 81.455
49.931
)]
−1
(−0.253)⁄
} 
 
In the Figure 3.9 above we can clearly notice that for White women with breast cancer 
the probability of surviving more than 100 months is little more than 50%. i.e. 𝑃(X𝑤 > 100)  =
 0.5. Thus, by 100 months, a White women identified with breast cancer has accumulated quite a 
bit of risk, which begins to accumulate more slowly after this point.  
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Similarly, from the Figure 3.10 below we can see that the probability of surviving 100 
months or fewer is near 60%. i.e., 𝑃(X𝑎𝑎 > 100)  =  0.4. Thus, by 100 months, an African 
American women identified with breast cancer has accumulated quite a bit of risk, comparatively 
more than White women, which then begins to accumulate more slowly after this point.  
 
 
Figure 3.10 CDF for African Americans 
The fitted GEV CDF for the other AA women is given below. The CDF graph is given in 
Figure 3.10.  
𝐹(𝑥) = 𝑒𝑥𝑝 {− [1 + (−0.174)(
𝑥 − 67.907
49.663
)]
−1
(−0.174)⁄
} 
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Figure 3.11 CDF for Others 
The fitted Lognormal CDF for the other race women is given below.  The graph of the 
same is given in Figure 3.11. 
𝐹(𝑥) = Φ {
ln(𝑥 − (−529.26)) − 6.4442
0.0744
} 
From the above Figure 3.11 the probability of surviving 100 months or fewer for other 
race women is near 50%. i.e., 𝑃(X𝑜𝑡ℎ > 100) =  0.5. Thus, by 100 months, equaling with White 
women survival, a patient from other races identified with breast cancer has accumulated quite a 
bit of risk by then. 
 
3.7 Survival Function 
Let T > 0 have a probability density function (PDF) 𝑓(𝑡)and cumulative distribution 
function (CDF)𝐹(𝑡). Survival experience is described by the cumulative survival function given 
by 
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Survivor function 𝑆(𝑡) = chance of surviving to age t 
 = percent still alive at age t 
𝑆(𝑡)  =  𝑃 {𝑇 >  𝑡}  =  1 −  𝐹(𝑡) 
Evidently, 𝑆(𝑡)is the survival probability: the probability that the event will not happen 
until time t. The survival function gives the probability of surviving or being event-free beyond 
time t. Because 𝑆(𝑡) is a probability, it is positive and ranges from 0 to 1. It is defined as 𝑆(0)  =
 1 and as t approaches ∞, 𝑆(𝑡) approaches 0. The Kaplan-Meier estimator, or product limit 
estimator, is the estimator used by most software packages because of the simplistic step idea. 
The Kaplan-Meier estimator incorporates information from all of the observations available, both 
censored and uncensored, by considering any point in time as a series of steps defined by the 
observed survival and censored times. The survival curve describes the relationship between the 
probability of survival and time. 
From the Figure 3.12, the probability of White women surviving beyond 150 months is a 
little less than 0.2, and we see that the probability of surviving 150 months or fewer is a little 
more than 0.8. From the Figure 3.13 and Figure 3.14, we notice that, the probability of African 
American women and other race women surviving beyond 150 months is a little less than 0.1 
and 0.15 respectively. Clearly White women has more probability of survival than other two 
races. The fitted form of survival functions for all the three races are given below. 
For white women: 𝑆(𝑥) = 1 − 𝐹(𝑥) = 1 − 𝑒𝑥𝑝 {− [1 + (−0.253)(
𝑥−81.455
49.931
)]
−1
(−0.253)⁄
} 
For AA women: 𝑆(𝑥) = 1 − 𝐹(𝑥) = 1 − 𝑒𝑥𝑝 {− [1 + (−0.174)(
𝑥−67.907
49.663
)]
−1
(−0.174)⁄
} 
 
For Other race women: 𝑆(𝑥) = 1 − 𝐹(𝑥) = 1 − Φ {
ln(𝑥−(−529.26))−6.4442
0.0744
} 
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Figure 3.12 Survival DF for Whites 
 
Figure 3.13 Survival DF for African Americans 
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Figure 3.14 Survival DF for others 
 
3.8 Hazard Function 
The hazard at time t, ℎ(𝑡) as the probability of an event at the interval [𝑡, 𝑡 + 𝛥𝑡], 
when𝛥𝑡 → 0.   To find an expression for ℎ(𝑡), we should realize that ℎ(𝑡) must be a conditional 
probability: it is conditional on not having the event up to time t (or conditional on surviving to 
time t.). The hazard is the probability of dying (or experiencing the event in question) given that 
patients have survived up to a given point in time, or the risk for death at that moment. 
The connection between hazard, survival, PDF and CDF is given below. The CDF is the 
best starting point. From CDF we get to PDF and then to hazard. Hazard function, 
ℎ(𝑡) = age-specific death rate = percent dying at age t of those alive at age greater or equal to t, 
ℎ(𝑡) =  
𝑑𝐹
𝑑𝑡⁄
𝑆(𝑡)
=
𝐹′(𝑡)
𝑆(𝑡)
=
𝑓(𝑡)
𝑆(𝑡)
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The hazard function has formulation as in the Cox model assumes the subject i at time t 
of the form, ℎ𝑖(𝑡) = ℎ0(𝑡) 𝑒𝑥𝑝(𝑋𝑖𝛽
𝑃𝐻), where Xi is the set of covariates for subject i (at time t), 
βPH is the vector of fixed effects regression coefficients, ho (t) is the baseline hazard (at time t ). 
The meaning of the formula stated above implies that if you survive to 𝑡, you will succumb to the 
event in the next instant. This function additionally assumes baseline h0 to correspond to specific 
distribution with PH property. The above equation is the number of deaths per unit time in the 
interval divided by the average number of survivors at the midpoint of the interval. The hazard 
function is commonly known as the instantaneous failure rate. It is the measure of the risk of 
failure at a point in the time during the aging process. 
 
The graph of the hazard rates of White women (Figure 3.15) shows that probability of 
failing (conditional on having survived to time t) remains below 0.05 for the first 100 months 
whereas from Figure 3.16 for African American Women probability of failing remains below 
0.02 for the first 100 months and hazard rises steeply over 100 months. The hazard of other race 
women from Figure 3.17 displays the probability of failing is below 0.016 until first 100 months 
and then rising linearly thereafter. The fitted hazard function for all the three races are given 
below. 
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Figure 3.15 Hazard Function for Whites 
 
ℎ(𝑥) =
1
49.931
exp {−(1 + (−0.253)𝑧)−1 (−0.253)⁄ (1 + (−0.253)𝑧)−1−(−0.253)}
1 − 𝑒𝑥𝑝 {− [1 + (−0.253)(
𝑥−81.455
49.931
)]
−1
(−0.253)⁄
}
 
 
 
 
Figure 3.16 Hazard Function for African Americans 
ℎ(𝑥) =
1
49.663
exp {−(1 + (−0.174)𝑧)−1 (−0.174)⁄ (1 + (−0.174)𝑧)−1−(−0.174) }
1 − 𝑒𝑥𝑝 {− [1 + (−0.174)(
𝑥−67.907
49.663
)]
−1
(−0.174)⁄
}
 
 47 
 
 
Figure 3.17 Hazard Function for Others 
ℎ(𝑥) =
 
1
(0.0744)(𝑥−(−529.26))√2𝜋
𝑒𝑥𝑝 {−
[ln(𝑥−(−529.26))−6.444]2
2(0.0744)2
} 
1 − Φ {
ln(𝑥−(−529.26))−6.4442
0.0744
}
 
 
3.9 Cumulative Hazard Function 
The cumulative hazard function 𝐻(𝑡)is the integral of the hazard function ℎ(𝑡). It can be 
interpreted as the probability of failure at time x given survival until time x. As the name implies, 
cumulative hazard function cumulates hazards over time.  
𝐻(𝑡) =  ∫ ℎ(𝑥)𝑑𝑥
𝑡
0
 
Clearly is the area under the curve of the function ℎ(𝑥), on the interval from 0 to t. A 
given cumulative hazard will remove a certain proportion of objects (or be associated with a 
probability of surviving beyond t). For example, a cumulative hazard of 0 (i.e.,𝐻(𝑡) = 0) has 
100% associated survival (i.e.𝑆(𝑡) = 1). The above equation can also be expressed as 𝐻(𝑡) =
−ln (1 − 𝐹(𝑡)). The cumulative hazard function gives the number of expected number of failures 
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over time interval t. When the survival function is at its maximum at the beginning of analysis 
time, the cumulative hazard function is at its minimum. As time progresses, the survival function 
proceeds towards it minimum, while the cumulative hazard function proceeds to its maximum.  
From Figure 3.18, Figure 3.19 and Figure 3.20 it is clear that the cumulative hazard 
function, H (t) increases more rapidly over time, supporting our previous results. H (t) for 
African Americans is comparatively more than the other two races. 
 
 
Figure 3.18 Cumulative Hazard Function for Whites 
 
Figure 3.19 Cumulative Hazard Function for African Americans 
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Figure 3.20 Cumulative Hazard Function for others 
3.10 Conclusion 
Lower p-values in log-rank test and product-limit survival curves indicated a statistically 
significant difference between the survival times of all the three races. Compared with White 
women and African American women, other race women has more probability of survival. This 
is also supported by survival curves and hazard functions in the later sections of this chapter. 
However the median survival for other race women and White women is almost same and 
African American women has comparatively very less median survival.  
Survival resulting from breast cancer specifically were analyzed for the study population 
overall by race and treatment taken at diagnosis and summarized in Table 3.3 and Table 3.4. 
From Table 3.4, it is interesting to learn that the probability of survival and death is almost very 
close for the patients who underwent radiation alone. The probability density function that best 
characterizes the behavior of survival time are identified as GEV distribution for Whites and 
African American race women and Log Normal distribution for other race women. The 
parameter estimates of these distributions are given in Table 3.7.  
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CHAPTER FOUR  
Modeling of Breast Cancer Survival Data 
 
4.0 Introduction 
Survival analysis today is widely implemented in the fields of medical and biological 
sciences, social sciences, econometrics, and engineering. The basic principle behind the survival 
analysis implies to a statistical approach designed to take into account the amount of time 
utilized for a study period, or the study of time between entry into observation and a subsequent 
event. The event of interest pertains to death and the analysis consisted of following the subject 
until death (36). Events or outcomes are defined by a transition from one discrete state to another 
at an instantaneous moment in time. Examples include time until onset of disease, time until 
stock market crash, time until equipment failure, and so on. Although the origin of survival 
analysis rests with the mortality tables from centuries ago, this type of analysis was not well 
developed until World War II (37). At the end of the war, the use of these newly developed 
statistical methods quickly spread through private industry as customers are demanding for safer 
and more reliable products.  
In survival analysis, a data set can be categorized as exact or censored, and it may also be 
truncated. Another name for exact data is uncensored data which occurs only when the precise 
time until the event of interest is known. Censored data arises when a subject’s time until the 
event of interest is known to occur only in a certain period of time. For example, if an individual 
drops out of a clinical trial before the event of interest has occurred, then that individual’s time-
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to-event is right censored at the time point at which the individual left the trial. The time until an 
event of interest is truncated if the event time occurs within a period of time that is outside the 
observed time period (38).  
4.1 Questions of Interest 
Q1: How long a woman with breast cancer will survive after undergoing certain 
treatments? (Radiation or surgery or both radiation and surgery or no treatment).  
Q2: What is the effectiveness of treatments when implemented in different stages of 
breast cancer? 
Q3: Given a vector of covariates or explanatory variables is there a parametric survival 
model that may affect survival time of breast cancer women? 
Q4: How good is the popular Kaplan Meier survival analysis when compared with others 
(parametric and nonparametric functions)? 
Q5: Does the Cox proportional hazards survival analysis provide any additional 
information with respect to survival function? 
Q6: Is there any significant difference in proposed parametric survival model and Cox 
PH models? 
 
4.2 Survival and Hazard functions 
Survival time can be estimated as a variable which calculates the time between the 
starting point and ending point of event of interest or time of interest. In medical field (39) it is 
termed as the period elapsing between the completion or institution of any procedure and death. 
The survival time and event data is collected on practical grounds which is either censored or 
truncated. 
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Let us recall the definition of survival function as discussed in the previous chapter.  This 
survival function is also termed as survivor or reliability function. It is defined as the probability 
associated with the mortality rate or failure of some system. This survival function (40) is 
obtained by plotting graph of associated probabilities against time. The survival function can be 
expressed with help of another distribution used commonly in statistical techniques, namely 
cumulative probability function CDF denoted as F(t). The survivor function is defined as the 
complement of the CDF which is formulated in the relationship below 
𝑆(𝑡)  =  𝑃𝑟(𝑇 > 𝑡)  =  1 −  𝐹(𝑡) 
Similarly Hazard function is an alternative representation of the distribution of T or the 
instantaneous occurrence of the event and is defined as 
𝜆(𝑡) = lim
𝑑𝑡→0
Pr (𝑡 < 𝑇 ≤ 𝑡 + 𝑑𝑡|𝑇 > 𝑡)
𝑑𝑡
 
The above expression is termed as the instantaneous rate of occurrence for the 
conditional probability that the event will occur in the time interval between t and (t+dt) as it has 
not occurred before. 
By the prior computation of the conditional probability in the numerator and application 
of limits gives the hazard function as 
𝜆(𝑡) =
𝑓(𝑡)
𝑆(𝑡)
 
In other words the hazard function can be stated as the rate of the occurrence of the event 
at time 𝑡 equals to the probability density at time 𝑡 divided over the probability of the surviving 
to that duration without experiencing the event. The above formula can be expressed using the 
relation between density and survival function as follows 
𝜆(𝑡) = −
𝑑
𝑑𝑡
log 𝑆(𝑡) 
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The above expression of hazard function is integrated using limits 0 to 𝑡 and applying the 
boundary condition S(0)=1 (which implies event not occurred at time 0) to obtain relation 
between hazard and survival function as follows 
𝑆(𝑡) = exp (− ∫ 𝜆(𝑥)𝑑𝑥)
𝑡
0
 
 
4.3 Statistical Approach of Survival Analysis 
The survival analysis can be carried out using various statistical approaches (41) like  
1. Descriptive statistics (includes mean or median of survival, average hazard rate etc.) 
2. Univariate statistics (survival curves) 
3. Multivariate statistics (Parametric, non-parametric and semi-parametric survival analysis) 
The first two classifications of survival analysis have their respective advantages and 
disadvantages which are applicable in only few cases. The third classification is observed to be 
present generation scenario for survival function analysis. Survival models for the analysis of 
data have three main characteristics: (i) the dependent variable or response is the waiting time 
until the occurrence of a well-defined event, (ii) observations are censored, in the sense that for 
some units the event of interest has not occurred at the time the data are analyzed, and (iii) there 
are predictors or explanatory variables whose effect on the waiting time we wish to assess or 
control (128).  
The basic definition of three types of analysis carried under multivariate statistics are 
given below. 
1. Parametric Analysis: This analysis assumes distributions for outcome, and base statistical 
analysis on assumed distributions (check the validity of assumptions). 
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2. Non-parametric Analysis: This analysis avoids distribution or quantitative assumptions and 
relies completely on design properties. 
3. Semi-parametric Analysis: This analysis is an intermediate between above two types of 
analysis, but will make some assumptions to avoid fully specified statistical model (42). 
4.4 Non-parametric Analysis (NP) 
Estimating the distribution of the dependent variable without making assumptions about 
its shape is an important first step in analyzing a dataset. Given the importance of the distribution 
of the dependent variable it is valuable to “let the data speak for itself” first (43). Estimating the 
probabilities without making any assumptions on its shape is called non-parametric analysis. The 
function used to represent the distribution is the Survivor function. Nonparametric methods do 
not require the knowledge of the underlying distribution of the failure time 𝑡. Hence it provides 
an edible way to deal with the data in many practical situations. The seminar paper by Kaplan 
and Meier (44) is the benchmark in survival analysis especially from nonparametric point of 
view. It compelled the application of descriptive statistics and improved the development of all 
existing NP approaches with censored data. The survivor function is calculated by dividing the 
number of survivors by the total number of subjects for every time. 
4.4.1 Kaplan-Meier Estimator 
The Kaplan-Meier estimator originally was derived as an NP maximum likelihood 
estimator of 𝐹(𝑡). Because of the latter method of derivation, it is also called as the product-limit 
(PL) estimator. If the data was not censored then the empirical survival function is given by 
𝑆(𝑡) =  
1
𝑛
∑ 𝐼{𝑡𝑖 > 𝑡},
𝑛
𝑖=1
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Where 𝐼 is termed as the indicator function which takes a value of one if the condition 
𝑡𝑖 > 𝑡 is true or zero otherwise (45). The estimator is simply the proportion alive at 𝑡. For the 
censored data, assume the ordered times of death as𝑡1 < 𝑡2 < 𝑡3 … … < 𝑡𝑚 and 𝑑𝑘 be the death 
occurred at 𝑡𝑘. Let 𝑛𝑘 be the number of persons alive just before 𝑡𝑘. This is the number exposed 
to risk at that time. The Kaplan-Meier (KM) or product limit estimate of the survivor function is 
?̂?(𝑡) = ∏ (1 −
𝑑𝑖
𝑛𝑖
)
𝑖:𝑡(𝑖)<𝑡
 
The justification of the estimate is explained as follows. In order to survive until the time 
𝑡 one must first survive until the time 𝑡1. And the conditional probability of surviving from 𝑡2 to  
𝑡1 given already survived  𝑡1 is to be satisfied. The Kaplan-Meier (KM) is a step function with 
jumps at the observed times. If no censoring is present, the KM coincides with the empirical 
survival function (46).  
As mentioned earlier, KM estimator can be interpreted as the non-parametric likelihood 
estimator (NPML) for the death or censored data at time 𝑡. The assumptions formulated for this 
method requires that the likelihood of the subject is 𝑆(𝑡) at 𝑡 is to be maximized as large as 
possible. Since the survival is a non-decreasing function, it does not change at the censoring 
times. Also if a person dies at 𝑡 which is distinct from times of the death we introduced before. 
Let it be time 𝑡𝑖. We need to make the survival function before  𝑡𝑖 as large as possible. Based on 
the above criteria the likelihood takes the form  
𝐿𝑖 = ∏[𝑠(𝑡(𝑖−1)) − 𝑆(𝑡(𝑖))]
𝑑𝑖𝑆(𝑡(𝑖))
𝑐𝑖
𝑚
𝑖=1
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This is the product over 𝑚 distinct times of death. By taking 𝑡(0) = 0 with 𝑆(𝑡(0))  =  1. 
Estimation of survival function at the death times 𝑡(1), 𝑡(2), . . . , 𝑡(𝑚) for 𝑚 parameters is 
obtained. 
𝜋𝑖 =
𝑆(𝑡𝑖)
𝑆(𝑡𝑖−1)
 
Writing the above expression for the conditional probability of surviving from 𝑆(𝑡𝑖−1) to 
𝑆(𝑡𝑖). Then we can write 𝑆(𝑡𝑖) =  𝜋1𝜋2 … … … 𝜋𝑖 , and the likelihood changes to the following 
expression 
𝐿𝑖 = ∏(1 − 𝜋𝑖)
𝑑𝑖𝜋𝑖
𝑐𝑖(𝜋𝑖𝜋2 … … . . 𝜋𝑖−1)
𝑑𝑖+𝑐𝑖
𝑚
𝑖=1
 
In all these cases, individuals who die at time 𝑡𝑖or the time between 𝑡𝑖 and 𝑡𝑖+1also 
contribute to the term 𝜋𝑗 to each of the previous term of death from 𝑡(1)to 𝑡(𝑖−1). Let us assume 
𝑛𝑖 = ∑ (𝑑𝑗 + 𝑐𝑗)𝑗≥𝑖  to be number exposed to risk at 𝑡𝑖and now the L likelihood can be written as 
𝐿𝑖 = ∏(1 − 𝜋𝑖)
𝑑𝑖
𝑚
𝑖=1
𝜋𝑖
𝑛𝑖−𝑑𝑖 
The maximum likelihood estimator of 𝜋𝑖 is then  
?̂?(𝑡) = ?̂?𝑖 =
𝑛𝑖 − 𝑑𝑖
𝑛𝑖
= 1 −
𝑑𝑖
𝑛𝑖
 . 
In order to estimate 𝑣𝑎𝑟 (?̂?(𝑡)), we use the delta method which says, if X ~𝑁(𝜇, 𝜎2) then 
𝑓(𝑋) is approximately normally distributed with mean 𝑓(𝜇) and variance [𝑓′(𝜇)]2𝜎2. Also 
instead of estimating the 𝑣𝑎𝑟 (?̂?(𝑡)), we can use the delta method to approximate the 
𝑣𝑎𝑟(log (?̂?(𝑡)) with  log (?̂?(𝑡))=∑ log (1 − ?̂?𝑗)𝑗:𝑡𝑗<𝑡 . Using independence of the ?̂?𝑗′𝑠 we get the 
Greenwood’s Formula given by 
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𝑣𝑎𝑟 (?̂?(𝑡)) = [?̂?(𝑡)]
2
𝑣𝑎𝑟 [log (?̂?(𝑡))],   
Implying, 
𝑣𝑎𝑟 (?̂?(𝑡)) = [?̂?(𝑡)]
2
∑
𝑑𝑗
(𝑟𝑗 − 𝑑𝑗)𝑟𝑗𝑗:𝑡𝑗<𝑡
 
And the sample standard error for computing confidence interval is given by  
𝑆𝐸 (?̂?(𝑡)) = ?̂?(𝑡)√ ∑
𝑑𝑗
(𝑟𝑗 − 𝑑𝑗)𝑟𝑗𝑗:𝑡𝑗<𝑡
 
4.4.2 The Nelson-Aalen Estimator 
For estimating a cumulative hazard 𝐻(𝑡), one simple approach is to find an estimator of 𝑆(𝑡) 
and take minus the log. An alternativeapproach is to estimate the cumulative hazard directly 
using the Nelson-Aalen estimator. The Nelson Aalen estimator is a non-parametric estimator of 
the cumulative hazard rate function from censored survival data (47). Consider a sample of n 
individuals from a right censored survival population. Our observation of the survival times for 
these individuals will typically be subject to right censoring meaning that for some individuals 
we only know that their true survival times exceed certain censoring times. The censoring is 
assumed to be independent in the sense that the additional knowledge of censorings before any 
time t does not alter the risk of failure at t. The Nelson-Aalen estimator is a step function with the 
location of the steps placed at each observed death time and the vertical size of the steps is the 
inverse of number at risk, Where number at risk is the number of patients just before the death 
that are still observed to be alive. With larger samples the Nelson-Aalen estimator will get closer 
to the true cumulative hazard. The Nelson-Aalen estimator is given by  
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𝐻(𝑡)̂ = ∑
𝑑𝑗
𝑟𝑗
𝑡𝑗<𝑡
 
where 𝑑𝑗  is the subjects who die at time𝑡𝑗and 𝑟𝑗is the number of subjects at risk just prior to time 
𝑡𝑗 . The variance of the estimator is given by  
𝑉𝑎𝑟(𝐻(𝑡)̂) = ∑
𝑑𝑗(𝑟𝑗 − 𝑑𝑗)
𝑟𝑗2(𝑟𝑗 − 1)
𝑡𝑗<𝑡
≈ ∑
𝑑𝑗
𝑟𝑗2
𝑡𝑗<𝑡
 
The advantage of non-parametric analysis is that the results do not rest on the 
assumptions. The disadvantage is that we can only compare limited number of groups which 
implies it is very difficult to see the impact of multiple explanatory variables on the subjects 
(48). Another disadvantage of non-parametric techniques is that it can only deal with the 
quantitative explanatory variables like GDP, rich and poor countries etc. 
4.4.3 Kaplan Meier Estimation for breast cancer survival 
4.4.3.1 Effect of treatments on survival of breast cancer 
Considering the breast cancer survival data, in this chapter we are interested in knowing 
how long women with breast cancer will survive after undergoing certain treatments. Treatments 
include radiation or surgery or both radiation and surgery or no treatment. Also we would like to 
know the effectiveness of treatments when implemented in different stages of breast cancer. 
Firstly we considered the effectiveness of treatments on survival for the overall data. From the 
Table 4.1 women who are treated with radiation have a median survival of 154 months with 95% 
CI (149, 157) months. Interestingly, women those who are treated with both treatments has the 
same median survival as of women who received surgery. There is no median value reported for 
the survival of women who did not receive any treatment because the KM estimator for these 
data never reached a failure probability greater than 41.50% or a survival probability lower than 
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58.50%. Figure 4.1 is the product-limit survival graph for all the four treatment types. 
Treatments 3 & 4 in the graph follow almost the same path. The probability of survival for a 
women identified with breast cancer to survive more than 50 months is approximately 82% for 
women who did not receive any treatment, 78% for surgery, 30% for combination of radiation 
and surgery and 30% for those who are treated with surgery. 
 
Table 4.1 Treatment wise KM estimates for median survival 
Treatment No treatment Radiation 
Radiation & 
Surgery 
Surgery 
Median Survival - 154 25 25 
95% CI - [149, 157) [21, 30) [21, 29) 
 
 
 
 
Figure 4.1 Product-Limit estimates for treatments 
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Table 4.2 Stage vs. Treatment Product-Limit Estimates for median survival 
 
No 
treatment 
Radiation 
Radiation & 
Surgery 
Surgery 
Stage I ─ 178(172, -) 104(53, -) 62(42, 100) 
Stage II ─ 
145(140, 
149) 
128(45, -) 43(32, 66) 
Stage 
III 
93(81, 103) 52(47, 57) 32(24, 110) 27(17, 31) 
Stage 
IV 
34(28, 39) 23(21, 27) 17.5(12, 22) 14.5(11, 18) 
 
 
 4.4.3.2 Stage wise effect of treatments of breast cancer 
Further we continued to check the survival probability of breast cancer women treated in 
every stage with different treatments. The median survival in months and the respective 95% 
confidence interval based on their stage of cancer is tabulated in Table 4.2. The median survival 
for those who are in stage I and stage II who did not receive any treatment for breast cancer is 
not reported because the KM estimator for these data never reached a failure probability greater 
than 35.28% or a survival probability lower than 64.72% for the former case and data never 
reached a failure probability greater than 45.29% or a survival probability lower than 54.71% for 
the latter case. The Figure 4.2 clearly depicts that the probability of survival for those who are 
treated with surgery in all the four stages falls down rapidly. 
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Figure 4.2 KM Estimates for Stages Vs. Treatments 
 
 
 
 
Stage-1 vs. Treatments Stage-2 vs. Treatments 
Stage-3 vs. Treatments 
Stage-4 vs. Treatments 
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4.5 Parametric Analysis 
This type of analysis assumes a functional form of the probability distribution and the 
way in which explanatory variables influence the survival time. The first assumption is also 
called as time dependence because of its functional form of probability distribution. With 
growing computing power and existing statistical programming languages, it is relatively simple 
to work with exact likelihood for censored or truncated data with a variety of parametric models. 
Parametric survival model provides the possibility of more efficiency (43). It is proved to be 
interesting to assume a specific distribution for underlying hazard function (to obtain a full 
hazard or survival function). There may be a provision for non-proportional hazard functions 
also. The direct regression approach for the survival time estimation is given by  
𝐸(𝑡𝑖) = 𝛽𝑜 + 𝑋𝑖𝛽  or  𝑡𝑖 = 𝛽𝑜 + 𝑋𝑖𝛽 + 𝜀𝑖 
where  𝜀𝑖 refers to the survival error distribution. 
This direct regression computation has some problems for estimating survival time like 
the distribution of ti is right skewed (non-normal), the estimator of time may not be the parameter 
of interest (not equal to hazard) and censoring must be accounted. 
The above concerns are addressed using two possible approaches of parametric analysis.  
1. Accelerated failure time models (AFT models) 
2. Proportional hazard model (PH models) (49) 
These models are provided as the common scales for the distributions in parametric 
survival models. Both PH and AFT models were analyzed on basis of t-scale over the 
distributions with interval (0, ∞), whereas the AFT models were also interpreted on the basis of 
𝑙𝑛(𝑡) − scale over the distributions termed as pure AFT models. Distributions that are commonly 
used in parametric analysis using AFT are addressed below.  
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4.5.1 Parametric Model selection: Goodness of fit Tests 
There are few common statistical methods for comparisons of survival models.  
a) Log-likelihood test for the censored data,  
b) AIC,  
c) Cox-Snell Residual plots and  
d) Likelihood-Ratio Statistic.  
The AIC is an operational way of trading off the complexity of an estimated model 
against how well the model fits the data. The AIC is calculated by 
𝐴𝐼𝐶 =  −2 𝑙𝑜𝑔 (𝑙𝑖𝑘𝑒𝑙𝑖ℎ𝑜𝑜𝑑)  + 2 (𝑝 + 𝑘), 
where 𝑝 is the number of parameters, 𝑘 = 1 for the exponential model, 𝑘 = 2 for the Weibull, 
log logistic, and log normal models and 𝑘 = 3 for generalized gamma.  
A likelihood ratio test (LRT) is also used to compare the fit of two models. The LRT test 
statistic is twice the difference in the log-likelihoods of the models considered for comparison. 
We generally select the model that gives the largest log-likelihood.  
Other methods include graphical methods (for all distributions mentioned), Cox-Snell 
Residual plots among others (52). Parametric models are ﬁt to the event times and semi-
parametric models are ﬁt to the ordered event times respectively. In both the cases we use the 
AIC to select between parametric models, or to select between semi-parametric models, but not 
to select from a mixture of the two. The AIC or likelihood tests allow us to assess relative model 
goodness of ﬁt, but not absolute model goodness of ﬁt. Just because the second model ﬁts better 
than the first model, it does not mean the second model adequately describes the data. Thus, we 
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would like a method, at least a graphical one that lets us assess the absolute goodness of ﬁt of a 
parametric model. The Table 4.3 below provides information regarding graphical check for 
goodness of fit for the identified parametric model for survival data (53, 54).  
Table 4.3 Graphical check for goodness of fit for parametric survival models 
Graph Behavior Resulting Distribution 
−𝑙𝑜𝑔𝑆(𝑡) versus 𝑡 Straight line through origin. Exponential 
log [−𝑙𝑜𝑔𝑆(𝑡)] versus log 𝑡 Straight line Weibull 
Φ−1(1 − 𝑆(𝑡)) versus log 𝑡 Straight line, where Φ( ) is the CDF. Log-normal 
log [
1−𝑆(𝑡)
𝑆(𝑡)
] versus log 𝑡 Straight line Log-logistic 
 
4.5.2 Parametric modeling of breast cancer data 
 
Our data consists of 47167 breast cancer patients identified with malignant breast tumors. 
Patients are either White women, African American women or other race women, stratified into 
four stages of cancer and are treated with either radiation or surgery or combination of both or no 
treatment. Other covariates include grade of tumors, number of primary tumors, age, and marital 
status. For the rest of this chapter the variables and their representations are given in the Table 
4.4 below. 
It is of substantial interest in performing the parametric modeling is to see the difference 
in survival (in months) between those patients undergone with different treatments, after 
adjusting for patient’s cancer stage, age, marital status, race, grade of tumor, and the number of 
primary tumors. We used SAS software to fit different parametric models. After performing 
univariate analysis marital status of woman is not statistically significant and hence is dropped 
from modeling. 
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When comparing parametric models, the Akaike Information Criterion (AIC) and log-
likelihood values (54) can be used to select the best parametric model. The best fit model is the 
one with smaller AIC and largest Log-likelihood. Once the model is identified we will perform a 
residual analysis check that lets us assess the absolute goodness of ﬁt of the identified parametric 
model.  
Table 4.4 Variables used in survival modeling 
Age 𝑋1  
Grade 
𝑋2𝑖  
i=1:Well differentiated 
2:Moderately differentiated 
3:Poorly differentiated 
4:undifferentiated 
9:Cell type not determined 
(reference) 
Numprims 𝑋3  
Treatments 
𝑋4𝑖  
i=1:No Treatment 
2:Radiation 
3: Radiation & Surgery 
4: Surgery (reference) 
Stage 𝑋5𝑖 ; i=1,2,3,4(reference) 
Race 
𝑋6𝑖  
i=1: Whites 
2: African Americans 
3: Other races(reference) 
Tumor Size 𝑋7  
 
4.5.3 Parametric survival model using AFT class 
Let 𝑇𝑖denote a continuous non-negative random variable representing survival time of 
the 𝑖𝑡ℎ unit, the logarithm can be used as conventional modeling which is formulated below 
ln(𝑇𝑖) = 𝑋𝑖𝛽 + 𝜎𝜖𝑖  𝑜𝑟  𝑇𝑖 = exp(𝑋𝑖𝛽) exp(𝜎𝜀𝑖)  = 𝑇0𝑖 exp(𝑋𝑖𝛽) 
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where 𝜀𝑖 is termed as a suitable error in the ln(t)-scale which is specific for a distribution, 
and 𝑇0𝑖 = exp (𝜎𝜀𝑖) is the error corresponding to the original (t) scale. The term 𝑇0𝑖indicate the 
baseline function at 𝑖 = 0. This implies that the explanatory variables act in multiples and direct 
product on the survival time and their effect is to increase or decrease the time of death with 
respect to the baseline function. The baseline function is specified up to an unknown parameter. 
The term exp(−𝑋𝑖𝛽) is termed as the acceleration parameter. This parameter is different from 
the value in PH model. From the industrial applications point of view, the name ‘accelerated life’ 
implies to the testing of the units to substantial worse conditions rather than they actually 
encounter in real life. Different kinds of parametric models are obtained assuming different types 
of distributions for error term𝜖𝑖.Accelerated life models are considered as standard regression 
models appliedto the natural logarithm of survival time, and except for the fact that observations 
are censored, pose no new estimation problems. This model estimates goodness of fit for 
different distributions using Likelihood ratio (LRT) or Akaike Information criterion (AIC). Once 
the distribution of the error term is chosen, estimation is carried out by maximizing the log-
likelihood for censored data (50) which is also termed as a Tobit model in economic literature. 
 
4.5.4 Exponential distribution 
In regression models it is common practice that the dependent variable depends on the 
explanatory variables only through a linear function. Because of its historical significance, 
mathematical simplicity and important properties, the exponential distribution is one of the most 
popular parametric models. This is the simplest possible distribution with one parameter which is 
derived treating the hazard function as a constant and of monotonic value over baseline hazard 
function denoted as ℎ(𝑡) = 𝜆. 
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ℎ(𝑡) = exp(𝛽0) exp (𝑋𝑖𝛽) 
So for the exponential distribution the instantaneous failure rate is independent of 𝑡 so 
that the conditional chance of failure does not depend on how long the individual has been on 
trial. This is referred to as the memory less property of the exponential distribution. 
 
4.5.4.1 Fitting Exponential Model 
The survival and fitted survival functions for exponential parametric model are given by 
equations below. Table 4.5 has the analysis of the maximum likelihood estimation of parameters 
of the Exponential model for breast cancer patients. 
 𝑆(𝑡; 𝑿) = exp (−𝑡[𝑒𝑥𝑝(−𝑏0 − 𝑏1𝑋1 − 𝑏2𝑋2 … − 𝑏𝑘𝑋𝑘)]) and   
𝑆(𝑡; 𝑿) = 𝑒𝑥𝑝{−𝑡{exp (−5.36 + 0.03𝑋1 − 0.32𝑋21 − 0.14𝑋22 + 0.17𝑋23 + 0.21𝑋24 +
0.09𝑋3 − 0.95𝑋41 − 0.63𝑋42 − 0.26𝑋43 − 1.89𝑋51 − 1.46𝑋52 − 0.72𝑋53 + 0.15𝑋61 +
0.40𝑋62 + 0.0004𝑋7)}}.  
Table 4.5 Analysis of MLEs for Exponential Model 
Analysis of Maximum Likelihood Parameter Estimates 
Parameter   DF Estimate S. E. 95% Confidence 
Limits 
Pr >  
ChiSq 
Intercept   1 5.3589 0.0831 5.1960 5.5219 <.0001 
AGE   1 -0.0321 0.0006 -0.0334 -0.0309 <.0001 
GRADE 1 1 0.3171 0.0350 0.2485 0.3857 <.0001 
GRADE 2 1 0.1368 0.0293 0.0794 0.1943 <.0001 
GRADE 3 1 -0.1723 0.0291 -0.2293 -0.1153 <.0001 
GRADE 4 1 -0.2108 0.0560 -0.3206 -0.1011 0.0002 
GRADE 9 0 0.0000 . . . . 
NUMPRIMS   1 -0.0851 0.0135 -0.1116 -0.0586 <.0001 
TREATMENT 1 1 0.9496 0.0509 0.8499 1.0494 <.0001 
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Table 4.6 (Continued) Analysis of MLEs for Exponential Model 
Analysis of Maximum Likelihood Parameter Estimates 
Parameter   DF Estimate S. E. 95% Confidence 
Limits 
Pr >  
ChiSq 
TREATMENT 2 1 0.6257 0.0499 0.5278 0.7236 <.0001 
TREATMENT 3 1 0.2614 0.0869 0.0910 0.4318 0.0026 
TREATMENT 4 0 0.0000 . . . . 
STAGE 1 1 1.8855 0.0381 1.8108 1.9602 <.0001 
STAGE 2 1 1.4624 0.0373 1.3894 1.5354 <.0001 
STAGE 3 1 0.7280 0.0418 0.6462 0.8099 <.0001 
STAGE 4 0 0.0000 . . . . 
RACE 1 1 -0.1512 0.0265 -0.2033 -0.0992 <.0001 
RACE 2 1 -0.3980 0.0337 -0.4642 -0.3319 <.0001 
RACE 3 0 0.0000 . . . . 
TUMOR_SIZE   1 -0.0004 0.0001 -0.0005 -0.0002 <.0001 
Scale   0 1.0000 0.0000 1.0000 1.0000   
Weibull Shape   0 1.0000 0.0000 1.0000 1.0000   
 
 
4.5.4.2 Exponential Residual Plot 
To evaluate the goodness of fit for exponential model we performed a residual analysis 
for observed and fitted data. The result shows that the mean residual is 0.3785, with a standard 
deviation of 0.3523 and a range of 12.157. A residual graph of survival functions for exponential 
parametric model is shown in Figure 4.3. Clearly the fitted data does not fall close to the straight 
line which explains that exponential is not the best fit for this data. 
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Figure 4.3 Residual plot for exponential distribution 
 
4.5.5 Weibull distribution 
Although the exponential model is good, there is improper assumption that the hazard 
function is constant over the time. If the hazard model is increasing or decreasing over the time, 
the exponential model will miss this fact under such assumption. The general Weibull model as a 
hazard function can be formulated as 
ℎ(𝑡) = 𝑝𝜆𝑡𝑝−1 
The parameter p is called as the shape parameter which is one in case of exponential 
distribution. For the values of p other than one the hazard function increases or decreases 
monotonically. In case of AFT, Weibull model is represented as, 
𝑇𝑖 = exp (𝑋𝑖𝛽) × 𝜎𝜖𝑖 
Which implies the shape function is determined by the variance of the residuals. 
Intuitively, data with low variance duration dependence will tend to exhibit positive duration 
dependence, due to their relative lack of heterogeneity. Furthermore, Weibull in case of hazard 
ratio for two observations with different values i and j can be interpreted as follows 
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𝐻𝑅𝑖
𝑗
=
exp (𝑋𝑖𝛽)
exp (𝑋𝑗𝛽)
 
This indicates that the hazard ratio for different cases can only differ by dichotomous 
variable which is exp (𝛽). 
 
4.5.5.1 Fitting Weibull Model 
The survival and fitted survival functions for Weibull parametric model are given by 
equations below. Table 4.6 has the analysis of the maximum likelihood estimation of parameters 
of the Weibull model for breast cancer patients. 
𝑆(𝑡; 𝑿) = exp (−𝑡𝑘𝑒𝑥𝑝(−𝑏0 − 𝑏1𝑋1 − 𝑏2𝑋2 … − 𝑏𝑘𝑋𝑘)) and  
𝑆(𝑡; 𝑿) = 𝑒𝑥𝑝{−𝑡0.85{exp (5.22 + 0.03𝑋1 − 0.25𝑋21 − 0.10𝑋22 + 0.20𝑋23 + 0.21𝑋24
+ 0.07𝑋3 − 0.88𝑋41 − 0.59𝑋42 − 0.24𝑋43 − 1.7𝑋51 − 1.32𝑋52 − 0.67𝑋53
+ 0.13𝑋61 + 0.35𝑋62 + 0.0003𝑋7)}} 
 
4.5.5.2 Weibull Residual Plot 
To evaluate the goodness of fit for the Weibull model we performed a residual analysis 
for observed and fitted data. The result shows that the mean residual is 0.3785, with a standard 
deviation of 0.3887 and a range of 14.633. A residual graph of survival functions for Weibull 
parametric model is shown in Figure 4.4. Clearly the fitted data does not fall close to the straight 
line which explains that exponential is not the best fit for this data. 
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Table 4.7 Analysis of MLEs for Weibull Distribution 
Analysis of Maximum Likelihood Parameter Estimates 
Parameter   DF Estimate S. E. 95% Confidence 
Limits 
Pr >  
ChiSq 
Intercept   1 5.2216 0.0708 5.0827 5.3604 <.0001 
AGE   1 -0.0287 0.0006 -0.0297 -0.0276 <.0001 
GRADE 1 1 0.2513 0.0298 0.1929 0.3097 <.0001 
GRADE 2 1 0.0974 0.0249 0.0486 0.1462 <.0001 
GRADE 3 1 -0.1761 0.0247 -0.2245 -0.1277 <.0001 
GRADE 4 1 -0.2086 0.0475 -0.3017 -0.1155 <.0001 
GRADE 9 0 0.0000 . . . . 
NUMPRIMS   1 -0.0694 0.0115 -0.0919 -0.0469 <.0001 
TREATMENT 1 1 0.8678 0.0433 0.7829 0.9527 <.0001 
TREATMENT 2 1 0.5897 0.0424 0.5065 0.6728 <.0001 
TREATMENT 3 1 0.2360 0.0738 0.0914 0.3805 0.0014 
TREATMENT 4 0 0.0000 . . . . 
STAGE 1 1 1.6954 0.0331 1.6305 1.7603 <.0001 
STAGE 2 1 1.3236 0.0320 1.2608 1.3863 <.0001 
STAGE 3 1 0.6660 0.0355 0.5964 0.7356 <.0001 
STAGE 4 0 0.0000 . . . . 
RACE 1 1 -0.1255 0.0225 -0.1696 -0.0813 <.0001 
RACE 2 1 -0.3465 0.0287 -0.4028 -0.2903 <.0001 
RACE 3 0 0.0000 . . . . 
TUMOR_SIZE   1 -0.0003 0.0001 -0.0005 -0.0002 <.0001 
Scale   1 0.8484 0.0055 0.8376 0.8593   
Weibull Shape   1 1.1787 0.0077 1.1638 1.1939   
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Figure 4.4 Residual plot for Weibull distribution 
 
4.5.6 Log-normal and Log-Logistic distributions 
There are also certain other models which received importance in social sciences. They 
can be noted probably as common models which are beyond the exponential and Weibull 
models. Both of the models are considered strictly AFT models. Recalling the general equation 
of AFT model, ln(𝑇𝑖) = 𝑋𝑖𝛽 + 𝜎𝜖𝑖. 
If the error 𝜖𝑖 in the above equation is assumed to follow a logistic distribution (55) then 
the resulting model is termed as the log-logistic survival model. If the model follows a standard 
normal distribution, it is termed as log-normal survival model. The standard log-logistic survival 
function is equal to  
𝑆(𝑡) =  
1
1 + (𝜆𝑡)𝑝
 
and the corresponding hazard function is equal to  
ℎ(𝑡) =
𝜆𝑝(𝜆𝑡)𝑝−1
1 + (𝜆𝑡)𝑝
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Similarly the log-normal model is assumed to have bell-shaped symmetrical distribution 
(51) for the error term. If we assume errors to be normally distributed then the corresponding 
cumulative errors are also normal. The survival function of the log-normal is given by 
𝑆(𝑡) = 1 − Φ [
𝑙𝑛𝑇 − ln (𝜆)
𝜎
] 
In general, log-logistic and log-normal models are very similar and will produce similar 
results like logit and probit models in the regression analysis. Also, log-logistic models with p>1 
and log-normal models with all possible values of the p will first rise and then fall over time. 
 
4.5.6.1 Fitting Log-Normal and Log-Logistic distribution 
The survival and fitted survival functions for lognormal parametric model are given by 
equations below. Table 4.7 has the analysis of the maximum likelihood estimation of parameters 
of the lognormal model for breast cancer patients. 𝑆(𝑡) = Φ[𝑏0 + 𝑏1𝑋1 + 𝑏2𝑋2 + ⋯ − 𝑘 log(𝑡)]; 
Here Φ is the cumulative distribution function of standard normal distribution. 
𝑆(𝑡) = Φ[4.69 − 0.03𝑋1 + 0.27𝑋21 + 0.12𝑋22 − 0.2𝑋23 − 0.24𝑋24 − 0.82𝑋3 + 1.06𝑋41
+ 0.76𝑋42 + 0.35𝑋43 + 1.96𝑋51 + 1.54𝑋52 + 0.8𝑋53 − 0.13𝑋61 − 0.38𝑋62
− 0.0004𝑋7 − 1.07 log(𝑡)] 
The survival and fitted survival functions for log-logistic parametric model are given by 
equations below. Table 4.8 has the analysis of the maximum likelihood estimation of parameters 
of the log-logistic model for breast cancer patients. 
𝑆(𝑡; 𝑿) = {1 + 𝑡𝑘 ∗ 𝑒𝑥𝑝(−𝑏0 − 𝑏1𝑋1 − 𝑏2𝑋2 … − 𝑏𝑘𝑋𝑘)}
−1 
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𝑆(𝑡; 𝑿) = {1 + 𝑡0.7exp (−4.29 + 0.03𝑋1 − 0.25𝑋21 − 0.11𝑋22 − 0.22𝑋23 + 0.25𝑋24 + 0.09𝑋3
− 1.14𝑋41 − 0.84𝑋42 − 0.42𝑋43 − 2.06𝑋51 − 1.65𝑋52 − 0.86𝑋53 + 0.13𝑋61
+ 0.39𝑋62 + 0.0004𝑋7)}
−1 
Table 4.8 Analysis of MLEs for Log-Normal Distribution 
Analysis of Maximum Likelihood Parameter Estimates 
Parameter Estimate S. E. 
95% Confidence 
Limits 
Pr >  
ChiSq 
Intercept 4.1885 0.0877 4.0167 4.3604 <.0001 
AGE -0.0277 0.0006 -0.0289 -0.0265 <.0001 
GRADE 0.2947 0.0343 0.2274 0.3619 <.0001 
GRADE 0.1404 0.0299 0.0818 0.1990 <.0001 
GRADE -0.2083 0.0300 -0.2670 -0.1495 <.0001 
GRADE -0.2638 0.0565 -0.3746 -0.1531 <.0001 
GRADE 0.0000 . . . . 
NUMPRIMS -0.0929 0.0139 -0.1201 -0.0656 <.0001 
TREATMENT 1.2631 0.0580 1.1495 1.3768 <.0001 
TREATMENT 0.9212 0.0574 0.8088 1.0337 <.0001 
TREATMENT 0.4702 0.1060 0.2624 0.6780 <.0001 
TREATMENT 0.0000 . . . . 
STAGE 2.1276 0.0447 2.0400 2.2151 <.0001 
STAGE 1.6874 0.0438 1.6015 1.7733 <.0001 
STAGE 0.8968 0.0493 0.8002 0.9933 <.0001 
STAGE 0.0000 . . . . 
RACE -0.1385 0.0243 -0.1861 -0.0909 <.0001 
RACE -0.3934 0.0325 -0.4571 -0.3298 <.0001 
RACE 0.0000 . . . . 
TUMOR_SIZE -0.0004 0.0001 -0.0006 -0.0002 <.0001 
Scale 1.3005 0.0075 1.2859 1.3154   
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Table 4.9 Analysis of MLEs for Log-Logistic Distribution 
Analysis of Maximum Likelihood Parameter Estimates 
Parameter Estimates S. E. 
95% Confidence 
Limits 
Pr > 
ChiSq 
Intercept 4.2928 0.0837 4.1287 4.4568 <.0001 
AGE -0.0277 0.0006 -0.0288 -0.0266 <.0001 
GRADE 0.2501 0.0316 0.1881 0.3121 <.0001 
GRADE 0.1071 0.0274 0.0534 0.1607 <.0001 
GRADE -0.2197 0.0275 -0.2736 -0.1658 <.0001 
GRADE -0.2483 0.0529 -0.3519 -0.1446 <.0001 
GRADE 0.0000 . . . . 
NUMPRIMS -0.0863 0.0127 -0.1112 -0.0614 <.0001 
TREATMENT 1.1434 0.0567 1.0323 1.2545 <.0001 
TREATMENT 0.8498 0.0562 0.7397 0.9599 <.0001 
TREATMENT 0.4233 0.1025 0.2224 0.6242 <.0001 
TREATMENT 0.0000 . . . . 
STAGE 2.0563 0.0426 1.9727 2.1398 <.0001 
STAGE 1.6454 0.0418 1.5635 1.7274 <.0001 
STAGE 0.8608 0.0467 0.7692 0.9524 <.0001 
STAGE 0.0000 . . . . 
RACE -0.1313 0.0231 -0.1767 -0.0860 <.0001 
RACE -0.3862 0.0305 -0.4460 -0.3263 <.0001 
RACE 0.0000 . . . . 
TUMOR_SIZE -0.0004 0.0001 -0.0006 -0.0002 <.0001 
Scale 0.6987 0.0045 0.6899 0.7076   
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4.5.6.2 Lognormal and Log-Logistic Residual Plots 
To evaluate the goodness of fit for the lognormal and log-logistic models we performed a 
residual analysis for observed and fitted data. The result shows that the mean residual for 
lognormal is 0.3740, with a standard deviation of 0.3737 and range of 5.258. Log-logistic 
distribution has a mean residual of 0.3770, with a standard deviation of 0.3357 and a range of 
4.608. Residual graphs of survival functions for lognormal and log-logistic parametric models 
are shown in Figure 4.5 and Figure 4.6 respectively.  
Clearly the lognormal is slightly parabolic and the points does not fall close to the 
straight line which explains that lognormal is not the best fit for this data. From Figure 4.6 
below, the graphical check of residual analysis for the log-logistic model, the graph is almost 
linear and hence is the winner parametric model among all others.  
 
 
Figure 4.5 Residual plot for log-normal distribution 
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Figure 4.6 Residual plot for log-logistic distribution 
 
4.5.7 Generalized Gamma Distribution 
The survival function of the gamma distribution is the nested form of number of other 
distributions which is given by the equation below. Note that this model changes to log-
normal as 𝑝 → ∞; Weibull when 𝑘 𝑒𝑞𝑢𝑎𝑙𝑠 𝑡𝑜 1; Exponential when  𝑘 𝑎𝑛𝑑 𝜎 𝑒𝑞𝑢𝑎𝑙𝑠 𝑡𝑜 1; 
regular gamma distribution if 𝑝 𝑒𝑞𝑢𝑎𝑙𝑠 𝑡𝑜 1. The main disadvantage of this generalized 
gamma distribution is slow and difficult to converge.  
 
𝑆(𝑡) = 1 − Γ {𝑘, 𝑘𝑒𝑥𝑝 [
𝑙𝑛𝑇𝑖−𝜆
𝜎
𝑝0.5
]} 
 
4.5.7.1 Fitting Gamma Distribution 
The survival functions for Gamma parametric model are given by equations below. Table 
4.10 has the analysis of the maximum likelihood estimation of parameters of the gamma model 
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for breast cancer patients. Due to complexity we haven’t given the fitted gamma survival 
function. The residual plot given in Figure 4.7, the data does not fall close to a straight line, so 
we conclude that gamma is not a best fit parametric model. 
𝑆(𝑡; 𝑿) = 1 − 𝜙𝑘(𝜆𝑡)   Where 𝜙𝑘(𝜆𝑡) = ∫ (
(𝜆𝑘−1𝑒−𝑥)
Γ(𝑘)
)
𝑥
0
 
 
Figure 4.7 Residual plot for gamma distribution 
 
4.5.8 Selection of best fit parametric model 
 We use the model selection criteria discussed in section 4.4.1 to select the best parametric 
model. From the previous sections, by performing the residual analysis for the fitted parametric 
models log-logistic parametric model performed better than other models. Also from the Table 
4.9, we identify that the log-logistic model has the lowest AIC and highest likelihood values 
performs better than other models. This supports our choice of log-logistic model selection. 
From Table 4.9, we see that Gamma model is also performing close to log-logistic. To address 
this concern, we computed the likelihood ratio test statistic to compare these models. The test 
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statistic value as 31.21 and the corresponding p-value is 0.0001 which concludes that log-logistic 
is better. Comparison of maximum likelihood estimates for all parametric models is given in 
Table 4.10. 
Based on the estimates of log-logistic model provided in the Table 4.10, when compared 
to women treated with surgery, those who received no treatment has better survival estimates 
compared with radiation followed by combination of radiation and surgery. However, from this 
model, tumor size, marital status, race has no much effect on the breast cancer.  
 
Table 4.10 Goodness of fit for parametric models 
Distribution Log-Likelihood AIC 
Gamma -43730.415 87506.83 
Log-Normal -43957.83687 87959.67 
Weibull -43961.92163 87967.84 
Exponential -44259.26034 88560.52 
Log-Logistic -43714.80892 87473.62 
 
Table 4.11 Summary of MLE results for fitted parametric models 
Parameter   DF Gamma Log-Normal Weibull Exponential Log-Logistic 
Intercept   1 4.6896 4.1885 5.2216 5.3589 4.2928 
Age   1 -0.0284 -0.0277 -0.0287 -0.0321 -0.0277 
Grade 1 1 0.2747 0.2947 0.2513 0.3171 0.2501 
Grade 2 1 0.1206 0.1404 0.0974 0.1368 0.1071 
Grade 3 1 -0.1972 -0.2083 -0.1761 -0.1723 -0.2197 
Grade 4 1 -0.2355 -0.2638 -0.2086 -0.2108 -0.2483 
Grade 9 0 0.0000 0.0000 0.0000 0.0000 0.0000 
Numprims   1 -0.0815 -0.0929 -0.0694 -0.0851 -0.0863 
Treatment 1 1 1.0637 1.2631 0.8678 0.9496 1.1434 
Treatment 2 1 0.7573 0.9212 0.5897 0.6257 0.8498 
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Table 4.12 (Continued) Summary of MLE results for fitted parametric models 
Parameter   DF Gamma Log-Normal Weibull Exponential Log-Logistic 
Treatment 3 1 0.3489 0.4702 0.2360 0.2614 0.4233 
Treatment 4 0 0.0000 0.0000 0.0000 0.0000 0.0000 
Stage 1 1 1.9563 2.1276 1.6954 1.8855 2.0563 
Stage 2 1 1.5448 1.6874 1.3236 1.4624 1.6454 
Stage 3 1 0.7996 0.8968 0.6660 0.7280 0.8608 
Stage 4 0 0.0000 0.0000 0.0000 0.0000 0.0000 
Race 1 1 -0.1340 -0.1385 -0.1255 -0.1512 -0.1313 
Race 2 1 -0.3790 -0.3934 -0.3465 -0.3980 -0.3862 
Race 3 0 0.0000 0.0000 0.0000 0.0000 0.0000 
Tumor size   1 -0.0004 -0.0004 -0.0003 -0.0004 -0.0004 
Scale   1 1.0748 1.3005 0.8484 1.0000 0.6987 
 
 
4.6 Semi Parametric Analysis: Cox PH regression 
The main disadvantage of non-parametric analysis is that it can only compare the survival 
functions of a limited number of groups whereas the parametric analysis has disadvantage of two 
assumptions as discussed in previous section.  There is an intermediate technique whereby only 
an assumption is made about the way that the explanatory variables. This technique is called 
semi-parametric analysis, or Cox-regression. Proportional hazards regression (56) assumes that 
different groups have proportional hazard functions. Suppose with two groups A and B, there is a 
common hazard function ℎ(𝑡), which applies to group A. Being in group B multiplies the hazard 
by 𝑟. i.e. ℎ𝑠(𝑡) = 𝑟. ℎ𝐴(𝑡) 
Proportional hazards regression estimates 𝑟 without estimating ℎ(𝑡). Since hazards are 
chances, this means that the ratio of the hazard functions can be interpreted as a relative risk or 
relative rate. 
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𝑟 =
ℎ𝑠(𝑡)
ℎ𝐴(𝑡)
 
This relative risk type ratio is very desirable in explaining the risk of events for certain 
categories of covariates or variable of interest. 
 
4.6.1 Assumptions underlying Proportional Hazard Modeling 
1. There exists a baseline hazard function ℎ𝑜(𝑡)common to all individuals in all the study 
groups. The baseline hazard function captures the shape of the hazard function.  
2. When there is a covariate (dichotomous variable) the hazard function becomes the 
exponential of the parameter of interest which is termed as the exponential distribution under 
PH modeling. 
3. Another attractive feature of Cox regression is not assuming the distributions as in the case of 
parametric regression. Instead refers to the fact that the hazard functions are multiplicatively 
related. 
4. Explanatory variables act only on the 𝑟 not on the baseline hazard. 
4.6.2 Proportional Hazard Modeling 
The formulation of Cox’s regression model assumes the hazard of the subject 𝑖 at the 
time 𝑡 of the form 
ℎ1(𝑡) = ℎ0(𝑡)exp (𝑋𝑖𝛽) 
Given two covariate profiles(𝑍1,𝑍2) the hazard ratio 
ℎ(𝑡|𝑧1)
ℎ(𝑡|𝑧2)
= 𝑒𝑥𝑝(
(𝑍1−𝑍2)
𝛽
) is constant in 
time. Usually 𝛽 is of the main interest and can be estimated independently by the partial 
likelihood approach (57) when right-censored data are observed. This appealing property of the 
PH model, together with its great flexibility, has made it one of the most popular models in 
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survival analysis during the past three decades. For the two-sample semi-parametric modeling, 
the proportional hazards model is perhaps the most widely used model and under this model, the 
hazard ratio for the two groups is a constant. Sometimes the constant hazard ratio may be in 
questioned and in this case, one can use the proportional odds model, which allows the time-
dependent hazard ratio. One shortcoming of these models is that they do not apply if the two 
hazard or survival functions cross and this can happen in, for example, a medical study where a 
Treatment may be effective in long run but can have certain adverse effects during the early 
stage. For investigating whether there is really a difference between the two groups or whether 
there is really a treatment effect (58), we test the null hypothesis 𝐻0: 𝛽1 = 0 against the 
alternative hypothesis𝐻1: 𝛽1 ≠ 0. One has to take 𝑇 =
?̂?1
𝑆(?̂?1)
 as testing statistic with ?̂?1 being the 
estimate of 𝛽1 and 𝑆(?̂?1) being the corresponding standard error. The distribution of the testing 
statistic is approximated by the standard normal distribution under the null hypothesis. The null 
hypothesis is rejected if  𝑇 ≤ −𝑐 or ≥ 𝑐 .The advantage is that the results can no longer be 
influenced by assumptions about time-dependence, since no such assumptions are made. The 
disadvantages are that hypotheses about time dependence can no longer be tested and that 
parametric analysis yields more precise estimates than the semi-parametric analysis if the 
assumptions about the time dependence are correct. 
 
4.6.3 Cox Proportional Hazards Regression for breast cancer data 
Using the same breast cancer survival data used in parametric survival analysis, in this 
section, we will examine cox regression models for the hazard function ℎ(𝑡). As with other 
regression models, the identification of significant covariates and the interpretation of the 
estimated model coefficients is of primary interest. We will identify the likelihood that an 
 83 
 
individual alive at time t (with the specific set of covariates as described in parametric survival 
modeling section) will experience the event of interest in the next very small time period. The 
Cox proportional hazard model (58) is used to determine the difference of survival time between 
races, age at diagnosis, stage of cancer, treatment, tumor size, grade, marital status and number 
of primary tumors. The variables in the model are introduced stepwise. The fitted Cox model 
reached its convergence. The model fit statistics are given below in Table 4.11. The results of 
three tests (likelihood, score and Wald tests) given below in Table 4.12 are used to test the 
hypothesis of whether the full model with all variables is better than no variables in the model. 
The p-value for all the three tests supported the model with all variables is statistically 
significant. The parameter estimate values of semi parametric cox regression model along with 
hazard ratios are given in Table 4.14. 
From the Table 4.14, we can say that every year of age hazard increases by 3%. White 
women have 16% and African women has 50% greater hazard than other race women. When 
compared to women who are treated with surgery, those who are treated with radiation has 
50.5% and women who did not receive any treatment has 64% lower hazard rate. While the 
combination of both surgery and radiation has 24% lower hazard rate. Type 3 tests are used to 
test whether there are any differences in event rate across any of the levels of the covariates used 
in the model. P-values reported in Table 4.13 indicate that there are significant differences in 
mortality between the levels of covariates. The fitted Cox PH Survival and Hazard equations for 
breast cancer patients are:  
 
ℎ𝑖(𝑡) = ℎ0(𝑡)𝑒𝑥𝑝(0.033𝑋1 − 0.31𝑋21 − 0.13𝑋22 + 0.19𝑋23 + 0.23𝑋24 + 0.082𝑋3 − 1.03𝑋41
− 0.70𝑋42 − 0.26𝑋43 − 2.01𝑋51 − 1.57𝑋52 − 0.78𝑋53 + 0.15𝑋61 + 0.41𝑋62
+ 0.0003𝑋7) 
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𝑆𝑖(𝑡) = exp (− ∫ {ℎ0(𝑡)𝑒𝑥𝑝(0.033𝑋1 − 0.31𝑋21 − 0.13𝑋22 + 0.19𝑋23 + 0.23𝑋24 + 0.082𝑋3
𝑡
0
− 1.03𝑋41 − 0.70𝑋42 − 0.26𝑋43 − 2.01𝑋51 − 1.57𝑋52 − 0.78𝑋53 + 0.15𝑋61
+ 0.41𝑋62 + 0.0003𝑋7)} 𝑑𝑢) 
 
Table 4.13 Cox regression model fit statistics 
Model Fit Statistics 
Criterion Without 
Covariates 
With 
Covariates 
-2 LOG L 368614.59 358231.90 
AIC 368614.59 358269.90 
SBC 368614.59 358417.91 
 
 
Table 4.14 Test results for beta coefficients 
Testing Null Hypothesis: BETA=0 
Test Chi-Square DF Pr > ChiSq 
Likelihood Ratio 10382.6831 19 <.0001 
Score 14594.0408 19 <.0001 
Wald 12414.3302 19 <.0001 
 
Table 4.15 Type III tests for levels of covariates 
Type 3 Tests 
Effect DF Wald Chi-Square Pr > ChiSq 
Age 1 2677.5352 <.0001 
M_status 5 219.4995 <.0001 
Grade 4 543.3288 <.0001 
Race 2 161.6861 <.0001 
Treatment 3 677.9500 <.0001 
Stage 3 3555.2608 <.0001 
Numprims 1 36.2624 <.0001 
Tumor size 1 21.5580 <.0001 
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Table 4.16 Cox parameter estimates and hazard ratios 
Parameter  DF 
Parameter 
Estimate 
Standard 
Error 
Hazard 
Ratio 
95% Hazard 
Ratio 
Confidence 
Limits 
Age   1 0.03328 0.00064 1.034 1.033 1.035 
Grade 1 1 -0.31020 0.03505 0.734 0.685 0.786 
Grade 2 1 -0.12712 0.02937 0.880 0.831 0.932 
Grade 3 1 0.19351 0.02919 1.212 1.145 1.284 
Grade 4 1 0.23365 0.05602 1.259 1.128 1.406 
Race 1 1 0.15031 0.02654 1.163 1.104 1.225 
Race 2 1 0.40886 0.03375 1.504 1.408 1.607 
Treatment 1 1 -1.03141 0.05072 0.363 0.329 0.401 
Treatment 2 1 -0.70261 0.04975 0.505 0.458 0.557 
Treatment 3 1 -0.25560 0.08686 0.763 0.644 0.905 
Stage 1 1 -2.01361 0.03759 0.138 0.128 0.148 
Stage 2 1 -1.57326 0.03686 0.213 0.198 0.229 
Stage 3 1 -0.78178 0.04177 0.459 0.423 0.498 
Numprims   1 0.08168 0.01353 1.085 1.056 1.114 
Tumor size  1 0.000384 0.0000826 1.000 1.000 1.001 
 
Finally we obtained the Cox PH survival function model for each of the three races 
respectively. The fit equations are given below. 
Cox PH Survival and Hazard equations for White woman 
ℎ𝑖(𝑡) = ℎ0(𝑡)𝑒𝑥𝑝(0.04𝑋1 − 0.32𝑋21 − 0.11𝑋22 + 0.22𝑋23 + 0.28𝑋24 + 0.08𝑋3 − 0.94𝑋41
− 0.56𝑋42 − 0.17𝑋43 − 1.97𝑋51 − 1.54𝑋52 − 0.81𝑋53 + 0.0005𝑋7) 
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𝑆𝑖(𝑡) = exp (− ∫ {ℎ0(𝑡) exp(0.04𝑋1 − 0.32𝑋21 − 0.11𝑋22 + 0.22𝑋23 + 0.28𝑋24 + 0.08𝑋3
𝑡
0
− 0.94𝑋41 − 0.56𝑋42 − 0.17𝑋43 − 1.97𝑋51 − 1.54𝑋52 − 0.81𝑋53
+ 0.0005𝑋7)} 𝑑𝑢) 
Cox PH Survival and Hazard equations for African American woman 
ℎ𝑖(𝑡) = ℎ0(𝑡)𝑒𝑥𝑝(0.02𝑋1 − 0.28𝑋21 − 0.25𝑋22 + 0.03𝑋23 + 0.11𝑋24 + 0.08𝑋3 − 1.22𝑋41
− 1.02𝑋42 − 0.72𝑋43 − 2.07𝑋51 − 1.62𝑋52 − 0.75𝑋53 + 0.00007𝑋7) 
𝑆𝑖(𝑡) = exp (− ∫ {ℎ0(𝑡)𝑒𝑥𝑝(0.02𝑋1 − 0.28𝑋21 − 0.25𝑋22 + 0.03𝑋23 + 0.11𝑋24 + 0.08𝑋3
𝑡
0
− 1.22𝑋41 − 1.02𝑋42 − 0.72𝑋43 − 2.07𝑋51 − 1.62𝑋52 − 0.75𝑋53
+ 0.00007𝑋7)} 𝑑𝑢) 
Cox PH Survival and Hazard equations for other race woman 
ℎ𝑖(𝑡) = ℎ0(𝑡)𝑒𝑥𝑝(0.02𝑋1 − 0.18𝑋21 − 0.11𝑋22 + 0.2𝑋23 − 0.08𝑋24 + 0.08𝑋3 − 1.03𝑋41
− 0.95𝑋42 − 0.03𝑋43 − 2.12𝑋51 − 1.59𝑋52 − 0.72𝑋53 + 0.0003𝑋7) 
𝑆𝑖(𝑡) = exp (− ∫ {ℎ0(𝑡)𝑒𝑥𝑝(0.02𝑋1 − 0.18𝑋21 − 0.11𝑋22 + 0.2𝑋23 − 0.08𝑋24 + 0.08𝑋3
𝑡
0
− 1.03𝑋41 − 0.95𝑋42 − 0.03𝑋43 − 2.12𝑋51 − 1.59𝑋52 − 0.72𝑋53
+ 0.0003𝑋7)} 𝑑𝑢) 
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Table 4.17 Estimates of Cox and Log-logistic models 
Parameter   DF Cox Log-Logistic 
   Estimates Hazard Estimates Hazard 
Age   1 0.03328 1.034 -0.0277 1.028087 
Grade 1 1 -0.31020 0.734 0.2501 1.284154 
Grade 2 1 -0.12712 0.880 0.1071 1.113046 
Grade 3 1 0.19351 1.212 -0.2197 1.245703 
Grade 4 1 0.23365 1.259 -0.2483 1.281844 
Race 1 1 0.15031 1.163 -0.1313 1.14031 
Race 2 1 0.40886 1.504 -0.3862 1.471379 
Treatment 1 1 -1.03141 0.363 1.1434 3.137417 
Treatment 2 1 -0.70261 0.505 0.8498 2.339179 
Treatment 3 1 -0.25560 0.763 0.4233 1.526992 
Stage 1 1 -2.01361 0.138 2.0563 7.816993 
Stage 2 1 -1.57326 0.213 1.6454 5.183083 
Stage 3 1 -0.78178 0.459 0.8608 2.365052 
Numprims   1 0.08168 1.085 -0.0863 1.090133 
Tumor size   0.000384 1.000 -0.0004 1.000384 
AIC   358269.90  87473.62  
Log likelihood   -179115.95  -43714.81  
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4.7 Comparison of Survival Curves 
 The Table 2.16 below has the details about all the fit models with and without covariates. 
Log-logistic model outperformed Cox. However based on the data and attributable variables 
available, one can choose their best model. Table 2.15 has the comparison of Log-logistic and 
Cox PH estimates along with the hazard ratios. 
Table 4.18 Comparison of Parametric and Cox PH models 
Models Without Covariates With Covariates 
Distribution Parameters 
-Log 
Likelihood 
AIC Parameters 
-Log 
Likelihood 
AIC 
Gamma 3 49170.0137 98346.03 16 43730.415 87506.83 
Log-Normal 2 49366.8675 98737.74 15 43957.837 87959.67 
Weibull 2 49244.9480 98493.90 15 43961.9216 87967.84 
Exponential 1 49280.6023 98563.20 14 44259.2603 88560.52 
Log-Logistic 2 49175.7691 98355.54 15 43714.8089 87473.62 
Cox PH - 184307.293 368614.59 16 179115.950 358269.90 
 
4.8 Conclusion 
Women who are treated with radiation alone have a median survival of 154 months.  And 
women treated with surgery alone and both radiation & surgery reported a median survival of 25 
months. Non-parametric method for survival, based on the treatment indicated that the 
combination of radiation and surgery has the same effect on survival as treated with surgery 
alone. Also from the results of Table 4.2, women in stage-4 breast cancer can be advised to stay 
away from any treatment for a better survival. Financially, this could really save so much for 
women. Further we investigated the effect of treatment stage wise. It is an interesting observation 
that women who are identified with malignant breast cancer tumor, but have not received any 
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treatment has more survival rate when compared to women who are treated with either radiation 
or surgery or combination of both.  
This result is also supported by the results in Table 4.2.  After analyzing the breast cancer 
data using the non-parametric Kaplan Meier method, we further performed a multivariate 
approach parametrically and semi-parametrically. In parametric survival modeling, we modeled 
the data using exponential, Weibull, log-normal, log-logistic and generalized gamma. Based on 
the AIC and log-likelihood comparison, log-logistic resulted as the best fit model for the data. 
Residual plots for the log-logistic model also fall close to the straight line, supporting our choice 
of parametric model.  
Both intercepts and beta coefficients for almost all variables except for the women who 
are singled, widowed and separated, in the model are significantly differ from 0 at 0.05 level. 
Finally, we modeled Cox semi-parametric regression model and tabulated the hazard results with 
95% confidence intervals. Neither parametric nor the Cox semi-parametric models provided any 
evidence about significant differences in covariates stage, race, grade and treatment. Based on 
AIC, as anticipated, all parametric models were performed better than the cox models.  
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CHAPTER FIVE  
Breast Cancer Stage Classification using Multilayer Neural Networks using various 
Activation functions 
 
5.1 Introduction 
Artificial Neural Networks (also called connectionist models or parallel distributed 
processing systems) whose architecture and operation are inspired from our knowledge about 
biological neural cells (neurons) in the brain (59). Artificial Neural Networks (ANNs) can be 
described either as mathematical and computational models for non-linear function 
approximation, data classification, clustering and non-parametric regression or as simulations of 
the behavior of collections of model biological neurons. These are not real neurons in the sense 
that they do not model the biology, chemistry or physics of real neuron. They do, however, 
model several aspects of information combining and pattern recognition behavior of real neurons 
in a simple yet meaningful way. 
Conceptually, Artificial Neutral Networks are computing constructs which mimic the 
process of the human brain. 
Mathematically, they are a system of linked parallel equations which are solved 
simultaneously and iteratively (60). 
Artificial Neural Networks (ANNs) or in short neural networks (NNs), like people, 
learn by example. An ANN is configured for a specific application, such as pattern recognition 
or data classification (61), through a learning process. Learning in biological systems involves 
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adjustments to the synaptic connections that exist between the neurons. This is true for ANNs 
as well. 
The power and usefulness of ANNs have been demonstrated in several applications 
including speech synthesis (62), diagnostic problems and medicine (63), business and finance, 
robotic control (64), signal processing (65), computer vision and many other problems that fall 
under the category of pattern recognition. 
Neural Networks has a large appeal to many researchers due to their great closeness to 
the structure of the brain, a unique characteristic not shared by many traditional systems. 
In an analogy to the brain, an entity made up of inter connected neurons, neural networks 
are made up of interconnected processing elements called units (or nodes), which respond in 
parallel to a set of input signals given to each unit. The unit is the equivalent to its brain 
counterpart, the neuron. 
 
A typical neural network consists of four main parts: 
4. Processing units {𝑢𝑗}, where each 𝑢𝑗 has a certain activation level 𝑎𝑗(𝑡) at any point in time 𝑡. 
5. Weighted interconnection between the various processing units which determine how the 
activation of one unit leads to input for another unit. 
6. An activation rule which acts on the set of input signals at a unit to produce a new output 
signal, or activation. 
7. Optionally, a learning rule that specifies how to adjust weights for a given input output pair. 
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Figure 5.1 Architecture of ANN 
 
5.1.1 Questions of Interest 
Q1: Are MLP neural networks applicable to stage classification problems in Breast 
cancer research?  
 Q2: Under what conditions can MLP type neural networks be applied to stage 
classification problems in breast cancer data? 
Q3: What are the different kind of activation functions available in MLP neural 
networks? 
Q4: Which activation function in the training and testing of the ANN give the better 
performance? 
Q5: What is the best activation function that can be applied to neural networks for stage 
classification problems in Breast cancer research? 
Q6: How to evaluate the identified MLP type neural networks with different activation 
functions to classify breast cancer stages? 
Q7: After dropping the attributable variables from the full model that contribute less in 
breast cancer stage classification, does the reduced model perform the same as the full model? 
Artificial Neural Networks
MLPs, RBFs, Hopfield, etc
Interconnections
Feed Forward, 
Feed backward, 
Recurrent, etc
Learning
Supervised, 
Unsupervised 
Reinforcement
Activation function
Hyperbolic Tangent, 
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5.2 The First Step: McCulloch-Pitts Model 
Using one of the characteristics of the biological neuron, McCulloch and Pitts (66) 
proposed a model for artificial neuron. The neuron model proposed by them is given in the 
Figure 5.2 below and is the one that widely used in ANNs with some minor modifications on it. 
The artificial neuron given in the Figure 5.2 has N inputs, denoted as 𝑢1, 𝑢2, … , 𝑢𝑛. Each 
line connecting these inputs to the neuron is assigned a weight, which are denoted as 
𝑤1, 𝑤2 … , 𝑤𝑛 respectively. Weights in the artificial neuron corresponding to the synaptic 
connections in biological neurons. The threshold in artificial neuron is usually represented by θ 
and the activation corresponding to the graded potential is given by the formula:  
𝑎 = (∑ 𝑢𝑖𝑤𝑖
𝑁
𝑖=1
) + 𝜃 
 
Figure 5.2 Mc Culloch-Pitts Model 
 
5.3 A brief history of ANNs 
Neural network simulations appear to be a recent development. However, this field was 
established before the advent of computers, and has survived at least one major setback and several 
areas. Many important advances have been boosted by the use of inexpensive computer 
emulations. Following an initial period of enthusiasm, the field survived a period of frustration 
𝑢1 
𝑢2 
 
𝑢𝑁  
w1 
w2 
wN 
 
(∑ 𝑢𝑖𝑤𝑖
𝑁
𝑖=1
) + 𝜃 
  
x=f(a) 
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and disrepute. During this period when funding and professional support was minimal, important 
advances were made by relatively few researchers. These pioneers were able to develop 
convincing technology which surpassed the limitations identified by Minsky and Papert. Minsky 
and Papert (67), published a book in 1969 in which they summed up a general feeling of frustration 
against neural networks among researchers, and was thus accepted by most without further 
analysis. Currently, the neural network field enjoys a resurgence of interest and a corresponding 
increase in funding.  
 
5.4 Timeline of ANN 
 
1943 McCulloch and Pitts (66) proposed the McCulloch-Pitts neuron model. 
1949 Hebb published his book “The Organization of Behavior” in which the Hebbian learning 
rule was proposed. 
1958 Rosenblatt introduced the simple single layer networks called Perceptrons. 
1969 Minsky and Papert’s (67) book “Perceptrons” demonstrated the limitation of single layer 
perceptrons, and almost the whole field went into hibernation. 
 1970’s and 1980’s: ANN renaissance 
1982 Hopfield published a series of papers on Hopfield networks. 
1982 Kohonen developed the self-Organizing Maps that now bear his name. 
1986 The Back-Propagation learning algorithm for Multi-Layer Perceptrons was re- 
discovered and the whole field got attention. 
1989     Tsividis: Implemented Neural Network on a chip 
1990 The sub-field of Radial Basis Function Networks was developed. 
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2000 The power of Ensembles of Neural Networks and support vector Machines becomes 
apparent. 
 
5.5 Inspiration for ANN: Biological Prototype 
Much is still unknown about how the brain trains itself to process information, so theories 
abound (Figure 5.4).In the human brain, a typical neuron collects signals from others through a 
host of fine structures called Dendrites. The neuron sends out spikes of electrical activity through 
a long, thin stand known as an axon, which splits into thousands of branches. At the end of each 
branch, a structure called a synapse converts the activity from axon into electrical effects that 
inhibit or excite activity in the connected neurons. When a neuron receives excitatory input that 
is sufficiently large compared with its inhibitory inputs, it sends a spike of electrical activity 
down its axon (Figure 5.3). Learning occurs by changing the effectiveness of the synapse so that 
the influence of one neuron on another changes. 
 
Figure 5.3 Biological Neuron 
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Figure 5.4 Human Brain 
 
5.6 Brain versus Computers: Some interesting numbers 
1. There are approximately 10 billion neurons in the human cortex, compared with thousands 
of processors in the most powerful parallel computers. 
2. Each biological neuron is connected to several thousands of other neurons, similar to the 
connectivity in powerful parallel computers. 
3. Lack of processing units can be compensated by speed. The typical operating speeds of 
biological neurons (68) is measured in milliseconds (10–3s), while a silicon chip can 
operate in nanoseconds (10–9s). 
4. The human brain is extremely energy efficient, using approximately 10-6 joules per 
operation per second, where as the best computers today use around 10–16 joules per 
operation per second. 
5. Brains have been evolving for tens of millions of years; computers have been evolving for 
tens of decades. 
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5.7 ANN Types 
 
Feed forward: Single Layer Perceptron (69), MLP, ADALINE (Adaptive Linear Neuron) 
(70), RBF. 
Self-Organized: SOM (Kohonen Maps). 
Recurrent: Simple Recurrent Network, Hopfield Network (71). 
Stochastic: Boltzmann machines (72), RBM. 
Modular: Committee of Machines, Associative Neural Networks (ASNN), Ensembles. 
Others: Instantaneously trained, Spiking Neural Networks (SNN) (73), Dynamic, 
Cascades, Neuro Fuzzy (74), PPS, GTM (75). 
5.8 Learning methods in ANN 
As listed in previous section, there are many forms of neural networks. Most operate by 
passing neural ‘activations’ through a network of connected neurons. One of the most powerful 
features of neural networks is their ability to learn and generalize from a set of training data. 
They adapt the strengths/ weights of the connections between neurons so that the final output 
activations are correct. 
 
There are three broad types of learning: 
1) Supervised learning (i.e., learning with a teacher) 
2) Unsupervised learning (i.e., learning with no help) 
3) Reinforcement learning (i.e., learning with limited feedback) 
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Figure 5.5 ANN Architecture 
 
 
Figure 5.6 Learning Methods in ANN 
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5.8.1 Supervised learning 
Which incorporates an external teacher, so that each output unit is told what its desired 
response to input signals ought to be. In this mode, the actual output of a neural network is 
compared to the desired output. Weights, which are usually randomly set to begin with, are then 
adjusted by the network so that the next iteration, or cycle, will produce a closer match between 
the desired and the actual output. The learning method tries to minimize the current errors of all 
processing elements. This global error reduction is created over time by continuously modifying 
the input weights until acceptable network accuracy is reached. Paradigms of supervised learning 
include error-correction learning reinforcement learning and stochastic learning (76). 
With supervised learning, the Artificial Neural Network must be trained before it 
becomes useful. Training consists of presenting input and output data to the network. That is, for 
each input set provided to the system the corresponding desired output set is provided as well. 
This training is considered complete when the neural network reaches a user defined 
performance level. 
An important issue concerning supervised learning is the problem of error convergence, 
i.e., the minimization of error between the desired and computed unit values. The aim is to 
determine a set of weights which minimizes the error. One well-known method, which is 
common to many learning paradigms is the Least Mean Square (LMS) convergence (77). 
 
5.8.2 Unsupervised learning 
Uses no external teacher and is based upon only local information, it is also referred to as 
self-organization, data presented to the network and detects their emergent collective properties. 
Paradigms of unsupervised learning are Hebbian learning and competitive learning. From 
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Human Neurons to Artificial Neuron Esther aspect of learning concerns the distinction or not of 
a separate phase, during which the network is trained, and a subsequent operation phase. We say 
that a neural network learns off-line if the learning phase and the operation phase are distinct. A 
neural network learns on-line if it learns and operates at the same time. Usually, supervised 
learning is performed off-line, whereas unsupervised learning is performed on-line. 
A simple version of Hebbian learning rule (78) is that when unit 𝑖 and unit 𝑗 are 
simultaneously excited, the strength of the connection between them increases in proportion to 
the product of their activations. 
In competitive learning, if a new pattern is determined to belong to a previously 
recognized cluster, then the inclusion of the new pattern into that cluster will affect the 
representation (e.g., centroid) of the cluster. This will in turn change the weights characterizing 
the classification network. If the new pattern of ‘input-outputs’ determined to belong to none of 
the previously recognized cluster, then (the structure and the weights of) the network will be 
adjusted to accommodate the new class (cluster). 
 
5.8.3 Reinforcement learning 
For many applications, the desired output may not be known precisely. Other learning 
law have been developed based on the information whether the response is correct or wrong. 
This mode of learning is called reinforcement learning or learning with critic. 
There are many situations where the desired output for a given input is not known. Only 
the binary result that the output is right or wrong may be available. This output is called 
reinforcement signal. This signal only evaluates the output. The learning based on this evaluate 
signal is called reinforcement learning. Since this is evaluative and not instructive, it is also 
called learning with critic as opposed to learning with teacher in the supervised learning. 
 101 
 
 
5.9 Multilayer Perceptron and Radial Basis Function 
Multilayer perceptrons (MLPs) and radial basis function (RBF) networks are the two 
most commonly-used types of feed forward network. They have much more in common than 
most of the neural network literature would suggest. The only fundamental difference is the way 
in which hidden units combine values coming from preceding layers in the network--MLPs use 
inner products, while RBFs use Euclidean distance. There are also differences in the customary 
methods for training MLPs and RBF networks, although most methods for training MLPs can 
also be applied to RBF networks. Furthermore, there are crucial differences between two broad 
types of RBF network, the ordinary RBF networks and the normalized RBF networks that are 
ignored in most of the neural network literature. These differences have important consequences 
for the generalization ability of the networks, especially when the number of inputs is large. Our 
focus in this chapter will be on MLPs. A network with three layers: input, hidden and output 
layers.  
An activation function 𝑓(𝑥,𝑤𝑖)connects the weights 𝑤𝑖of a neuron I to the input x and 
determines the activation or the state of the neuron. An input function x of the formal neuron I 
corresponds to the incoming activity of the neuron, the weight w represents the effective 
magnitude of information transmission between neurons, the activation function 𝑓(𝑥,𝑤𝑖) describes 
the main computation performed by a biological neuron and the output function 𝑜𝑢𝑡𝑖  corresponds 
to the overall activity transmitted to the next neuron in the processing stream. 
 
5.10 Activation Functions 
The crucial step in MLP neural network structure is generating the net inputs by using a 
scalar-to-scalar function which is known as the "activation function" or "threshold function" or 
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"transfer function" (79). These activation functions are used to limit the amplitude of the output 
of a neuron. The typical activation functions which are used to solve the non-linear problems are 
sigmoid, tangent, softmax, radial basis functions among others. These functions further process 
the output of the neuron after initial processing has taken place and are non-linear in nature by 
transforming the weighted sum of inputs to an output value and do the final mapping. In most 
cases these functions squash the amplitude range to a limited value probably the normalized 
value. Interestingly the outputs of these functions are further processed by running more number 
of iterations unless the network attains the desired convergence. In back propagation learning the 
functions implemented should have the characteristics like the continuous, differentiable, and 
monotonically non-decreasing and output should be bounded. 
As mentioned earlier, ANNs are mostly used in modeling nonlinear data. Neural 
networks because of its nonlinear structure are used either to approximate a posteriori 
probabilities for clustering/classification or to approximate probability densities of the training 
data (80, 81). Nonlinearity is introduced into an MLP network in the form of an activation 
function for the hidden units. The nonlinearity in the network is the reason why MLPs are so 
powerful. Below are few important papers surveyed which show that the choice of transfer 
functions is considered by some experts to be as important as the network architecture and 
learning algorithm.  
G. Cybenko (1989), K. Hornik et al. (1989) in their research articles (82, 83) discussed 
about using sigmoidal functions generating sigmoidal outputs as universal approximators. 
However E. J. Hartman, et al. (1990) and J. Park, et al. (1991) also termed Gaussian outputs also 
as universal approximators (82, 83). Hartman and Keeler (1991) proposed a new activation 
function called Gaussian bars (84). Pao (1989) in his book “Adaptive Pattern Recognition and 
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Neural Networks” discussed about using a combination of various activation functions (85). 
Simon Haykin and Leung (1993) were very successful with using radial transfer functions (86). 
Dorffner (1994) using conic section function networks introduced new transformation 
functions that change smoothly from sigmoidal to Gaussian-like (87). Girauld, et al. (1995) 
introduced simplified Gaussian functions called Lorentzian transfer functions which are widely 
used in many research works (88).  
Two most popular feed forward neural networks models, the multi-layer perceptron 
(MLP) and the Radial Basis Function (RBF) networks, are based on specific architectures and 
the transfer functions. Below are few activation functions in detail. 
 
5.10.1 Identity Function 
The Identity function is also known a linear function. The output of the function is same 
as the input variable. Sometimes a constant is used to multiply it to form a linear function with 
scaled magnitude. The activation function needs to introduce non linearity in to the networks for 
the network to be robust. 
( )f x x  
( )f x kx  Where k is a scaling constant 
 
Figure 5.7 Identity Function 
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5.10.2 Binary Step Function 
This function is also known as the Heaviside function or threshold function or hard limit 
function, with threshold θ. The output is always a binary value and it is decided by the function. 








xif
xif
xf
    
    0
)(
 
 
Figure 5.8 Binary Step Function 
 
5.10.3 Saturating linear function 
This function is also known as ramp function or piece wise linear sigmoid function (89) 
combines the Heaviside function with a linear output function. 
𝑓(𝑥) = {
0,        𝑥 ≤ 0
𝑥, 0 < 𝑥 < 1
1, 𝑥 ≥ 1
 
 
Figure 5.9 Ramp Function 
 
 
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5.10.4  Sigmoid Functions 
Sigmoidal output functions smooth out many shallow local minima in the total output 
functions of the network. For classification type of problems this may be desirable, but for 
general mappings it limits the precision of the adaptive system (90). This is the most commonly 
used transfer function in MLP as it gives good results in most cases and can dramatically reduce 
the computation burden of training. The term sigmoid mean a graph which is 'S-shaped' curve. It 
is most commonly used function in the neural networks where the training is implemented by 
using the back propagation algorithms. The significance of this function is that the computation 
capacity for training is reduced and can be distinguished easily. 
Uni-polar sigmoid 
The output of this function is bounded to [0, 1]. The function gets zero to as the value of 
x tends to infinity in the negative side. Its analytic equation is given below. 
𝑓(𝑥) =
1
1 + 𝑒𝑥
 
 
Figure 5.10 Uni-polar Sigmoid Function 
Bi-Polar Sigmoid Function 
The bi-polar sigmoid function is similar to the uni-polar sigmoid except that the limits of 
the output range between [-1, 1].  
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𝑓(𝑥) =
1 − 𝑒𝑥
1 + 𝑒𝑥
 
Bipolar binary and uni-polar binary are called as hard limiting activation functions used 
in discrete neuron model. Uni-polar continuous and bipolar continuous are called soft limiting 
activation functions are called sigmoidal characteristics.  
 
Figure 5.11 Bi-Polar Sigmoid function 
 
5.10.5 Hyperbolic Tangent Function 
 
The hyperbolic transfer function also ranges between [-1, 1]. This function is 
implemented in the replication of the sigmoid function where the output range is varying 
between -1 to 1. 
𝑓(𝑥) =
𝑒𝑥 − 𝑒−𝑥
𝑒𝑥 + 𝑒−𝑥
=
sinh 𝑥
cosh 𝑥
= tanh 𝑥 
0 
1 
 
-1 
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Figure 5.12 Hyperbolic Tangent function 
 
5.10.6 Radial basis functions (RBFs) 
As MLP's implement sigmoidal transfer functions, RBFs typically use Gaussian 
functions. Both types of networks are universal approximators. This is an important, but almost 
trivial property, since any network using non-polynomial transfer functions are always universal 
approximators. The speed of convergence and the complexity of these networks to solve a given 
problem is more interesting.  
𝑔(𝑥, 𝑐) = 𝑔(||𝑥 − 𝑐||) 
𝑦(𝑥) = ∑ 𝑤𝑖𝑔(||𝑥 − 𝑐𝑖||)
𝑁
𝑖=1
 
 Where𝑦(𝑥) is represented as a sum of N radial basis functions and each of them 
are associated with a different center ci and weighted by an appropriate weight 𝑤𝑖and 𝑤𝑖can be 
obtained by the matrix methods of linear least squares.(91) 
0 
1 
 
-1 
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Figure 5.13 Radial basis function 
 
5.11 Evaluation of model performance 
 The methods used for the model performance evaluation of different neural networks 
include comparison of area under ROC curves, positive predictive values (PPVs) and overall 
accuracy. The values of training and testing the full and reduced models were evaluated and 
tabulated in the following sections. In the ROC graph the diagonal line represents diagnostic test 
where sensitivity equals (1– specificity) which refers that the test has no diagnostic value. A test 
where both sensitivity and specificity are close to 1, which in turn will return a ROC value also 
close to 1, has good diagnostic ability. 
5.11.1 Accuracy, ROC, PPVs 
Receiver operating characteristic (ROC) curves (92) are frequently used to compare the 
diagnostic qualities of statistical models. For a given confidence threshold, the fraction of 
negative outcomes that are correctly identified as negatives is called the true-positive fraction 
(TPF = sensitivity) and the fraction of the positive outcomes that are correctly identified is called 
the true-negative fraction (TNF = specificity). The false-positive fraction (FPF) and the false-
negative fraction (FNF) are defined in the same way. Confusion matrix generated for a model 
gives all these details of classification. For the actually positive and the actually negative 
outcomes, probability distributions can be derived for the various states of truth. 
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Table 5.1 Classification Table 
X 
Actual State 
Positive Negative 
Considered 
positive 
True positive (TP) False positive (FP) 
Considered 
negative 
False negative 
(FN) 
True negative 
(TN) 
 
There are three components to predict the accuracy:  the amount and quality of the data, 
the predictive power of the prognostic factors, and the prognostic method’s ability to capture the 
power of the prognostic factors (93). This study is mainly focused on the area under curve 
(AUC). The measure of comparative accuracy is the trapezoidal approximation to the area under 
the receiver operating characteristic curve. The area under this curve is a nonparametric measure 
of discrimination. While squared error summarizes how close each individual’s survival 
prediction is to the true outcome, the receiver operating characteristic area measures the relative 
goodness of the set of predictions as a whole by comparing the predicted probability of each 
individual with that of all pairs of individual s. This area is calculated using the predictive scores 
of each algorithm in order to compare their average accuracy in predicting outcome. The receiver 
operating characteristic area is independent of both the prior probability of each outcome and the 
threshold cutoff for categorization, and its computation requires only that the algorithm produce 
an ordinal-scaled relative predictive score. In terms of mortality, the receiver operating 
characteristic area estimates the probability that the algorithm will assign a higher mortality 
score to the patient who died than to the patient who lived. The receiver operating characteristic 
area varies from 0 to 1. When the prognostic score is unrelated to survival, the score is 0.5, 
indicating chance accuracy. The farther the scoreisfrom0.5, the better, on average, the prediction 
model is at predicting which of the individuals who will survive. Positive predictive values 
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(PPVs) refers to the chance that a positive test result will be correct, negative predictive value is 
concerned only with negative test results. The interesting thing about positive and negative 
predictive values is that they change if the prevalence of the disease changes. In fact, for any 
diagnostic test, the positive predictive value will fall as the prevalence of the disease falls while 
the negative predictive value will rise (94).  
5.12 Breast Cancer stage classification using various activation functions 
In traditional regression, a specific equation must be predetermined based on the data in 
the system in order to find a relation between the inputs to output variable. Whereas the general 
structure of an ANN can be applied practically on any system. Also, ANNs have been shown to 
outperform regression models when outliers exist in the data and a MLP neural network with an 
appropriate activation function in the hidden layer is always considered as a better model. 
 
The objective of using MLP neural networks in this chapter is to be able to classify stages 
of breast cancer data.  In order to classify the stages we hves chosen MLP network as the 
classifier. We designed different feed forward MLP networks with one hidden layer with 
different inputs. One hidden layer MLP is almost always sufficient to approximate any 
continuous function up to certain accuracy (95). It is proven in many situations that MLPs 
possess the ability to learn and give the better performance especially in the case of 
classification. The MLP network has to be trained before it able to perform specific task with 
less error. In this study we used 33152 (70%) data for training, 14015 (30%) data for testing the 
trained network.  
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Table 5.2 Activation Functions 
Activation function Definition 
Linear ( )f x x  
Binary step 






0,1
0,0
)(
x
x
xf  
Ramp function  or 
Saturating linear 








1,1
10,
0,0
)(
x
xx
x
xf  
Uni polar Sigmoid  
1
1 x
f x
e


 
Bi-polar  
1
1
x
x
e
f x
e





 
Hyperbolic tangent  
sinh( )
cosh( )
x x
x x
e e x
f x
e e x



 

 
Radial Basis Function 
𝑔(𝑥, 𝑐) = 𝑔(||𝑥 − 𝑐||) 
𝑦(𝑥) = ∑ 𝑤𝑖𝑔(||𝑥 − 𝑐𝑖||)
𝑁
𝑖=1
 
 
 
In this study we compared the performance of an MLP network by using different 
activation functions. Every MLP network consists of an input layer, hidden layer and an output 
layer. For all the MLPs with different activation functions hidden nodes are selected 
automatically based on the requirement for training. The best number of hidden nodes required 
in the hidden layer depends on the number of inputs and outputs, amount of noise in the  
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Table 5.3 Input Variables & types 
Input 
Variables 
Modalities Details 
Tumor Size Real 1mm – 998mm 
Treatment Categorical 
1= No Treatment 
2= Radiation 
3=Radiation & Surgery 
4= Surgery 
Age Real 21 - 102 
Number of  
primary tumors 
Real 
1,2,3,4,5 = able to detect 
9 = not able to be detected 
Grade Categorical 
1=Well differentiated 
2=Moderately differentiated 
3=Poorly differentiated 
4=undifferentiated 
9=Cell type not determined 
Marital Status Categorical 
1 = Single 
2 = Married 
3 = Separated 
4 = Divorced 
5 = Widowed 
9 = Unknown 
Race Categorical 
1 = Whites 
2 = African Americans 
3 = Other races 
Duration Real 1-203 months 
 
targets, activation function used. Rules of thumb don't usually work. The number of hidden 
neurons decided upon training stage of the MLP networks. Four output neurons for four stage 
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classification are needed to classify the class of the target outputs. The performances of the MLP 
networks will be evaluated in terms of percentages for correct classification, defined as the 
difference between the actual and the simulated results and by ROC analysis.  
The work in this chapter is divided into two parts. In the first part we designed six neural 
networks models using all combinations of activation functions with all the inputs including 
tumor size, treatment, age, number of preliminary tumors, and grade of the tumor, marital status 
and race of women to classify their stage of breast cancer. At the end of first part of work, our 
objective is to find the best combination of activation function pair that classifies the breast 
cancer stages, by comparing the number of hidden nodes, positive predictive values (PPVs), 
percent of correct classification and comparing ROCs (96). Table 5.2 has the details of input 
variables used in modeling the neural networks. After identifying the best activation function, in 
our second part of work, we tried to reduce the neural network model by eliminating the inputs 
which perform the least. Inputs which fall below 5% normalized importance are eliminated and 
the networks are rerun to check the efficiency of the model. 
For the first part, fixing Hyperbolic Tangent as the activation function for hidden layer, 
we used softmax, hyperbolic tangent, sigmoid as the transfer functions in output layer. Later 
fixing sigmoid function as activation function we have used the softmax, hyperbolic tangent, 
sigmoid as the transfer functions in output layer. This resulted in total of 6 different models. 
 Results of 6 full models with the percentage of correct predictions, positive predicted 
values (PPVs) during training and testing along with stage wise area under curve values are given 
in Table 5.3 and Table 5.4. From these tables, the model with hyperbolic tangent and softmax 
function has a better prediction with less number of hidden nodes. Figure 5.14 gives the ROC of 
the selected model.  
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Table 5.4 Full Model stage classification probabilities 
Full Model details Positive Predictive Probabilities  
Training 
Number 
of hidden 
units 
P(1|1) P(2|2) P(3|3) P(4|4) 
Overall 
Accuracy 
HT– Softmax 8 88.9% 75.0% 41.9% 33.8% 79.0% 
HT – HT 9 91.7% 73.7% 45.3% 26.3% 79.8% 
HT – Sigmoid 9 90.4% 76.4% 0% 0% 77.0% 
Sigmoid – Softmax 9 89.5% 74.5% 46% 26% 79.1% 
Sigmoid – HT 9 90.6% 75.1% 40.7% 1.2% 79.0% 
Sigmoid – Sigmoid 9 91.7% 73.7% 50.9% 0% 79.4% 
Testing  
HT– Softmax 8 88.9% 75.0% 39.3% 28.8% 78.8% 
HT – HT 9 92.1% 72.7% 43.0% 26.1% 79.5% 
HT – Sigmoid 9 90.9% 76.1% 0% 0% 77.6% 
Sigmoid – Softmax 9 89.8% 74.5% 45.1% 23.7% 79.1% 
Sigmoid – HT 9 90.8% 73.5% 43.1% 0.8% 78.5% 
Sigmoid – Sigmoid 9 91.7% 72.5% 51.2% 0% 79.0% 
HT-Hyperbolic Tangent 
Figure 5.15 and Figure 5.16 are the performance analysis of PPVs for training and testing of 
the full models. From these figures and the results given in Table 5.3 and Table 5.4, though the 
sigmoid-softmax pair has comparatively same results like hyperbolic tangent-softmax pair, we 
prefer to select hyperbolic tangent-softmax pair for the following reasons. A MLP model with the 
best performance using less number of hidden units is considered as the best ANN representing 
the problem. Hyperbolic tangent-softmax model uses only 8 hidden units whereas softmax-
sigmoid network uses 9 hidden units. Also since the hyperbolic tangent activation function has a 
derivative, it can be used with gradient descent based training methods. The hyperbolic tangent 
activation function is perhaps the most common activation function used for neural networks. The 
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hyperbolic tangent function provides similar scaling to the sigmoid activation function, however, 
the hyperbolic tangent activation function has a range from -1 to 1. Because of this greater numeric 
range the hyperbolic activation function is often used in place of the sigmoid activation function. 
The neural network diagram for the selected full model is given in Figure 5.17. 
 
 
 
Table 5.5 ROC values of full models 
Activation 
Functions 
AUROC Stages 
 1 2 3 4 
HT– Softmax 0.911 0.866 0.910 0.910 
HT– HT 0.910 0.866 0.882 0.895 
HT– Sigmoid 0.910 0.859 0.909 0.886 
Sigmoid – Softmax 0.912 0.868 0.913 0.919 
Sigmoid –HT 0.909 0.863 0.862 0.881 
Sigmoid – Sigmoid 0.910 0.862 0.909 0.882 
HT-Hyperbolic Tangent 
Figure 5.14 ROC of the full model 
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Figure 5.15 Testing performance of full models 
HT-Hyperbolic Tangent; SM-Softmax; S-sigmoid 
 
Figure 5.16 Testing performance of full models 
HT-Hyperbolic Tangent; SM-Softmax; S-sigmoid 
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Figure 5.17 Full MLP model  using Hyperbolic tangent-softmax activation function 
 118 
 
5.13 Reduced Neural Network Model and Conclusion 
After identifying that the neural network using the combination of hyperbolic tangent-
softmax pair as the best neural network model for breast cancer stage classification, we further 
proceed to identify the reduced neural network model. Using the same activation pair selected 
from full model we try to find reduced model, if any, by using fewer input units and/or hidden 
units which can perform equivalent to full model or even better than the full model. In order to do 
this, we rerun a neural network model by eliminating the input variables from the full model which 
have less than 5% normalized importance in performance of breast cancer stage classification.  
 
Table 5.6 Importance and Normalized Importance of input variables 
Inputs 
HT – SM HT – HT HT – S S – SM S – HT S – S 
Imp N.Imp Imp N.Imp Imp N.Imp Imp N.Imp Imp N.Imp Imp N.Imp 
M_STATUS .021 3.8% .064 14.6% .090 15.3% .025 4.2% .037 7.6% .040 6.9% 
RACE .018 3.4% .016 3.6% .018 3.1% .018 3.0% .013 2.7% .016 2.8% 
GRADE .025 4.6% .037 8.5% .035 6.0% .023 3.9% .050 10.3% .033 5.7% 
TREATMENT .127 23.4% .150 34.3% .069 11.7% .111 18.7% .134 27.6% .110 19.3% 
AGE .059 10.9% .106 24.3% .095 16.2% .048 8.1% .103 21.3% .118 20.7% 
NUMPRIMS .085 15.7% .108 24.7% .060 10.2% .021 3.5% .099 20.5% .034 6.0% 
TUMOR_SIZE .543 100.0% .437 100.0% .586 100.0% .593 100.0% .484 100.0% .573 100.0% 
DURATION .121 22.3% .083 18.9% .047 8.1% .162 27.3% .081 16.8% .075 13.0% 
 
From Table 5.5 for the selected activation pair of full model neural network, the input 
variables race, marital status and grade are the variables fall below 5% normalized importance and 
are eligible for elimination. Eliminating these input variables we modeled a reduced network 
model to perform stage classification of breast cancer. The reduced model has 8 input variables, 6 
hidden units to classify breast cancer stages compared with 22 inputs and 8 hidden units of full 
model. An output equation of ANN will be a composite function given as  
 
𝑦𝑖 = 𝑓 {∑ 𝑔 (∑(⦁))} ;   
𝑤ℎ𝑒𝑟𝑒 𝑖 = 1,2,3,4;  𝑓(⦁) 𝑖𝑠 𝑡ℎ𝑒 𝑜𝑢𝑡𝑝𝑢𝑡 𝑓𝑢𝑛𝑐𝑡𝑖𝑜𝑛  𝑎𝑛𝑑 𝑔(⦁)𝑖𝑠 𝑎 ℎ𝑖𝑑𝑑𝑒𝑛 𝑙𝑎𝑦𝑒𝑟 𝑜𝑢𝑡𝑐𝑜𝑚𝑒 
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Table 5.7 Training and Testing results of the reduced neural network model 
 Positive Predictive Probabilities  
Reduced 
Model 
details 
ANN 
Architecture 
I – H – O 
P(1|1) P(2|2) P(3|3) P(4|4) 
Overall 
Accuracy 
Training 8-6-4 89.8% 74.2% 49.8% 30.3% 79.5% 
Testing 8-6-4 90.0% 73.5% 49.2% 24.9% 79.0% 
I-Input units; H-Hidden units; O- Output units 
 
 
 
Figure 5.18 ROC of the reduced neural network model 
 
Table 5.8 ROC Comparison for Full and reduced models 
Models Stage-1 Stage-2 Stage-3 Stage-4 
Reduced Model 0.911 0.868 0.912 0.915 
Full Model 0.911 0.866 0.910 0.910 
 
Table 5.6 has the results of reduced neural network architecture, positive predictive values, 
and overall accuracy of training and testing classification results. The reduced model area under 
curve and full model area under curve results are compared and presented in Table 5.7. Reduced 
model works efficiently using 8 input units and 6 hidden units only. Figure 5.18 gives the ROC of 
the reduced model. Reduced model performed almost close to the full model but with fewer units 
in input and hidden layers. Clearly the reduced model with hyperbolic tangent-softmax activation 
pair is opted as précised one for breast cancer stage classification.  
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CHAPTER SIX  
A Comparison of Artificial Neural Network and Decision trees with Logistic Regression as 
Classification Models for Breast Cancer Survival 
 
6.1 Introduction 
Computer models are being employed actively in the clinical diagnostic field to 
differentiate between healthy and disease suffering patients. These computer models are 
responsible in facilitation of making accurate decisions towards likelihood of disease based on 
certain characteristics of the patient. Many different modeling techniques have been developed, 
tested and refined.  These techniques include both statistical (Linear Discriminant Analysis, 
Logistic Analysis, etc.) and non-statistical techniques (Decision Trees, k-Nearest Neighbor, 
Cluster Analysis, Neural Networks, etc.).  Each technique utilizes different assumptions and may 
or may not achieve similar results based upon the context of the data. Three of such models 
developed are regression methods, decision trees and artificial neural networks. Regression 
methods were termed as the study of dependence (97). This means it measures or calculates the 
relationship between dependent variable and one or more independent variables. Regression 
models are central part of many research projects. It has been used to predict the survival of 
critical conditioned patients who are generally admitted to intensive care unit as a function of 
physiological variables (98). Basically, regression models are classified into two main categories 
i.e. linear models and logistic regression models. The logistic regression model is quite often 
employed technique in data analysis. It is considered as a well-known classification modeling 
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that allows probabilistic decisions and shows promising results on several problems. Like all 
others regression models, which are used for description, control and prediction, logistic model 
(also called as logit model) produce similar results with a best fitting which is considered as a 
clinically interpretable model.  
Survival analysis can be considered a classification problem in which the application of 
machine-learning methods is appropriate. By establishing meaningful intervals of time according 
to a particular situation, survival analysis can easily be seen as a classification problem. Survival 
analysis methods deals with waiting time, i.e. time till occurrence of an event. Commonly used 
method to classify this sort of data is logistic regression. Sometimes, the underlying assumptions 
of the model are not true. In model building, choosing an appropriate model depends on 
complexity and the characteristics of the data that affect the appropriateness of the model. Two 
such strategies, which are used nowadays frequently, are artificial neural network (ANN) and 
decision trees (DT), which needs a minimal assumption. This study aimed to compare 
predictions of the ANN, DT and logistic models by breast cancer survival.  
6.2 Questions of Interest 
Q1: What are the significant attributable variables which play an important role in 
classifying breast cancer survival? 
Q2: What are the different models using different classification methods will be able to 
give improved prediction of survival in breast cancer women? 
Q3: Which of the following techniques will produce the model with the highest precision 
in classifying the breast cancer survival data: logistic regression, decision trees, or neural 
networks?   
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Q4: How does ANN model and decision tree model perform compared with logistic 
regression model in the analyses breast cancer survival using different input variables for the 
same individuals?  
Q5: Are there any benefits of Artificial Neural Network analyses (ANN) and decision 
tree models compared with logistic regression analyses? 
Q6: Using the identified model, what is the probability of survived subject is correctly 
classified as survived and not survived woman as not survived? 
Q7: Will the model selection vary based on the selected evaluation method? 
 
6.3 Logistic Regression 
The linear logistic regression assumes that natural logarithm of odds is in linear 
relationship with corresponding independent covariates. The linear logistic function is 
characterized by three main components. They are random experiment (identifies the PDF of 
response variable), a systematic component (linear relationship of explanatory variables which 
are used as predictors), link function (describes relationship between the first and second 
components). The logistic regression is distinguished from linear model based on its binary 
outcome. Logistic model is a type of predictive model which relates two categories of variables 
like dependent variables (dichotomous or binary outcome either 0 or 1) and independent 
variables (predictor or explanatory variables). In the binary response model, an individual takes 
one of the two possible outcomes. Some of the expected binary outcomes are active-inactive, 
healthy-unhealthy, normal-abnormal etc. For example the probability of officer promotion would 
relate to his characteristics like annual performance and CEP. This model estimates or predicts 
by fitting the occurrence of events into logistic curve. A broad choice of aspects using various 
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links functions that describe the relationship between the probability distribution of response 
variables and the linearity of explanatory variables are listed below. 
1. The logistic function:  𝑔1 (𝜋)  =  𝑙𝑜𝑔 {𝜋/(1 − 𝜋)} 
2. The inverse normal function:  𝑔2(𝜋)  =  Ф − 1 (𝜋) 
3. The complementary log – log function: 𝑔3 (𝜋)  =  −𝑙𝑜𝑔 {−𝑙𝑜𝑔 (1 − 𝜋)} 
4. The log – log function:  𝑔4 (𝜋)  =  −𝑙𝑜𝑔 {−𝑙𝑜𝑔 (𝜋)} 
Apart from this logistic function also possess one important characteristic feature is its 
overall transformations in that it is eminently suited for analysis of data collected. Logistic 
regression architecture is given in Figure 6.1. For example, one can try to predict whether a 
subject will suffer from heart attack at a specified time based on certain characteristics like 
person age, sex, habitats etc. Logistic regression is extensively used in medical diagnosis like 
brain injury, different types of cancer prediction like breast, cervical, prostate etc. More details 
can be found in text book Applied Logistic Regression of Hosmer and Lemeshow (99). Example 
of logistic curve is shown in Figure 6.2. 
 
Figure 6.1 Architecture of Logistic regression 
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Figure 6.2 Logistic Curve 
In case of polytomous response model, the response of a specific item or individual is 
restricted to only a fixed set of possible values. The binary response model falls under the 
category of polytomous response model as a special case. The logit models utilize the ordering of 
response variables by nature. One such example is usage of rating scales in testing of food and 
wine tasting. 
McFadden (100) was the first person who linked the multinomial logit function to theory 
of mathematical psychology and received Nobel Prize in 2000. And many more articles in the 
21st century have made their own and unique way of importance to logistic regression. At present 
wide range of applications using logistic function are being explored in various fields like 
medicine, biological sciences, sociology, psychology, business, management etc. 
In our present work, the outcome variable, survival prediction with breast cancer or 
otherwise is predicted from the knowledge of the patient’s age, tumor size, stage of cancer, 
treatment, administered and duration. 
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6.4 Timeline of Logistic Function 
 
6.4.1: 19th Century 
Alphonse Quetelet (1795-1874), Belgian astronomer turned statistician was first person 
who extrapolated the exponential growth of human population. Pierre-Francois Verhulst (1804-
1847) derived the expression and named the expression as ‘Logit function’ (102). He included 
the expression, functions, properties and applications in three papers published at Proceedings of 
the Belgian Royal Academy (101). 
 
6.4.2: 20th Century 
1920-1930 
Until 1920 there are no specific articles or reviews that discuss about logistic functions. 
Raymond Pearl and Lowell J Reed (1920) were the persons who discovered the logistic function 
for the study of population growth of United States of America. The curve gave a good fit for 
population during the period of 1790 to 1910. They do not have the knowledge of Verhulst 
works on Logit function. Berkson and Reed (1929) published papers on the application of logit 
function (103) to autocatalytic reactions in Proceedings of the National Science Academy of 
Sciences. Yule (1925) was the first person who provoked the name of logit function and 
appreciated the works of Verhulst in his papers in Yule’s Presidential Address of the Royal 
Statistical Society (104). 
1930-1940 
Gaddum and Bliss (1933-1934) introduced the probit model also called as “Probability 
Unit”. But the authors gave more importance to logarithmic transformations rather than common 
normal distributions in bioassay for the study of stimulus and its responses. 
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1940-1950  
Berkson (1944) was the first person who substituted ‘Probit’ with ‘Logit’ by conducting 
many experiments on the method of maximum likelihood estimation and its advocacy in 
minimum chi-square estimation which were not approved at that time (105).Wilson(1943)was 
probably the first person to publish as application of the logistic function in bioassay in Wilson 
and Worcester. 
1960-1970 
Cox (1960-1970) gave equal importance to logit functions compared with probit 
functions in his articles published in JSTOR electronic repertory, which is one among the 12 
major statistical journals in the English language. He covered the importance of multinomial 
generalization of logit function (37). 
1970-1980 
Mckelvey and Zavoina (1975) formulated the latent regression model for an ordered 
probit model of the voting behavior of United States congressmen (106). In 1977 BDR 
(Biomedical Data Processing) which is a computer package offered the facility of maximum 
likelihood estimation of logit and probit functions. 
 
6.4.3: Recent Trends 
Ever since the demand for logistic regression has increased tremendously, many articles 
in name and application of function evolved in many international journals. Few of much cited 
works are listed below for reference. 
1991: The Importance of Assessing the fit of Logistic Regression Models (106). 
1993: Nontraditional Regression Analysis (107) 
1995: Regression Shrinkage and Selection via the Lasso (108) 
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1997: A Comparison of Goodness-of-Fit tests for the Logistic Regression Models (109). 
1999: Additive Logistic Regression: A Statistical View of Boosting (110). 
 
6.4.4 Underlying assumptions 
There were many numbers of assumptions made to the logistic regression compared to ordinary 
regression methods.  
8. The data collected is assumed to be completely randomized during the assignment of 
treatments to experimental subjects. 
9. Multinomial logistic regression does not consider the sample size estimations and 
identifications of outliers. 
10. The attracting aspect of multinomial logistic regression analysis is, it does not assume 
normality, linearity and homoscedasticity. In order to meet the requirements multinomial 
logistic regression is subjected to discriminant analysis because this analysis does not have 
any presumed assumptions. 
11. The assumption of independent variables by logit function can be tested by McFadden-
Hausman test (111). 
12. Furthermore, Multinomial logistic regression assumes non-perfect separation which means if 
the outcomes of variables can be separated by predictor variables then unrealistic coefficients 
appear which influence the size. 
 
6.4.5 Fitting the Logistic Regression Model and Significance Tests 
Consider a sample size of n with observations 𝑥1, 𝑥2, 𝑥3, … . 𝑥𝑛which denote the predictor 
variables that produce the binary output either Y=0 (absence) or Y=1(presence) of the disease. 
‘Y’ represents the dichotomous outcome variable corresponding to the xi value of the 𝑖𝑡ℎvariable. 
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Assuming each of these variables is at least scaled interval, the conditional probability that is 
present denoted by 𝑃(𝑌 = 1|𝑥)  =  𝜋 (𝑥) where π denotes the probability of disease is present. 
The probability of outcome is related to the potential predictor variables by the equation of the 
form 
𝑙𝑜𝑔𝑖𝑡 [𝜋(𝑥)] = 𝑙𝑜𝑔
𝜋 (𝑥)
1 − 𝜋 (𝑥)
=  𝛼 + 𝛽1𝑥1 +  𝛽2𝑥2 +  … … + 𝛽𝑘𝑥𝑘 
Where(𝛼, 𝛽1, 𝛽2 … 𝛽𝑛) are termed as the regression coefficients of the predictor variables  
(𝑥1, 𝑥2, 𝑥3 … . 𝑥𝑛 ). The coefficients of regression are extracted from the availability of data. The 
regression coefficients measure the percentage of contribution of predictor variables towards the 
outcome. This prediction is generally followed by the odds ratio of independent variable. The 
odds ratio is estimated by taking the exponential ratio of the coefficient (say:𝑒𝑥𝑝 (𝛽1)). For 
example the odds ratio for breast cancer can be estimated by taking into consideration the age as 
independent variable along with exponential function of regression coefficient. This estimation 
represents the likelihood of occurrence of breast cancer based on age. The use of probability 
values determines the importance of variables in terms of statistical significance in producing 
outcomes. Increasing the sample size, predictors with small effects on the outcomes become 
statistically significant. Hence, the selection of significant variables is important in such a 
prediction. This selection is usually compelled either by forward or backward selection or step-
wise selection depending upon the size of the sample. Sometimes clinically important variables 
may show statistically insignificant prediction of outcomes due to influence of strong predictors. 
In such case the criterion level of significance can be increased to avoid conflicts. 
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6.4.6 Survival prediction using Logistic, ANN and Decision tree modeling 
In this chapter, using the same input and output variables we established four models 
using both logistic regression, ANNs, decision trees and compared their performances.  
Event history models and logistic regression models are the two commonly used analyses 
of survival, where the former models use target survival as a continuous variable of survival 
time, while the latter models use a fixed survival length. The target is thus a dichotomous 
variable, survived or not. In this chapter, using logistic regression model as a classifier we 
predict the survival of breast cancer women. 
The main idea of this chapter is to design four models with significant attributable 
variables to predict the survival of a breast cancer woman. The significant independent variables 
used in this modeling are selected by logistic regression analysis. As discussed earlier, logistic 
regression is a statistical technique used to examine the relationship between a dependent 
variable (survival or otherwise) and a one or more independent variables (numerical or 
categorical). Initially, we have used all the independent variables including: tumor size, age, 
stage of cancer, treatment, duration, grade of tumor, race, marital status, and number of primary 
tumors. Based on the logistic regression results the independent variables grade of tumor, race, 
marital status, and number of primary tumors nor their interaction terms were not statistically 
significant in providing the best prediction of survival of breast cancer women. Leaving these 
insignificant variables out of the modeling we designed four models inputting one variable at a 
time. The output vector in these models contains two variables for each case: predicted survival 
either 0 (not survived/dead) or 1 (survived/alive). A number between 0 and 1 gives an estimate 
of the accuracy of the predicted value.  
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The first model, named model-1 is using two variables including: age and tumor size 
only. The second model, named model-2 is using three variables including: age, tumor size, and 
stage of cancer. The third model, namely model-3 includes treatment along with the three 
variables chosen in model-2. The last model, model-4 has the variables including: age, tumor 
size, and stage of cancer, treatment and duration. In all these models our output is to predict the 
survival or otherwise of a breast cancer women. We interpret this overall accuracy, as a measure 
of the reliability of a given estimate. 
Table 6.1 summarizes the specificity, sensitivity and overall accuracy results of the four 
logistic regression models. Table 6.2 has the ROC area values for the four logistic models. The 
results showed that the overall accuracy jumps from 70.42% for model-3 to 80% for model-4. 
This is not a surprising result. As anticipated, duration of stay for a woman with breast cancer, 
during the study period has a lot of importance for predicting accurate survival. The logistic 
regression model-1 yielded a ROC area of 68.8%, and sensitivity to survival of 95% gave a 
specificity of only 25%, model-2 with a ROC area of 71% and sensitivity to survival of 95% has 
a specificity of 30%. For the remaining two models the ROC area is 71.8% and 85.5% 
respectively and the sensitivity to survival of 95% has a specificity of 29% and 61% respectively. 
The results of model-4 logistic regression providing with overall accuracy of 80% along with 
81.54% specificity, 76.82% sensitivity and 61% specificity at 95% sensitivity is often desirable. 
The sensitivity and specificity of all the four models with their respective confidence intervals 
are given in Table 6.1.  For computing confidence intervals for sensitivity and specificity see 
Altman et al. The ROC graphs of the four logistic models are given in Figure 6.3.  
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Table 6.1 Sensitivity, specificity and overall results of Logistic regression models 
Logistic 
Regression 
Model 
Sensitivity (%) Specificity (%) 
Accuracy 
(%) value 95% C.I value 95% C.I 
LR 1 68.01 (67.04, 68.96) 69.45 (68.99, 69.91) 69.2 
LR 2 67.31 (66.39, 68.21) 70.47 (70.0, 70.93) 69.78 
LR 3 67.69 (66.80, 68.55) 71.26 (70.78, 71.72) 70.42 
LR 4 76.82 (76.14, 77.47) 81.54 (81.11, 81.97) 79.98 
 
Table 6.2 LR models ROC area values 
LR 
Models 
ROC 
At 95% 
sensitivity 
Specificity 
LR-1 68.8% 25% 
LR-2 71.0% 30% 
LR-3 71.8% 29% 
LR-4 85.5% 61% 
 
 
 
 
 
 
LR-2 LR-1 
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Figure 6.3 ROC graphs for four LR models 
 
6.5 ANN Perceptron Classification 
Major amount of research works during 1960’s were carried under the name of 
“Perceptron”. Frank Rosenblatt (1958) was the person who coined the term “Perceptron” in his 
psychological magazine (112). The word perceptron is derived from English word “Perception” 
which means ability of an individual to understand. He has written in his book named 
“Principles of Neurodynamics” on how to train these kinds of neurons to enable them perform 
pattern recognition tasks. He further provided information on how perceptron provide solution to 
particular problem in finite number of steps. The perceptron turns out to be McCulloch-Pitts 
model which mean a neuron with weighted outputs and with additional pre-processing. 
 
6.5.1 Definition of Perceptron 
A perceptron can be termed as a classification of different sets of data probably unseen 
data sets into learned ones. The structure of perceptron possesses a number of inputs, a bias and 
an output. A simple schematic diagram of perceptron is shown in Figure 6.4. 
 
LR-4 LR-3 
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Figure 6.4 A simple perceptron 
Another definition of perceptron can be considered as “An arrangement of one input 
layer of McCulloh-Pits neurons feeding forward to one output layer of McCulloch-Pitts neurons 
is known as perceptron”. 
6.5.2 Multilayer Perceptron 
The concept of multilayer perceptron is built using number of single layer neurons. Each 
of the perceptron layers is used to solve nonlinearly separable problems by breaking them into 
small linearly separable sections of inputs provided. The outputs of each individual perceptron is 
extracted and combined with another series of perceptrons to obtain final output. In most cases 
the hard-limiting function (step function) is used for producing outputs. This step function 
prevents the information of the inputs to overflow into the inner neurons. To solve this problem 
step function is replaced with a sigmoid function. In a multilayer perceptron, the neurons are 
arranged in order of the input layer, one or more hidden layers and an output layer as shown in 
Figure 6.5. The architecture (113) is designed to possess better properties like no direct 
connection between input and output layers, full connection between layers, number of outputs 
need not be equal to number of inputs, there is no limit for number of hidden layers i.e. they can 
be more or less than input and output units. 
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Figure 6.5 A simple feed forward perceptron model 
 
 ADALINE is an acronym for ADAtive LINear Element. Bernard Widrow and Marcian 
Hoff (1960) developed and presented this as single staged network. It is also called as the delta 
rule; the least-mean-squares rule; the Widrow Hoff rule. The binary values for input and output 
were assumed to be -1 and +1 respectively. Adaline possess similar architecture to perceptron, 
but the difference lies in type of learning rule used and thresholding step. These enable the user 
to solve the linearly inseparable problems which is impossible with single layer perceptron. The 
Widrow-Hoff learning (114) is applicable for trained supervisor, it is independent of the 
activation functions of neurons used. The LMS algorithm was proposed for Adaline. It is evident 
from above that training of perceptron requires modification of weights. The delta rule states that 
weights need to be adjusted corresponding to difference between desired and actual output. 
 
6.5.3 Introduction to Back Propagation 
The most widely used search technique for training artificial neural networks is back 
propagation. This can also be termed as “Feed-Forward back-propagation network”. This is a 
Input Units  Hidden Units    Output Units 
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user friendly model which can be understandable and implemented as software simulation. The 
development of the back propagation training algorithm was credited to Werbos (1993), Parker 
(1985) and LeCun (1986).  It is considered as the most widely used learning which is easy to 
implement and train. Rumelhart, Hinton and Williams have made important contributions 
towards the development and analysis of back propagation (115). They have concentrated on the 
improvement of the original back propagation algorithm. The attempts include working on 
different strategies like scaling differentiation, error metric modification, transfer modification, 
architectural restructuring, and constraining the solution set of the problem. 
The Back propagation is a local search technique which is still a popular and successful 
tool. It requires training for conditioning the network before used for processing other data. 
Networks possess one or more hidden layers depending upon the training introduced. Supervised 
training provides preliminary adjustments to the weights associated to organize the patterns 
categorically. Even though BP is most popular optimizing method to train networks it has certain 
limitations like inconsistency and unpredictable performances. The gradient nature of BP could 
be eliminated by using global search techniques which do not depend on their derivatives. There 
are some cases where large networks can take long time to be trained and may not converge to 
solution significantly. The building of neural network ideal to brain is impossible. However we 
can build some simpler artificial neural networks with a suitable transfer function to work almost 
similar to a biological neuron. The functions of neural network built works similar in meaning to 
the human brain. 
The Feed Forward, Back-Propagation architecture (116) was developed in the early 
1970’s by various independent sources (Werbor; Parker; Rumelhart, Hinton and Williams). In 
Feed-Forward propagation, neurons in present layer receive signals from preceding layers which 
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is multiplied by corresponding weights separately. Inputs from one or more previous neurons are 
individually weighted, then summed. The entire uniqueness of the network exists in the values of 
the weights between neurons. For this type of network in order to adjust weights the most 
common learning algorithm is called back propagation (BP).The use of term “Back Propagation” 
appears to be evolved after 1986 when researchers have presented their research of results on 
Parallel Distributed Processing (PDP) models. This synergistically developed back-propagation 
architecture which is most effective and easy to learn model for multilayer networks. Some work 
has been done which indicates that a maximum of five layers, one input layer, three hidden 
layers and an output layer are required to solve problems of complexity. 
6.5.3.1 Training with back propagation 
The problems are classified into training, testing and validation, files in the description of 
data sets. A BP network will search for a solution using the training data, if the error decreases 
during the testing & validation step, the training will discontinue. The researchers believe this 
step is necessary to not over fit a particular function being estimated. The problem of the 
algorithm begins with convergence. It may either converge to local or global solution. If a 
correct objective function is chosen and a global solution is obtained, then there will no such 
problem. Since, BP converges locally this type of NN training seems to be necessary. Learning 
rate (training parameter that controls the size of weight and bias changes during learning) and 
momentum coefficient (used to prevent the system from converging to a local minimum or 
saddle point) are the key factors that will help a network to train. Too low a learning rate makes 
the network learn very slowly. Too high a learning rate makes the weights and objective function 
diverge, so there is no learning at all. In training our networks we set the learning rate as 0.15 
and the momentum as 0.8.  
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6.5.3.2 Back-Propagation Algorithm 
A gradient search technique (117) like BP can provide the user with well recognized 
problem such as escaping local optima. The weights which are initialized randomly during 
training and starting point is located in local valley with high probability. Numerous solutions 
have been proposed to problems like differential scaling, the transfer function etc. assuming 
many different random starting points. A user must be able to choose different parameters to 
apply in neural networks software packages. The parameters include step size, momentum, 
learning rule, normalization technique, random seed etc. to find best combination to solve a 
particular problem. For the training of multilayer feed-forward ANNs, Error-Back propagation 
algorithm plays an important role. Generally the input layer is considered as a just distributor of 
signals from the external world and not taken into consideration as a layer.  
The back propagation training consists of two methods of computation: 
1. A forward pass 
2. A backward pass 
In forward pass an input pattern vector to the units in the input layer basically leads to the 
sensory nodes of the network. The signals from the input layer then propagate to series of layers 
finally producing the output. This process continuous until the signals reach output layer where 
actual response of the network to the input vector is obtained. In the backward pass, the synaptic 
weights are adjusted according to the signal which propagated backwards to the direction of the 
synaptic connections.  
6.5.3.3 Implementing Back Propagation 
The back propagation algorithm can be implemented in two different modes: 
1. On-line mode  
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2. Batch mode 
 In the on-line mode the error function is calculated after the presentation of the input 
pattern and the error signal is propagated back through the network modifying the weights before 
the presentations of the next pattern. The error function is generally the Mean Square Error of the 
difference between the desired and the actual responses of the network. All such presentations of 
such patterns is usually called as an epoch or one iteration. In batch mode the weights are 
modified only when the input pattern have been presented. Then the error function is calculated 
as the sum of the individual MSE for each of the input pattern and weights are modified 
accordingly before the next iteration. 
6.5.4 Error functions 
If a pattern is submitted and its classification or association is determined to be 
erroneous, the synaptic weights as well as the thresholds are adjusted so that the current least 
mean square classification error is reduced. The input - output mapping, comparison of target 
and actual values, and adjustment, if needed, continue until all mapping examples from the 
training set are learned within an acceptable overall error. Usually, mapping error is cumulative 
and computed over the full training set. Error is the measure of the discrepancy between the 
neural network output and the target. The most popular error functions are sum of squares (SSE) 
and cross entropy (CE) among others. 
 
6.5.5 Advantages of Multilayer Perceptrons 
The general characteristics of multilayer perceptrons are generalization and fault 
tolerance.  
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Generalization: Neural networks are capable of classifying unknown patterns with the support of 
known patterns that have some different level of features. This means incomplete inputs will be 
classified because of their similarity with complete inputs. 
Fault Tolerance: Neural networks are highly fault tolerant. This characteristic feature can also be 
termed as “graceful degradation” (118). Hence the neural networks keep on working even if 
some interconnections between some neurons fail. 
 
6.5.6 Limitations of Multilayer Perceptrons 
There are limitations to the feed forward, back propagation architecture. Back-
propagation requires a lot of supervised training, with lots of input-output examples. Sometimes, 
the learning can get stuck in local minima, limiting the best solution. This occurs when the 
network systems finds an error that is lower than the surrounding possibilities but does not 
finally gets to the smallest possible error. In typical feed forward, back-propagation applications, 
the desired output may not be known precisely. In such case the back propagation learning 
cannot be used directly. Examples like include speech synthesis from the text robot arms, 
evaluation of bank loans, image processing etc. 
6.5.7 ANN Modeling  
Neural networks are undoubtedly powerful nonlinear function estimators. As mentioned 
earlier there are several types of ANN architectures. They usually perform prediction tasks at 
least as well as other techniques, if not significantly better. Additionally, building an ANN 
requires minimum domain knowledge in the areas of mathematics and statistics, than does for 
building a logistic regression model. The ANN type used in this study is called a multilayer 
perceptron (MLP) or multilayer feed forward network, which propagates input signals forwards 
and error signals backwards. During the process, the weights are adjusted so that the output 
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grows more accurate. This process is prone to over fitting problems. In order to avoid over 
fitting, a common technique is to train the network with some portion of the data values, and 
then evaluate its performance by testing the trained network with the remaining data values. In 
our ANN modeling we used 70% data for training and remaining 30% data for testing. 
The four ANN models consisted of an input layer, a hidden layer and an output layer. 
Table 6.3 summarizes the specificity, sensitivity and overall accuracy results of the ANN models 
when training. Table 6.4 summarizes the specificity, sensitivity and overall accuracy results of 
the ANN models when testing the trained model. Table 6.5 has the ROC area values for the four 
ANN models. Since training is the key factor for an ANN model, here we will be discussing 
about training results of ANN models. Even in this case, the results showed that the overall 
accuracy jumps from 71.12% for model-3 to 82.80% for model-4 for the same reason as 
mentioned earlier. The ANN model-1 yielded a ROC area of 72.1%, and sensitivity to survival of 
95% gave a specificity of only 31%, model-2 with a ROC area of 73.1% and sensitivity to 
survival of 95% has a specificity of 32%. For the remaining two models the ROC area is 73.8% 
and 87.4% respectively and the sensitivity to survival of 95% has a specificity of 39% and 66% 
respectively. Comparing these results with logistic models, at a 95% sensitivity, ANN has a 
better specificity for all the four models. Table 6.5 gives the details about architecture and ROC 
area of ANN models and their respective ROC graphs of the four ANN models are given in 
Figure 6.7. The output of ANN will be a composite function of the form  
𝑦𝑖 = 𝑓 {∑ 𝑡𝑎𝑛ℎ (∑(⦁))} ;  𝑖 = 0,1;   
𝑓(⦁) 𝑖𝑠 𝑎 𝑠𝑜𝑓𝑡𝑚𝑎𝑥 𝑓𝑢𝑛𝑐𝑡𝑖𝑜𝑛 𝑎𝑛𝑑 𝑡𝑎𝑛ℎ(⦁)𝑖𝑠 𝑎 ℎ𝑦𝑝𝑒𝑟𝑏𝑜𝑙𝑖𝑐 𝑡𝑎𝑛𝑔𝑒𝑛𝑡 𝑓𝑢𝑛𝑐𝑡𝑖𝑜𝑛 
 
 141 
 
Table 6.3 Sensitivity, specificity and overall results of ANN training 
ANN 
Models 
Sensitivity (%) Specificity (%) Accuracy 
(%) Value 95% C.I Value 95% C.I 
ANN 1 66.78 (65.70, 67.83) 70.76 (70.19, 71.31) 69.85 
ANN 2 67.25 (66.19, 68.27) 71.48 (70.91, 72.03) 70.46 
ANN 3 68.23 (67.20, 69.23) 72.08 (71.51, 72.63) 71.12 
ANN 4 88.95 (88.27, 89.59) 80.60 (80.09, 81.09) 82.80 
 
 
Table 6.4 ANN models architecture and ROC values 
ANN 
Models 
Architecture 
ROC 
At 95% 
sensitivity 
I – H - O 
Specificity 
ANN-1 2 – 7 – 2 72.1% 30% 
ANN-2 6 – 3 – 2 73.1% 32% 
ANN-3 10 – 6 – 2 73.8% 39% 
ANN-4 11 – 3 – 2 87.4% 66% 
 
Table 6.5 Sensitivity, specificity and overall results of ANN testing 
ANN 
Model 
Sensitivity (%) Specificity (%) 
Accuracy 
(%) value 95% C.I value 95% C.I 
ANN 1 66.18 (64.52, 67.80) 70.66 (69.79, 71.51) 69.63 
ANN 2 68.66 (67.08, 70.20) 72.00 (71.14, 72.84) 71.20 
ANN 3 66.87 (65.26, 68.43) 71.89 (58.27, 59.97) 70.67 
ANN 4 89.36 (88.32, 90.32) 80.97 (80.20, 81.72) 83.20 
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Figure 6.6 ROC graphs for four ANN models 
 
 
6.6 Decision Tree Classification 
Data mining tools are proved to be successful in field of medical diagnosis. The 
combination of both data mining tools along with decision trees is popular and effective 
classification approach which provides understandable and clear classifications rules that transfer 
knowledge to physicians and medical specialists. Data mining methods help to reduce the false 
positive and false negative decisions (129-131). This is one of the actively employed techniques 
that provide promising results in the breast cancer diagnosis.  
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 A decision tree can be stated as the classification tool or classifier for determining 
appropriate action for the given situation. A simple decision tree consists of a root node (parental 
node), internal nodes or test nodes, and leaf nodes (terminal nodes or decision nodes). The final 
decisions for the target class are obtained on the leaf nodes from performing split test in the 
internal nodes. In complex cases, the leaf node possesses a probability vector for the target value 
of certain case (132). A simple decision tree classifying survival of breast cancer patients with 
treatment as an attributable variable is given below Figure 6.7.  
 
 
  
 
 
 
Decision tree usually consists of nominal and/or continuous attributes. In case of nominal 
attributes, one outcome is assigned for the target value whereas for continuous attributes there 
will be threshold which has two outcomes, one for each classified interval based on the 
conditions imposed by the fixed threshold. A more comprehensible decision trees are typically 
less complex preferred by the decision makers. Each designated path of the decision tree from 
root to leaf can be transformed into a rule by computing tests along the path which assign class 
prediction to terminal node. These predictions are termed as the class values.  
Figure 6.7 Simple Decision Tree example 
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6.6.1 Framework of Decision Trees: Algorithm 
Decision tree accuracy is affected by the total number of nodes, depth of the tree, total 
number of leaves and number of attributes used. The complexity is controlled explicitly by the 
stopping criteria used and pruning methods employed. The objective of the decision trees is to 
find the optimal decision tree by minimizing the general errors. In order to solve heuristic 
problems with large data sets decision tree inducers with growing and pruning are being actively 
employed.  The algorithms employed follow the concept of “divide and rule” in evaluating for 
the final optimal decision tree. In the foregoing process, partition of the training sets is executed 
based in the values of the discrete attributes. The appropriate function is selected based on the 
splitting measures. After the selection, nodes are further divided into subsections to carry out 
similar splitting procedures or stopped when the criteria is satisfied (133, 134).  
6.6.2 Splitting Techniques 
Decision trees are most commonly univariate splitting i.e., they make splitting measures 
based on the single attribute at each internal node. But, the inducer searches for the best attribute 
at internal node upon splitting. Various criteria contain measures for the splitting procedures to 
be executed. The splitting procedures are employed in different ways based on the originating 
measure (includes information theory, dependence and distance) and based on the measure of 
structure (impurity based criteria, normalized impurity based criteria, and binary criteria) more of 
which can be found in data mining books (135). In case of univariate splitting, many researchers 
claim that the choice of splitting criteria does not make much difference on the performance of 
the tree.  
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 Accordingly in the literature multivariate splits have been extensively employed in case 
complex decision making situations. The frame work for these splits is not well known as that of 
univariate splits. Several attributes are involved in the single node split test at each internal node. 
Generally, multivariate splits are based on the linear combination of the input variables. The 
problem of finding the optimal linear split is much more difficult than that of the univariate split. 
Methods used for finding optimal split include greedy search method (136), linear programming 
(137), linear discriminant analysis (138), and many others. 
6.6.3 Stopping Criteria 
All the decision trees require stopping criteria otherwise it would be an undesirable to 
grow a tree which occupies its own node. This would lead to expensive computation and 
difficulty in interpretation. Rules for stopping the growing phase are discussed below.  
1. Number of cases in the node is less than the pre-indicated value. 
2. The depth of the node should not exceed more that predefined or maximum value. 
3. The number of cases in the terminal nodes is less than the minimum number of cases for 
parent nodes. 
4. The best splitting should not exceed a certain threshold limit set. 
5. Predictor values for all records are identical – no further rule for splitting is computed. 
6.6.4 Pruning Methods 
Early studies have proved stopping criteria degrade the performance of tree. This might 
create small and under fitted trees or over-fitted trees depending on situations. Hence, an 
alternative method for stopping growth is to allow the tree to grow and prune back to the 
optimum size using certain pruning methods. Pruning methods gained importance based on 
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trading accuracy for simplicity. It has improved the generalized performance of the decision tree 
especially in noisy circumstances (139). There are various techniques for pruning the trees 
include cost-complexion, reduced and minimum error, pessimistic, optimal etc.  
6.6.5 Decision Tree Inducers 
The approach of induction is to develop a decision tree from set of examples. Various 
techniques like ID3, C4.5, Classification and regression trees (CART or CRT), chi-squared 
automatic interaction detector (CHAID), Quick, unbiased, efficient, and statistical tree (QUEST) 
and many others are actively employed based on the attributes.  For large data sets two methods 
developed have been popularly employed namely the Catlett method and SLIQ algorithm. 
Further advancements and extensions for decision trees like oblivious trees (140), fuzzy decision 
trees, and incremental induction (141) can be found in the literature. Here in this chapter we will 
construct decision trees based on CHAID and CRT methods and choose the best performing 
method. 
6.6.6 Chi-squared Automatic Interaction Detector (CHAID) 
CHAID is a type of decision tree technique, based upon adjusted significance testing 
(Bonferroni testing). It is one of the oldest tree classification methods originally proposed by 
Kass (1980; according to Ripley, 1996, the CHAID algorithm is a descendent of THAID 
developed by Morgan and Messenger). . CHAID algorithm only accepts nominal or ordinal 
categorical predictors. When predictors are continuous, they are transformed into ordinal 
predictors before using the following algorithm. After the merging of the continuous and 
categorical variables adjusted p-value is computed using Bonferroni adjustments (14). P-value 
decides further merging operation if needed or not. 
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6.6.7 Classification and Regression Trees (CART) 
CART algorithm was introduced in Breiman in 1986. These trees are characterized by the 
construction of binary trees implies that each external nodes consists of exactly two outgoing 
edges. It generates a regression model when the target variable is continuous else a classification 
model in case of categorical variables. In case of regression models, the CART looks for the 
splits that minimize the prediction square error (8). The prediction is based on the mean value of 
the target attribute of the rows falling under the terminal leaf node. The present research studies 
have employed these two methods which appeared to give better results compared to other 
evaluation methods. 
6.6.8 Advantages and Disadvantages 
Decision trees were pointed as good classification tools in literature due to its self-
explanatory nature and easy to understand and interpretation behavior. It takes into consideration 
both numerical and nominal input attributes. They have the capability to handle and deal with 
large datasets and datasets with large amount of errors. The predicted performance is proved to 
be much higher and better than traditional methods like neural networks, logistic methods etc. 
 Decision trees also possess certain disadvantages which include its sensitiveness to small 
changes in input data can alter the nature of trees. Most of the algorithms accept only discrete 
variables (like ID3 and C4.5). Decision trees perform well if few highly relevant attributes are 
present and less if more complexions interactions exists. 
6.6.9 Modeling using Decision Trees 
Table 6.6 summarizes the specificity, sensitivity and overall accuracy results of the four 
decision tree models using both CHAID and CRT based methods. Table 6.7 has the ROC area 
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values for these models. The results showed that the overall accuracy jumps from 71.10% for 
model-3 to 82.6% for model-4 in a CHAID decision tree. Similarly for a CRT based decision 
tree the accuracy jumps from 70.9% for model-3 to 83.2% for model-4. As noticed in both 
logistic and ANN models, duration under study for a woman with breast cancer, during the study 
period has a lot of importance for predicting accurate survival.  
For CHAID based decision tree the ROC for model-1 covered an area of 72%, and 
sensitivity to survival of 95% gave a specificity of only 22%, model-2 with a ROC area of 73.2% 
and sensitivity to survival of 95% has a specificity of 25%. For the remaining two models the 
ROC area is 73.6% and 87.6% respectively and the sensitivity to survival of 95% has a 
specificity of 29% and 62% respectively. The results of model-4 decision tree with overall 
accuracy of 82.6% along with 80.14% specificity, 89.67% sensitivity and 62% specificity at 95% 
sensitivity are often desirable. The sensitivity and specificity of all the four models with their 
respective confidence intervals are given in Table 6.6.  For computing confidence intervals for 
sensitivity and specificity see Altman et al. The ROC graphs of CHAID based decision tree 
models are given in Figure 6.9. 
The results of CRT based decision tree models reported a ROC of 71.9% for model-1, 
and sensitivity to survival of 95% gave a specificity of only 24%, model-2 with a ROC area of 
72.8% and sensitivity to survival of 95% has a specificity of 29%. For the remaining two models 
the ROC area is 72.7% and 87.4% respectively and the sensitivity to survival of 95% has a 
specificity of 28% and 62% respectively. The results of model-4 CRT decision tree with overall 
accuracy of 82.2% along with 79.86% specificity, 93.62% sensitivity and 62% specificity at 95% 
sensitivity are often desirable. The sensitivity and specificity of all the four models with their 
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respective confidence intervals are given in Table 6.6.  For computing confidence intervals for 
sensitivity and specificity see Altman et al. The ROC graphs of CRT based decision tree models 
are given in Figure 6.8. 
CHAID uses multi way splits by default (meaning that a given current node is split into 
more than two nodes), whereas CRT does binary splits (meaning each node is split into two sub-
nodes only). This difference between CRT and the CHAID has even an effect on the tree structures. 
In case of CHAID, trees sometimes look more like bushes. CHAID has been especially popular in 
marketing and medical research, where segmentation or classification has many major applications. 
Few more differences are listed below: 
 CHAID uses a p-value from a chi-square significance test to measure the desirability of a 
split, while CRT uses the reduction of an impurity measure.  
  CHAID searches for multi-way splits, while CRT performs only binary splits.  
 CHAID uses a forward stopping rule to grow a tree, while CRT deliberately over fits and 
uses validation data to prune back. 
 CHAID tree output is simple, short and easy to interpret, while CRT has a larger tree 
structure. 
Finally, one may prefer CHAID when the goal is to classify or understand the relationship 
between a response variable and a set of explanatory variables, whereas CRT is better suited for 
creating a regression model. In view of this, in this chapter we will choose CHAID over CRT for 
survival classification of breast cancer woman. 
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 Table 6.6 Sensitivity, specificity and overall results of Decision trees 
Training 
 Sensitivity Specificity Accuracy  
(%)  Value 95% CI Value 95% CI 
Model 1 
CHAID 64.77 (63.73,65.8) 71.12 (70.60,71.73) 69.6 
CRT 66.83 (65.74,67.91) 70.75 (70.19,71.30) 69.9 
Model 2 
CHAID 69.33 (68.27,70.37) 71.21 (70.65,71.76) 70.8 
CRT 69.2 (68.14,70.24) 71.2 (70.63,71.74) 70.7 
Model 3 
CHAID 67.59 (66.58,68.59) 72.25 (71.69,72.81) 71.1 
CRT 66.22 (65.22,67.21) 72.64 (72.07,73.20) 70.9 
Model 4 
CHAID 89.67 (89.00,90.30) 80.14 (79.63,80.63) 82.6 
CRT 93.62 (93.05,94.14) 79.86 (79.35,80.35) 83.2 
Testing 
 Sensitivity Specificity Accuracy 
(%)  Value 95% CI Value 95% CI 
Model 1 
CHAID 63.66 (62.07,65.22) 71.22 (70.35,72.09) 69.3 
CRT 67.33 (65.66,68.97) 69.69 (68.83,70.55) 69.2 
Model 2 
CHAID 68.63 (66.97,70.24) 71.27 (70.40,72.12) 70.7 
CRT 67.24 (65.56,68.87) 70.82 (69.95,71.67) 70 
Model 3 
CHAID 66.32 (64.75,67.85) 72.19 (71.31,73.04) 70.7 
CRT 65.11 (63.55,66.65) 71.42 (70.54,72.28) 69.8 
Model 4 
CHAID 88.2 (87.10,89.21) 80.38 (79.61,81.14) 82.4 
CRT 94.02 (93.19,94.76) 79.93 (79.16,80.69) 83.2 
 
 
Table 6.7 ROC of Decision tree using CHAID and CRT 
 CHAID CRT 
Model-1 72.0% 71.9% 
Model-2 73.2% 72.8% 
Model-3 73.6% 72.7% 
Model-4 87.6% 87.4% 
 
6.7 Performance Evaluation of models 
In the context of predictive binary classification models, one of four outcomes is possible: (a) 
a true positive (TP) – i.e., a survived subject is classified as “survived”; (b) a false positive (FP) 
– i.e., a not survived subject is classified as “survived”; (c) a true negative (TN) – i.e., a not 
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survived subject are classified as “not survived”; (d) a false negative (FN) – i.e., a not survived 
subject is classified as “survived”.  
The central concern of implementing different modeling applications in this chapter is to 
identify which of the proposed techniques are actually improving predictive accuracy.  An 
improvement of even a fraction of a percent can translate into significant savings or increased 
revenue.  
The performances of logistic, ANN and decision tree models in this chapter are evaluated 
based on the sensitivity, specificity, overall accuracy, and the area under curve values of each 
model. Sensitivity is the proportion of true positives that are correctly identified by the model. 
Specificity is the proportion of true negatives that are correctly identified by the model.  
 CHAID CRT 
Model-1 
  
Model-2 
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Model-3 
  
Model-4 
  
 
Figure 6.8 ROCs of Decision trees using CHAID and CRT 
In other words, sensitivity refers to how good is the designed model is at correctly identifying 
women who are dead with breast cancer and specificity refers to how good the designed model is 
at correctly identifying women who have survived breast cancer (119). However, as a matter of 
fact, reporting a high sensitivity is not necessarily a good thing, but it’s the specificity, which 
should not be worse, which in turn can conclude the designed model as useless (120). Also, we 
will compare the area under the ROC curve, which is a convenient way to compare different 
predictive binary classification models when the analyst or decision maker has no information 
regarding the costs or severity of classification errors. According to Thomas (2000), this 
measurement is equivalent to the Gini index and the Mann-Whitney-Wilcoxon test statistic for 
comparing two distributions (Hanley and McNeil) and is referred in the literature in many ways, 
including AUC or AUCROC values.  
 153 
 
Many research studies have exhibited the importance of ANNs, decision trees, logistic 
regression as predictor and classification tools in field of medical diagnosis. The works are 
extended in the risk prediction in a variety of cancers like breast (121), prostate (122), liver 
(123), ovarian (124), cervical (125), bladder (126), and skin cancer (127).  
We will compare the results of four logistic models with the results of four ANN models 
and decision tree models. The analytical description of designed neural network or the internal 
working of the ANN models will not be our point of concentration however we will treat them as 
black box which intakes input data and gives us the output. 
Table 6.8 has the performance evaluation of logistic, ANN and decision tree techniques. 
The overall accuracy for correct classification of survival of breast cancer women is almost the 
same in ANN and decision tree techniques compared to logistic. However the specificity of the 
model performance for logistic is slightly more than the ANN and decision trees. The ranking of 
these methods based on their classification performances are also tabulated in Table 6.8. The 
area under the curve ROC values of decision tree methods is slightly more compared to ANN 
and logistic regression methods. Table 6.9 has the details of comparing ROCs of the three 
different methods employed in this chapter with their ranking based on high ROC values.  
Table 6.8 Performance Comparison of Logistic, ANN and Decision tree 
 Overall Accuracy Specificity 
Model LR ANN CHAID LR ANN CHAID 
  Train Test Train Test  Train Test Train Test 
1 69.2 69.85 69.63 69.6 69.3 69.45 70.76 70.66 71.17 71.22 
2 69.78 70.46 71.2 70.8 70.7 70.47 71.48 72 68.63 71.27 
3 70.42 71.12 70.67 71.1 70.7 71.26 72.08 71.89 72.25 72.19 
4 79.98 82.31 81.95 82.6 82.4 81.54 79.76 79.22 80.14 80.4 
Rank III II I I III II 
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Table 6.9 ROCs of all methods 
Models LR ANN DT 
Model-1 68.8% 72.1% 72.0% 
Model-2 71.0% 73.1% 73.2% 
Model-3 71.8% 73.8% 73.6% 
Model-4 85.5% 87.4% 87.6% 
Rank III II I 
 
 
 
LR-Logistic Regression; ANN-Artificial Neural Network; DT-Decision tree 
Figure 6.9 Comparison of overall accuracy of LR and ANN models 
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LR-Logistic Regression; ANN-Artificial Neural Network; DT-Decision tree 
Figure 6.10 Specificity comparison of LR and ANN models 
 
 
Figure 6.11 Comparison of ROCs graphically for the three methods 
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6.8 Conclusion and discussion 
For maintaining consistency in comparing the models, we initially compared the accuracy 
of logistic distribution and accuracy in ANN and decision tree models in classification of 
survival of breast cancer data. Further we calculated the receiver operating characteristic (ROC) 
curves, compared them visually and calculate the area under the curve for comparison (121). The 
graph of comparison of three methods based on ROCs is given in Figure 6.11. Model-4 using the 
inputs including age, tumor size, stage of cancer, treatment and duration performed well by 
logistic, ANN and decision tree methods. The accuracy of classification for LR, ANN and DT 
models is recorded as 79.98%, 82.31% and 82.6%.  We find no much difference in these values 
for ANN and DT methods. However, at 95% sensitivity ANN has reported a better specificity 
compared to logistic and DT models. Using ROC analysis as a measure of discriminating ability 
of logistic, ANN and decision tree models we have not found convincing proof that the use of 
ANN model or decision tree models in general would increase the quality of the statistical 
studies that use traditional tools such as logistic regression models. 
In the present study, the effects of factors like age, tumor size, stage of cancer, treatment, 
and on the survival of a woman with breast cancer were designed. Four models for logistic and 
four models of ANN trained with gradient descent and four models of DT based on CHAID 
algorithm have been evaluated. The degree of generalization or the precision of predictive ability 
was measured for each logistic model, ANN model, decision tree model and  their predictive 
abilities were in the order of model-4 > model-3 > model-2 > model-1.  
As mentioned earlier, there is no significant difference in performance between LR, ANN 
model and decision tree models as measured by area under the ROC curve. Though all of them 
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have almost same area under curve, the shapes of these curves were different. i.e., at a fixed 
sensitivity, ANN’s and decision trees had higher specificity compared to LR. Figure 6.11 depicts 
this fact.  
In summary, it is hard to draw general conclusions regarding the performance or 
superiority of one model over the other on the basis of findings presented in this chapter or 
elsewhere, since the results for each of these studies are based on the specific kind of interest. 
Each model has its advantages, and the selection of a model should be based on these advantages 
and the intended purpose of the study. In this study, we conclude that ANN model-4 and decision 
tree model-4 has a better predictive probability compared to logistic model and can be used as 
the best for the modeling and prediction of breast cancer survival. 
Well-performing ANN models can be used for predictions when there is an unknown 
nonlinear relation between the independent variables and the dependent variables that is not well 
understood by other tools like logistic regression. 
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CHAPTER SEVEN  
Conclusion and Future work 
 
In this chapter we shall pose some possible extensions of the present research. This 
chapter stands on the foundations built on Chapters 2, 3, 4, 5 and 6. We make necessary 
connections between the methods employed in those chapters and report on ongoing work that 
could not be included in this thesis.  
In chapter two, we have used the Inverse Gaussian (IG) distribution for statistical 
modeling of the breast cancer tumor sizes for the three race women. At the end of this chapter 
grouping ages into groups of 5, we also stratified the number of women diagnosed with breast 
cancer in different stages. As a future research, it would be of interest to develop a 
statistical/mathematical model that identifies categorized age as the independent variable and 
tumor size as the response variable. Having established such models which may be non-linear in 
nature with a high degree of accuracy, namely, high R2 and adjusted R2 we can further proceed 
to calculate the rate of change of tumor size along with age.  
As a part of future research we plan to focus on the use of the kernel density estimation 
method. In case if we do not have enough information to fit the probability distribution of the 
parameters which behave as a random variable, we can proceed to investigate the applicability of 
the kernel density estimation method to obtain the density function of the parameters. 
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In chapters three and four, we have used the family of generalized extreme value 
distribution and log-logistic models to statistically model the survival of breast cancer women 
utilizing the available predictor variables for predictive purposes. As the part of future research, 
if we are given with more relevant information on breast cancer such as family history, age at 
first live birth, drinking and smoking habits, etc. we can be able to provide more compressive 
understanding of breast cancer. As a matter of fact, with the increased number of highly 
attributable variables and very handy software programs, it is of paramount importance that a 
survival model, incorporating such covariates be developed for more accurate and appropriate 
results of prediction. 
For the problem of breast cancer stage classification and classification of survival or 
otherwise of breast cancer woman we proposed artificial neural network approach in chapters 
five and six. There are many areas of research that can be explored further based on the findings 
from these chapters. Some specific ideas for future research are listed below: 
o The neural network parameters needs a random initializations of weights and 
biases Failing to declare proper initial values can in turn reduce the chances of 
proper training of network. Our proposal is to identify a relation, if any, that 
define neural network parameters such as weights and biases in terms of 
regression coefficients in statistical modeling.  
o Try to identify and explore the black box nature of ANNs. 
o Examine other network parameters that influence ANN performance, such as the 
activation function, number of hidden layers, number of epochs, learning rate, etc. 
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o To identify if there is any relationship between number of hidden layers, number 
of hidden units in each hidden layer and the output function of the network. This 
can mainly help us to reduce the training time. 
o Evaluate the application of different activation functions mathematically and 
statistically to identify their ability to provide robust results. 
o Linking ANNs, regression, differential equations and implementing them in 
applications of biological systems. 
Finally, the methods used in the current study could be implemented in the study of other 
types of cancers in providing important information on treatment and survival of cancer patients. 
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